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Summary 
Since in trypanosomes most protein-coding genes are constitutively transcribed by RNA 
polymerase II in a polycistronic manner, gene expression is mainly regulated at the post-
transcriptional level. It is therefore interesting to investigate the relevant regulatory factors. 
In a previous genome-wide tethering screen hundreds of putative mRNA-fate regulators 
were found, including the proteins BFR1L, an up-regulator of gene expression, and ZC3H5, 
a down-regulator of gene expression. 
BFR1L has some similarities to yeast Bfr1p, an ER- and polysome-associated protein. 
BFR1L displays in vivo mRNA binding although it lacks canonical RNA-binding domains. 
Double-knockout bloodstream form trypanosomes displayed a slight growth defect. By 
immunofluorescence microscopy, a tagged version was located in the cytoplasm and 
overlapped partially with an ER marker. RNA pull-down analysis suggested that most of the 
BFR1L-bound mRNAs encode ribosomal proteins, but no common RNA motif could be 
found by in silico analysis. The mRNAs encoding ribosomal proteins are known not to 
sequester in granules upon starvation stress or heat shock. Similarly, BFR1L protein did not 
go to granules under starvation stress. It is tempting to speculate that the interaction 
remains active during stress, and targeting of the mRNAs to the ER could prevent 
sequestration into granules and could keep the mRNAs in ribosomes. The attachment of 
BFR1L to the ER could be mediated via the putative interaction partner Tb927.9.9550, 
which has a transmembrane domain. 
ZC3H5 knock-down led to a fast growth defect, killing the cells after 48 h of RNAi induction. 
We therefore analyzed the RNAi effect on growth kinetics, protein levels, nuclei/kinetoplasts 
ratios and the transcriptome at different time points. After RNAi induction, the proportion of 
2N2K cells increased rapidly. In addition, the ZC3H5 RNAi cells often possessed abnormal 
and higher numbers of nuclei and kinetoplast. While short-term down-regulation of ZC3H5 
showed only a minor effect with respect to the transcriptome, an increase of mRNAs 
encoding ribosomal proteins, the increase of the monosomal peak without an increase of 
mRNAs in this fraction, the occurrence of half-mers as well as an increase of mRNAs 
encoding ribosomal proteins in the free fraction were observed with respect to the polysomal 
profiles. This suggest that the ribosome assembly is disturbed upon knock-down of ZC3H5. 
However, this seems to be a secondary effect. RNA pull-down analysis suggested that 
ZC3H5 binds mRNAs encode cytoskeleton proteins. Tandem Affinity Purification of ZC3H5 
followed by MS analysis revealed three putative interaction partners which were validated 
by co-immunoprecipitation (Tb927.8.1500, Tb927.7.3040 and Tb927.11.4900). In addition, 
tethering of ZC3H5 and its interaction partners to a CAT reporter showed that the proteins 
are repressors; thus, we have identified a novel repressor complex that may regulate genes 
required for cell cycle progression. The exact mechanism of action is not known at the 
moment, but it is tempting to speculate that the function of Tb927.11.4900 as a G protein is 
responsible for the association and dissociation of the complex. This could be cell cycle 
dependent, because the target mRNAs peak in S-phase. Maybe the ZC3H5 complex 
represses its targets during the rest of the cell cycle and targets are de-repressed in S-
phase to produce the proteins needed for cytokinesis. 
XIV 
Zusammenfassung 
In Trypanosomen werden die meisten Protein-kodierenden Gene konstitutiv durch die RNA 
Polymerase II transkribiert. Deswegen wird die Genexpression hauptsächlich durch post-
transkriptionelle Mechanismen reguliert, was die Untersuchung relevanter regulatorischer 
Faktoren interessant macht. In einem vorangegangenen „tethering screen“ wurden 
hunderte mögliche Regulatoren identifiziert, einschließlich BFR1L, welches die Gen-
expression hochreguliert, und ZC3H5, welches die Geneexpression herunterreguliert. 
BFR1L hat Ähnlichkeiten zu dem Hefeprotein Bfr1p, welches mit dem ER und Polysomen 
assoziiert. BFR1L kann in vivo an mRNA binden, obwohl es keine kanonische RNA-
bindende Domäne besitzt. Das Ausschalten von BFR1 in der Blutstromform von 
Trypanosomen führt zu einem leichten Wachstumsdefekt. Per Immunfluoreszenz-
mikroskopie konnte gezeigt werden, dass sich BFR1L im Zytoplasma befindet und teilweise 
mit einem ER-Marker überlappt. RNA Pull-Down Analysen deuten darauf hin, dass BFR1L 
hauptsächlich mit mRNAs, welche für ribosomale Proteine kodieren, interagiert. Mittels in 
silico-Analyse konnte jedoch kein übereinstimmendes RNA-Motiv unter den präferenziell 
gebundenen mRNAs gefunden werden. mRNAs, die für ribosomale Proteine kodieren, sind 
bekannt dafür, dass sie nicht in Stress- oder Hitzeschock-induzierten Granula 
akkumulieren. Ebenso befindet sich BFR1L unter Stressbedingungen nicht in diesen 
Granula. Daher wird vermutet, dass die Interaktion zwischen BFR1L und seinen 
interagierenden mRNAs auch unter Stressbedingungen aktiv bleibt, BFR1L die mRNAs 
zum ER rekrutiert und somit die Akkumulierung der mRNAs in Stressgranula verhindern 
könnte. Die Bindung von BFR1L zum ER könnte durch den möglichen Interaktionspartner 
Tb927.9.9550, welcher eine Transmembrandomäne hat, vermittelt werden. 
Das Herunterregulieren von ZC3H5 führte zu einem rapiden Wachstumsdefekt, was die 
Zellen innerhalb von 48 Stunden tötet. Es konnte festgestellt werden, dass die Menge an 
Zellen mit 2 Nuklei und 2 Kinetoplasten nach der Herunterregulierung rapide anstieg und 
die Zellen oft generell eine erhöhte Anzahl an Nuklei und Kinetoplasten besaßen. Das 
Transkriptom zeigte bei kurzzeitiger Herunterregulierung von ZC3H5 einen Anstieg von 
mRNAs, welche für ribosomale Protein kodieren, und wurde ansonsten kaum beeinflusst. 
Hinsichtlich des Polysomen Profils konnte ein Anstieg der Monosomendichte, jedoch ohne 
gleichzeitigen Anstieg der mRNA Menge in dieser Fraktion, das Auftreten von „half-mers“ 
und dem Anstieg von mRNAs, welche für ribosomale Proteine kodieren, in der freien 
Fraktion beobachtet werden. Dies lässt vermuten, dass es ich um einen Defekt in der Zu-
sammensetzung von Ribosomen handelt, was vermutlich ein sekundärer Effekt ist. Eine 
RNA-Pull-Down Analyse zeigte, dass ZC3H5 mit mRNAs interagiert, welche für Proteine 
des Zytoskeletts kodieren. Tandem-Affinitätsaufreinigung gefolgt von massenspektro-
metrischer Analyse konnte eine Interaktion von ZC3H5 mit drei potentiellen Proteinen 
zeigen (Tb927.8.1500, Tb927.7.3040 und Tb927.11.4900). Außerdem konnte gezeigt 
werden, dass alle vier Proteine die Genexpression eines Reporters herunterregulieren. Dies 
zeigt, dass ein neuer repressiver Komplex identifiziert wurde, welcher eventuell Gene 
reguliert, die eine Rolle im Fortschreiten des Zellzyklus spielen. Es wird vermutet, dass die 
Funktion von Tb927.11.4900 als G-Protein für die Assoziation und Dissoziation des 
Komplexes verantwortlich ist. Dies könnte abhängig vom Zellzyklus passieren, da die 
mRNAs, welche mit ZC3H5 interagieren, vermehrt in der S-Phase zu finden sind. Eventuell 
hemmt der ZC3H5-Komplex die mRNAs während des restlichen Zellzyklus, doch während 
der S-Phase, wenn der Komplex dissoziiert, können die mRNAs translatiert werden und die 
Proteine, welche für die Zytokinese benötigt werden, werden produziert. 
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1. Introduction 
1.1. Trypanosomes- disease and model organism 
Trypanosomes are single-celled eukaryotes, which belong to the order Kinetoplastida. They 
are spindle-shaped cells with a size from 8 to over 50 µm and a diameter of 1.5-3.5 µm 
depending on the life cycle stage (Uilenberg, 1998). The procyclic form found in the midgut 
of the Tsetse fly vector and the bloodstream form multiplies in mammalian blood and tissue 
fluids. The African trypanosomes, Trypanosoma brucei rhodesiense and Trypanosoma 
brucei gambiense, can cause the human disease African sleeping sickness 
(trypanosomiasis), which is transmitted by the Tsetse fly. It is estimated that 55 million 
people are at risk of the disease in sub-Saharan Africa, since the Tsetse fly infests 350000 
km2 of the landmass of Africa (Franco et al., 2017). However, the number of reported 
annually HAT cases decreased rapidly in the last decade with only 3797 new cases in 2014 
(Franco et al., 2017). If sleeping sickness is not or inadequately treated, it is usually lethal 
and is thereby a cause of morbidity and mortality in sub-Saharan Africa. However, for 
treating the disease only a few drugs are known. Some of them suffer from poor efficacy or 
contain toxic arsenic derivates leading to sever side effects (Field et al., 2017). In cattle, 
trypanosomiasis leads to a decrease in meat and milk production. Furthermore, the animals 
cannot act as draught animals in crop cultivation anymore.  
Besides the relevance of Trypanosomes as pathogenic parasites, they are an interesting 
model organism. They diverged early from the Opisthokonts, sharing the common features 
of eukaryotes, but also having special features (Adl et al., 2019). They have all the 
conventional organelles of a eukaryotic cell, like a nucleus, lysosomes, endo- and 
exocytosis system, Golgi and endoplasmic reticulum (ER) (Figure 1.1) (Clayton et al., 
1995). One peculiarity is the single mitochondrion with the mitochondrial genome that has 
a disc like structure composed of maxi- and minicircles (Shapiro and Englund, 1995; 
Simpson, 1987). This structure is called the kinetoplast, which gave the name to the 
Kinetoplastida. Interestingly, the mitochondrial RNA encoded in the maxicircles is edited by 
insertions and deletions of uridines by the editosome (Liu et al., 2005; Panigrahi et al., 
2006). However, the function of the mitochondrion differs in the two life cycle stages. In the 
bloodstream form, where the cells are in an environment with high glucose, the function of 
the mitochondrion is repressed, because the energy is mostly obtained by glycolysis. Most 
of the glycolytic enzymes can be found in another specific feature: the glycosomes (Michels 
et al., 2006; Opperdoes et al., 1984). In contrast to that, the procyclic form obtains the 
energy by oxidative phosphorylation of amino acids (Bringaud et al., 2006). Another 
peculiarity is the single flagellum that runs along the trypanosome. It exits near the posterior 
end from the flagellar pocket, which is in addition the place of endo- and exocytosis. The 
trypanosomes can move with the help of the flagellum, which is crucial for their viability 
Figure 1.1: The structure and 
morphology of T. brucei. 
Generalized cellular structure of the 
bloodstream form. Figure taken 
from: (Overath and Engstler, 2004). 
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(Broadhead et al., 2006). In addition, the flagellum plays a role in the attachment to the host 
surface and in the morphogenesis and cytokinesis (Kohl et al., 2003). Trypanosomes major 
surface proteins make up approximately 10% of the total protein content of the cell and are 
GPI-anchored. In the bloodstream form the variant surface glycoprotein (VSG) is 
expressed. The expression of VSGs undergoes antigenic variation, which ensures that only 
one VSG isoform is expressed at one time. This switching helps the cells to evade from the 
host immune response (Hovel-Miner et al., 2015).  
1.2. The life cycle of Trypanosoma brucei 
The whole life cycle is illustrated in figure 1.2 (Langousis and Hill, 2014). By having a blood 
meal on an infected host, the Tsetse fly can take up trypanosomes. The non-dividing short 
stumpy form is pre-adapted for the survival in the midgut of the fly, where it differentiates 
into the procyclic form (Matthews, 1999). This transformation includes many changes: in 
cell metabolism from glycolysis to oxidative phosphorylation (Matthews, 2005), in 
cytoskeleton architecture, functioning of the organelles and switching of the surface proteins 
from VSG to procyclins (Ziegelbauer and Overath, 1990). The procyclic trypanosomes can 
then migrate along the foregut to the proventriculus where they divide asymmetrically to 
make long and short epimastigotes (Figure 1.2 B). In this stage the parasites express the 
surface protein BARP (Ziegelbauer and Overath, 1990). The short epimastigotes will then 
migrate to the salivary glands and differentiate into non-dividing metacyclic trypomastigotes 
with a VSG coat on their surface. This form can then by transmitted to the mammalian host 
by another bloodmeal of the Tsetse fly (Matthews, 2005). In the tissue of the mammalian 
host, the metacyclic trypomastigotes differentiate into long slender trypomastigotes, which 
multiply and start to invade the lymph nodes through the lymphatic system. From there they 
establish the bloodstream infection. As soon as the levels of parasitemia increase a quorum 
sensing mechanism triggers the differentiation of long slender bloodstream form to the short 
stumpy form (Matthews, 2005).  
Figure 1.2: The life cycle of T. 
brucei and its migration within 
the host. A. Developmental cycle 
of the parasite. B. Parasite’s 
migration within the tsetse fly from 
the midgut to the salivary glands is 
shown with blue lines and further 
movement from there to the 
proboscis is indicated with red 
lines. Figure from: (Langousis and 
Hill, 2014). 
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1.3. The cell cycle in T. brucei and its regulation 
A typical cell cycle of eukaryotes consists of four phases: G0/G1, S, G2 and M. In the first 
gap phase (G0/G1) the cells are getting prepared for entry into a new round of replication 
and cell division. In the S-phase the DNA is replicated and after the second gap-phase (G2), 
the cells are dividing during the M-phase. The cell cycle of Trypanosomes follows this 
scheme, but it has some unique features and requirements (McKean, 2003). Trypanosomes 
have distinctive structures and organelles, which must be duplicated and segregated 
accurately during cell division, which happens in a precise order. At first, the basal body is 
elongated and maturated and the new flagellum is nucleated, which depends on the de 
novo recruitment of γ-tubulin (McKean et al., 2003). In the S-phase, the DNAs of the nuclear 
and kinetoplast genomes are replicated separately (Woodward and Gull, 1990). Kinetoplast 
S-phase (Sk) occurs before the nuclear S-phase (Sn) and the segregation of the kinetoplast 
(D) is completed before onset of mitosis (M) (Figure 1.3) (McKean, 2003). These separate 
events of kinetoplast and nuclear S-phase make it possible to determine the defined cell 
cycle stage of trypanosomes by staining of the DNA (e.g. with DAPI). At the beginning of 
Figure 1.3: Cell Cycle of T. brucei. A. The trypanosome cell cycle is separated into nuclear and 
kinetoplast components. Cell cycle duration for exponentially growing procyclic trypanosomes is 8.5 
h. Kinetoplast replication (S) initiates before nuclear S phase, but is considerably shorter and 
consequently kinetoplast segregation (D) occurs before the onset of nuclear mitosis (M). The phase 
annotated on the kinetoplast cycle as ‘A’ refers to the ‘apportioning’ phase during which basal bodies 
continue to move apart. B. Schematic representations of trypanosome cells taken from various time 
points through the cell cycle. The black arrow indicates the direction and position of the cleavage 
furrow. Figure and description from (McKean, 2003). 
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the G2-phase of the nuclear cycle, the basal bodies separate in a microtubule-dependent 
manner (Robinson and Gull, 1991). The kinetoplast is connected with the proximal end of 
the basal body by a tripartite attachment complex (TAC), which ensures that the movement 
of the basal body results in the segregation of the replicated kinetoplast DNA (kDNA) 
(Ogbadoyi et al., 2003). The mitosis in trypanosomes is a closed process meaning that the 
nuclear envelope is not disrupted and the spindle is formed intra-nuclearly (Ogbadoyi et al., 
2000). Finally, the trypanosome is divided into daughter cells along the longitudinal axis, 
where the cleavage furrow is formed. The ingression proceeds unidirectionally from the 
anterior to the posterior pole between the two flagella to form daughter cells. It has been 
proposed that the structural information, which is required for positioning of the cleavage 
furrow is provided by the flagellum attachment zone (FAZ) (Robinson et al., 1995).  
All steps of the cell cycle in Trypanosoma are regulated by proteins, that include cyclin-
dependent kinases (CDKs), mitogen-activated kinases (MAPK), aurora kinases and polo-
like kinases (PLKs). However, the kinase functions are often divergent to the mammalian 
system (Hammarton et al., 2003; Hammarton et al., 2005; Kumar and Wang, 2006). An 
example is the trypanosome receptor for activated C kinase (TRACK), which regulates 
cytokinesis. TRACK contains WD40 repeats and is a homologue of the conserved scaffold 
protein receptor for activated C kinase 1 (RACK1). RACK1 regulates a variety of cell 
activities, like protein translation, cell growth and cell shape (McCahill et al., 2002).  
1.4. Regulation of gene expression in T. brucei 
All organisms have to regulate gene expression and usually controlled steps include 
transcription, mRNA processing, export of mRNAs from the nucleus, nuclear and 
cytoplasmic degradation of mRNAs as well as regulation of translation. Due to the existence 
of different forms, the stage-specific regulation of gene expression is essential for the 
survival of trypanosomes. The wrong expression of stage-specific proteins (e.g. procyclic-
form proteins expressed in the bloodstream form) will lead to cell death (Blattner et al., 1998; 
Wurst et al., 2012). 
1.4.1. Transcription  
Kinetoplastid genes are constitutively transcribed as groups by RNA polymerase II in a 
polycistronic manner. These pre-mRNAs can consist of up to 100 different open reading 
frames (ORFs), that do not encode functionally related products (Clayton et al., 2008). The 
transcription is initiated and terminated at the so-called strand switch regions (SSRs), which 
are marked by modified histones (acetylation and methylation) and histone variants (Siegel 
et al., 2009). In general, the gene expression is not controlled by regulating transcription 
initiation. However, there is some specificity. A recent study showed that transcription can 
be driven by a GT-rich promoter, which can deposit the histone variant H2A.Z. The 
transcription by RNA pol II is then initiated at the 5’ end of H2A.Z peaks (Wedel et al., 2017). 
The rRNA genes as well as stage-specific surface proteins (VSGs and procyclins) are 
transcribed by RNA polymerase I (Hernandez and Cevallos, 2014). In addition, RNA 
polymerase III transcribes tRNAs, the 7SL RNA (component of the signal recognition 
particle) and all U-rich snRNA genes (Vanhamme and Pays, 1995). Polycistronic 
transcription results in a loss of transcriptional regulation, which means that regulation of 
gene expression can only be regulated post-transcriptionally. Different kinds of post-
transcriptional regulation are polyadenylation, trans-splicing, degradation of the mRNAs in 
the nucleus or cytosol, export from the nucleus or control of translation initiation or 
elongation (Clayton, 2014). During mRNA-processing the individual mRNAs are generated 
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by trans-splicing of the spliced-leader (SL) mini-exon at the 5’end and the addition of a 
poly(A) tail at the 3’end (Michaeli, 2011). As a result of this trans-splicing each mRNA 
contains the same 39 nucleotide long SL RNA sequence at its 5’end, which acquires the 
hypermethylated cap4 structure (Zamudio et al., 2009). Polyadenylation of the mRNA is 
coupled to the splicing reaction and occurs 100-300nt upstream of the splice site, which is 
marked with the polypyrimidine tract. Signals within the 5’untranslated region (5’UTR) and 
the polypyrimidine tract can regulate the efficiency of splicing and thereby influence the 
abundance of the mature mRNAs (Michaeli, 2011). The hypermethylated cap of the 
processed transcripts is then bound by the cap-binding complex (CBC), which consists of 
five subunits: CBP20 (binds directly to the cap), importin-α (might play a role in shuttling 
between nucleus and cytoplasm) and three uncharacterized proteins (Li and Tschudi, 
2005).  
1.4.2. Export of mRNA from the nucleus 
As soon as the mRNAs are transcribed, the transcripts are bound by various RNA-binding 
proteins to form messenger ribonucleoproteins (mRNPs) and are exported from the 
nucleus. This process occurs by a RanGTP-dependent mechanism. In Trypanosomes 
some components of this complex are conserved, while others are specific for 
trypanosomes. One example is the heterodimeric nuclear export receptor Mex67-Mtr2, 
which is conserved in all eukaryotes, but has some special features in trypanosomes 
(Dostalova et al., 2013). In contrast to yeast, the trypanosome Mex67 contains a N-terminal 
CCCH-domain, which might be involved in the recruitment of the heterodimeric complex to 
the SL sequence at the 5’-end of the mRNAs. Downregulation of Mex67 and Mtr2 is 
essential and leads to a retention of mRNAs in the nucleus (Dostalova et al., 2013). 
However, there are also other proteins included in the export from the nucleus, like NMD3, 
which plays a role in the export of procyclin associated genes (PAG) transcripts that are 
transcribed by RNA pol I (Buhlmann et al., 2015).  
1.4.3. mRNA decay in Trypanosomes 
Recently, the decay of trypanosome mRNAs was analyzed by a transcriptome-wide study 
in procyclic and bloodstream forms using transcription inhibition and RNA sequencing 
(Fadda et al., 2014). The authors found that in the bloodstream form the mRNAs have on 
average half-lives between 10 and 20 min and are present at 1-4 copies per cell (Fadda et 
al., 2014; Manful et al., 2011). In general, low abundant mRNAs are unstable, while 
abundant mRNAs are more stable than the average and/or encoded by more gene copies 
per cell. Furthermore, mRNAs, which are developmentally regulated, frequently show 
regulated decay rates. It seems like steady-state mRNA levels are influenced by mRNA 
splicing and polyadenylation. Nevertheless, this appears to be dependent on the rates of 
RNA processing and co-transcriptional mRNA precursor destruction (Fadda et al., 2014). 
Decay of mRNAs usually starts with the removal of the Poly(A) tail (deadenylation) and is 
followed by removal of the cap (decapping) and degradation. Like in other eukaryotes, 
deadenylation is carried out by the CAF1/NOT complex (Erben et al., 2014a; Fadda et al., 
2013; Farber et al., 2013) and by the PAN2/PAN3 complex, whose role is not so clear 
(Fadda et al., 2013; Schwede et al., 2009). After the removal of the poly(A) tail, the mRNA 
is degraded in the 3’-5’ direction by the exosome (Clayton and Estevez, 2010; Fadda et al., 
2013) and in the 5’-3’direction by the exoribonuclease XRNA (Manful et al., 2011). In 
contrast to the deadenylation complex, Trypanosomes lack all homologues of proteins 
known to be responsible for the decapping of mRNAs. However, Susanne Kramer recently 
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identified an ApaH-like phosphatase 1 (ALPH1) as major mRNA decapping enzyme. It co-
localizes with XRNA at the posterior end of the cell. Knock-down of ALPH1 leads to an 
increase of total mRNA, which are deadenylated but not yet degraded by 5’-3’ decay. This 
suggests that ALPH1 operates after deadenylation happened, but before mRNA 
degradation occurs (Kramer, 2017).  
1.4.4. Localization of mRNAs in Trypanosomes  
An additional way to regulate gene expression on a post-transcriptional way is the storage 
or decay of mRNA in RNP granules, which are distinct non-membranous structures 
(Cassola, 2011). Different types of RNP granules exist in trypanosomes. One type are P-
bodies, which contain enzymes of the 5’-3’ RNA degradation pathway and proteins involved 
in translational repression, like Caf1 (Kruger et al., 2013). P-bodies are constitutively 
present in the cells and they contain mRNA in equilibrium with the translating polysomes. If 
the global translation is repressed, the amount of P-bodies increases, whereas the amount 
decreases when the dissociation of polysomes is blocked by cycloheximide (Kramer, 2014).  
Another type of RNP granule are stress granules, which are larger than P-bodies. They are 
formed upon stress, like starvation or heat shock, and contain components of the translation 
initiation machinery (Kruger et al., 2013). It has been shown that starvation stress granules 
contain proteins like the DEAD box RNA helicase DHH1, the Xrn1 homologue XRNA, the 
scaffold protein SCD6, the Poly(A) binding proteins PABP1 and PABP2, the U-rich RNA 
binding protein, translation initiation factors, like eIF4E1, 2 and 3 as well as several RBPs 
(Kramer, 2014). In contrast to mammalian stress granules, neither ribosomal subunits nor 
the eIF4G scaffold proteins were detected in stress granules (Cassola, 2011). Stress 
granules are suggested to serve as temporal storage compartment of mRNAs during stress, 
because they contain polyadenylated mRNAs (Cassola et al., 2007). As soon as the 
starvation stress is over, the stress granules disassemble and the mRNAs can be 
translated. A novel method, which allows the purification of stress granules in 
trypanosomes, gave new insights in the components of starvation stress granules. The 
stress granule purification consists of two steps. At first, the plasma membrane of the 
trypanosomes is lysed. Due to the cage-like subpellicular microtubule array of the 
cytoskeleton (Angelopoulos, 1970; Lacomble et al., 2009; Sherwin and Gull, 1989), the 
stress granules will be kept inside this cage while soluble proteins can be washed out. In 
the second step, the granules are released by depolymerization of the microtubules. Mass 
spectrometry analysis of the granules enriched fraction identified 463 putative stress 
granule proteins and RNA seq showed that mRNAs encoding ribosomal proteins are 
excluded from stress granules (Fritz et al., 2015). This is different to the mammalian system, 
where most mRNAs encoding ribosomal proteins contain the 5’ Terminal Oligo Pyrimidine 
(5’TOP) motif (Yoshihama et al., 2002) and they are recruited to stress granules in a TIA-
dependent manner (Ivanov et al., 2011). This cis-regulatory element functions in 
translational repression of the mRNAs and is also conserved in vertebrates. The 5’TOP 
mRNAs have an invariable C residue at the cap followed by a stretch of 4 to 15 pyrimidines. 
Most members have a similar number of C and U residues within this pyrimidine stretch and 
a CG-rich region downstream of the 5’TOP motif (Meyuhas and Kahan, 2015). Under stress 
conditions, like nutritional stress, the translation of the 5’TOP mRNAs is repressed. It is 
known that mRNAs encoding ribosomal proteins are not particularly well translated although 
they are abundant and very stable in Trypanosoma (Antwi et al., 2016). The regulation of 
mRNAs encoding ribosomal proteins after stress is very different from that of most RNAs, 
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since they are neither found in starvation stress granules (Fritz et al., 2015) nor in heat-
shock granules (Minia et al., 2016). 
In addition to the mentioned types of granules, there are nuclear periphery granules, 
posterior pole granules and tRNA half granules (Kramer, 2014).  
1.4.5. Translation 
In general, during translation initiation of eukaryotes eIF4E binds to the cap at the 5’UTR of 
the mRNA. eIF4E can then interact with the scaffold protein eIF4G, which on its part recruits 
eIF4A. eIF4A is an RNA helicase, which is involved in the unwinding of secondary structures 
of the target mRNA. eIF4A thereby facilitates, together with eIF4B, the scanning of the 40S 
subunit on the target mRNA. The complex consisting of eIF4E, eIF4G and eIF4A is called 
eIF4F complex. It is known that eIF4G and eIF4B interact with the poly(A)-binding protein 
(PABP), which binds to the poly(A) tail at the 3’ end of the mRNA target. This leads to the 
circularization of the mRNA, which is suggested to increase translation efficiency and 
ribosome recycling (Sonenberg and Hinnebusch, 2009). In trypanosomes six eIF4Es, five 
eIF4Gs and two eIF4As are known. Not all these factors can bind the same proteins and 
thereby also differ in function (Freire et al., 2017). The six eIF4Es, for example, can be 
divided in 3 different groups. Group one contains eIF4E1 and eIF4E2, which cannot form 
eIF4F-like complexes and thereby would not function in general translation (Freire et al., 
2017). eIF4E1 is suggested to repress translation by interaction with 4E-IP, which is needed 
for normal differentiation (Terrao et al., 2018). In addition, eIF4E1 is suggested to stimulate 
translation by interaction with the eIF3 complex. However, this interaction could not be 
confirmed by our lab (unpublished data). Not much is known about the function of eIF4E2. 
Group 2 contains eIF4E3 and eIF4E4, which can form eIF4F complexes and therefore are 
responsible for general translation. Group 3 contains eIF4E5 and eIF4E6, which can bind 
to eIF4G and form eIF4F(-like) complexes. However, these complexes are suggested to not 
be involved in general translation (Freire et al., 2017). 
Studies comparing the transcriptomes and proteomes of procyclic and bloodstream forms 
(Butter et al., 2013; Gunasekera et al., 2012; Urbaniak et al., 2012) showed that mRNA and 
protein levels correlate comparatively poorly meaning that there has to be regulation of 
protein stability or translation. The enormous regulation of translation could be shown by 
ribosome profiling data. The translation efficiency varies heavily between the different life 
cycle stages and up to 100-fold between different genes. This suggests that the gene 
expression is regulated by translation efficiency as much as by mRNA stability (Vasquez et 
al., 2014). As described above: upon stress conditions the translation is generally 
suppressed and mRNA sequester in granules (Kruger et al., 2013; Zinoviev et al., 2012). 
Not much is known about the mechanism of translational regulation in trypanosomes. Only 
some mechanisms for translational regulation of specific transcripts by RBPs are known for 
Opisthokont cells, like the pumilio domain proteins that lead to the sequestration in granules 
(Kotani et al., 2013) or the inhibition of translation elongation by interaction with eEF1A 
(Friend et al., 2012). 
1.4.6. Influence of codon usage on the regulation of gene expression  
in the last years, it has been shown that codon usage can determine mRNA levels in a 
variety of organisms. These data show that codons, which are translated into the same 
amino acid, are used with a different abundance dependent on the different species, but 
also within one organism and even between different transcripts. It is thought that the 
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abundance of the tRNA at least partly determines the codon optimality (how fast and 
efficient a codon is translated) and that transcripts with higher codon optimality are prone 
to be more stable (Hanson and Coller, 2018). More recently two studies also showed the 
influence of codon usage on translation in Trypanosomes. Both groups compared the 
mRNA abundances, determined by RNA-Seq, with the codon usage (de Freitas Nascimento 
et al., 2018; Jeacock et al., 2018). Jeacock et al. could show that highly abundant mRNAs 
encoding abundant proteins have a higher codon optimality, whereas it decreases in poorly 
expressed genes. In addition, they could show that it is more likely for genes encoding 
proteins of one protein complex to have a similar codon composition (Jeacock et al., 2018). 
de Freitas Nascimento et al. observed quite similar results showing that the codon optimality 
correlates with the reporter protein and mRNA levels. In addition, they could show that the 
codon usage influences the mRNA half-life and that translation is needed for that process 
(de Freitas Nascimento et al., 2018). Taken together, these two studies suggest an 
influence of the codon usage on the half-life of the mRNAs in Trypanosoma. However, it is 
not known if and how the codon usage influences mRNA decay rates.  
1.5. RNA-binding proteins and their role in regulation of gene 
expression in T. brucei 
RNA-binding proteins (RBPs) play an important role in the post-transcriptional regulation of 
gene expression (Kramer and Carrington, 2011). RBPs are classified according to their 
structural domains that are involved in the interaction with RNA. The genome of T. brucei 
encodes about 48 CCCH-type zinc finer domain proteins (Kramer et al., 2010), over 75 RNA 
recognition motif (RRM) proteins (De Gaudenzi et al., 2005), 4 ‘acetylation lowers binding 
affinity’ (ALBA) domain proteins (Mani et al., 2011) and at least 12 PUF domain proteins 
(Caro et al., 2006). The RBPs can bind to specific sequences within each transcript and can 
regulate the localization, stability or translation of the target. The majority of regulatory cis-
elements are located within the 3’UTR of target mRNAs (Clayton and Shapira, 2007). In 
addition, each RBP can have multiple targets. 
1.5.1. RRM domain containing proteins 
The RRM domain is one of the most abundant protein domains in eukaryotes (Clery et al., 
2008). A single RRM domain consists of two α-helices and a four-stranded β-sheet and can 
interact with a 2-8 nucleotide long sequences on single stranded RNA (Lunde et al., 2007). 
Approximately half of the RRM domain-containing proteins are essential in at least one life 
cycle stage of T. brucei (Alsford et al., 2011) and many are known to regulate mRNA 
degradation, splicing or translation. However, only some RRM-domain containing proteins 
in Trypanosoma have orthologues in other eukaryotes, like PABP1 and PABP2, the 
translation initiation factor eIF3B and the splicing factor U2AF35 (Kramer and Carrington, 
2011). The uridine-binding proteins UBP1 and UBP2, which are two related proteins with a 
single RRM domain, affect the abundances of F-box protein mRNAs involved in cell cycle 
control (Hartmann et al., 2007). The cytosolic RBP42 binds to the coding sequence (CDS) 
of mRNAs encoding proteins involved in energy metabolism (Das et al., 2012). In addition, 
two RRM domain containing proteins, RPB6 and RBP10 are involved in the life-stage 
specific gene expression (Kolev et al., 2012; Mugo and Clayton, 2017; Wurst et al., 2012). 
RBP10 is a cytoplasmic protein specifically expressed in the bloodstream from cells. While 
knock-down of RBP10 leads to a decrease of mRNAs specific for the bloodstream form, 
expression of RBP10 in the procyclic form leads to an increase of mRNAs specific for the 
bloodstream form (Wurst et al., 2012). In the bloodstream form RBP10 binds to an 
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UAUUUUUU motif of procyclic-specific mRNAs leading to their translational repression and 
destruction. On one hand, knock-down of RBP10 in the bloodstream form enabled the 
differentiation to procyclic cells, when the cells were transferred to 27°C and procyclic 
medium, even without cis-aconitate, which usually primes the cells for differentiation. On 
the other hand, expression of RBP10 in the procyclic form leads to cells with higher 
expression of VSGs and reduced expression of procyclin and culturing of these cells in 
bloodstream form medium and at 37°C leads to differentiation to bloodstream form cells 
(Mugo and Clayton, 2017). Procyclic cells expressing RBP10 do not form epimastigotes, 
although they become infective for mice, which suggests an alternative differentiation 
pathway (Mugo and Clayton, 2017; Mugo et al., 2017). Expression of RBP6 in the procyclic 
form initiates the differentiation to epimastigotes and metacyclic cells and after transfer to 
mice the cells differentiate to bloodstream form cells. However, in vitro the metacyclic cells 
could not differentiate to the bloodstream form (Kolev et al., 2012). A more recent study 
could show that expression of RBP6 containing a single point mutation (Q109K) enables 
the procyclic cells to differentiate into metacyclic cells and then progress to the bloodstream 
form in vitro. In addition, the expression of the mutated RBP6 skips the intermediate 
epimastigotes form (Shi et al., 2018) as it was shown for RBP10 (Mugo and Clayton, 2017). 
1.5.2. ALBA domain containing proteins 
In T. brucei only four ALBA domain proteins are known: ALBA 1-4. All four are can form 
homo- and heterodimeric complexes and are located in the cytoplasm. In addition, knock-
down of all four ALBA domain proteins leads do a decrease of translation of a reporter 
mRNA (Mani et al., 2011). Dimers of ALBA1/2 and ALBA 3/4 can be found in starvation 
stress granules together with poly(A) RNA, whereas dimers of ALBA2/3 interact with eIF4E4 
and partially associate with polysomes. The association of the ALBA proteins with stress 
granules and the translation machinery suggests a role in the control of translation (Mani et 
al., 2011). Subota et al. published a study about the characterization of ALBA3/4, where 
they could show that ALBA3/4 co-localizes with DHH1 and poly(A) RNA in stress granules 
(Subota et al., 2011), which coincide with the localization studies of Mani et al. (Mani et al., 
2011). However, they went further and could show that ALBA3/4 is expressed in all 
developmental stages of Trypanosomes in the Tsetse fly, except for the transition states in 
the proventriculus region. In this phase the nucleus migrates towards the posterior end of 
the cell, which can be disturbed by the expression of ALBA3 (Subota et al., 2011).  
1.5.3. PUF domain containing proteins 
A typical PUF domain includes eight tandemly-repeated α-helices, which separately interact 
with eight bases of the RNA binding sequence (Wang et al., 2002). PUF9, for example, 
binds to the putative recognition motif UUGUAC of a small number of target mRNAs and 
thereby stabilizes them during S-phase (Archer et al., 2009). PUF7 and PUF10 are both 
involved in rRNA maturation and localize to the nucleolus (Droll et al., 2010; Schumann 
Burkard et al., 2013). PUF7 interacts with a nuclear cyclophilin-like protein and knock-down 
of PUF7 results in reduced cell growth and inhibition of ribosomal RNA processing (Droll et 
al., 2010). Another study showed that PUF7, as well as PUF10, interact with BOP1, which 
is a protein involved in rRNA processing, and all of them interact with the nucleolar regulator 
of GPEET 1 (NRG1). Knock-down of any of these proteins leads to a reduction of the 5.8S 
rRNA level and its immediate precursor, and to increased GPEET expression. These data 
suggest that the proteins of the rRNA maturation complex can in addition regulate mRNAs 
with origin in the nucleolus (Schumann Burkard et al., 2013). PUF1, interacts with the 
expression site-associated gene 8 (ESAG8) protein as well as mRNA. Expression sites (ES) 
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promote the expression and switching of VSGs and the ESAGs are co-transcribed from the 
upstream promoter. Overexpression of PUF1 protein leads to an increase of ESAG8 mRNA, 
which suggests a positive feedback loop: high PUF1 levels will lead to an increase of the 
levels of ESAG8 mRNA and protein. In addition, overexpression of PUF1 leads to a reduced 
parasite virulence. However, it is not clear, if this is a direct effect of PUF1 overexpression 
and its interaction with ESAG8 (Hoek et al., 2002). In contrast to these results, depletion of 
PUF1 did not affect cell growth or the abundances of any other mRNAs in trypanosomes. 
This suggests a functional redundancy of the PUF proteins in Trypanosoma (Luu et al., 
2006).  
1.5.4. Zinc finger domain containing proteins 
Proteins containing a zinc finger domain are defined by the presence of a C-X4-15-C-X4-6-C-
X3-H, which mostly binds single stranded RNA. These proteins have widespread functions 
in RNA metabolism. Around 65% of the zinc finger proteins have only one CCCH motif, 
while the rest have additional domains (Kolev et al., 2014; Kramer and Carrington, 2011). 
The three zinc finger proteins ZFP1, ZFP2 and ZFP3 play a role in differentiation from the 
bloodstream form to the procyclic form (Hendriks and Matthews, 2005; Hendriks et al., 
2001). ZC3H11 is essential in the bloodstream form and procyclic cells, and is required to 
survive a heat-shock response at 41°C. ZC3H11 binds to mRNAs encoding chaperones 
and stabilizes these mRNAs. While the zinc finger domain at the N-terminus of ZC3H11 
recognizes UAU repeats in the 3’-UTR of the mRNA, the C-terminal domain stabilizes the 
bound mRNA (Droll et al., 2013). ZC3H11 then recruits MKT1 and PBP1. PBP1 in turn 
recruits LSM12 and PABP. This could protect the poly(A) tail against deadenylation and in 
addition might facilitate the circularization with the cap-binding complex (Singh et al., 2014). 
In addition, ZC3H20, ZC3H18 and ZC3H13 are needed for differentiation and cell growth 
(Benz et al., 2011; Ling et al., 2011; Ouna et al., 2012). 
1.5.5. Non-canonical RBPs 
A major feature of proteins that regulate post-transcriptional gene expression is their ability 
to bind to mRNA. To identify these RBPs, the mRNA-bound proteome of bloodstream cells 
was analyzed (Lueong et al., 2016). Proteins were crosslinked with the mRNAs in vivo and 
the polyadenylated mRNAs were enriched by oligo (dT) magnetic beads. The mRNA 
interactome was then determined by quantitative mass spectrometry (Castello et al., 2013). 
This screen identified many putative RBPs, of which many were not known to bind to mRNA 
before. They include non-canonical RBPs (Lueong et al., 2016), which can bind to RNAs 
even without a known RBP (Gerstberger et al., 2014; Hogan et al., 2008; Lueong et al., 
2016). A trypanosome example is Tb927.10.14150, which was one of the strongest hits in 
the T. brucei mRNA interactome (Lueong et al., 2016).  
One non-canonical RBP in yeast is Bfr1p (Brefeldin A resistance protein). It was discovered 
in the 90s in a genetic screen for high-copy suppressors of Brefeldin A (BFA) in 
Saccharomyces cerevisiae. BFA, which is a fungal toxin, influences the function and 
structure of the organelles of the secretory pathway (Klausner et al., 1992; Lippincott-
Schwartz, 1993). It leads to tubulation of the lysosome, to fusion of the trans-Golgi network 
with the endosomes and to tubulation and fusion of the Golgi with the ER (Hunziker et al., 
1992; Klausner et al., 1992; Pelham, 1991). Bfr1p can partially suppress the phenotypes 
caused by BFA (Jackson and Kepes, 1994). Bfr1p is not essential (Jackson and Kepes, 
1994) and localizes to the outside of the ER (Lang et al., 2001). Lang and colleagues could 
show that Bfr1p is part of a polyribosome-associated mRNP complex, which contains 
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Scp160p, Pap1p, additional unidentified proteins and polyadenylated mRNA (Lang and 
Fridovich-Keil, 2000; Lang et al., 2001). A more recent study suggests that Bfr1p together 
with Scd160 inhibits P-body formation under normal growth conditions and thereby protects 
RNAs at ribosomes (Figure 1.4 A). By an interaction with RNA and P-body components, the 
P-bodies are left in a ‘waiting position’ and P-body formation is inhibited (Simpson et al., 
2014; Weidner et al., 2014). In Bfr1p-depleted cells (Figure 1.4 B), Scp160p cannot be 
recruited to the polysomes efficiently and thereby cannot protect the RNA, which leads to 
the formation of P-bodies. In contrast, if Scd160 is depleted (Figure 1.4 C), Bfr1p can, to an 
extent, still be recruited to the polysomes. 
However, P-bodies cannot be assembled properly without Scp160, which leads to the 
formation of pseudo P-bodies. This model suggests that under stress conditions, Scp160 
and Bfr1 cannot protect the polysomes anymore, which gives the P-body components 
access to the mRNAs and leads to P-body formation (Weidner et al., 2014). Scd160p as 
well as Bfr1p were identified to bind to more than a thousand mRNA targets by RIP-Chip 
and the targets were enriched for mRNAs encoding proteins that localize to the nucleolus 
and that are involved in ribosome biogenesis and RNA processing (Hogan et al., 2008). A 
more recent study identified the mRNA targets of Bfr1p by RNA tagging. The targets were 
enriched for mRNAs encoding for proteins involved in cytoplasmic translation, containing 
ribosomal proteins, and membrane-associated functions (Lapointe et al., 2015). Taken 
together, the localization of Bfr1p at the outside of the ER (Lang et al., 2001), the association 
of Bfr1p with polysomes (Weidner et al., 2014) and the enrichment of its mRNA targets for 
Figure 1.4: Scp160 and 
Bfr1 inhibit P body 
formation under normal 
growth conditions. A. In 
wild-type cells under 
normal growth conditions, 
Scp160 and Bfr1 protect 
RNA at polysomes. Scp160 
interacts with RNA and P 
body components and 
leaves P bodies in a 
‘waiting’ position while still 
inhibiting P body formation. 
B. In Δbfr1 cells, Scp160 is 
not efficiently recruited to 
the polysomes and cannot 
properly protect the RNA, 
thus, allowing P body 
components to access 
RNAs. C. In Δscp160, Bfr1 
can, to an extent, be 
recruited to polysomes, but 
without Scp160, proper P 
body assembly cannot 
occur, leading to the 
formation of pseudo P 
bodies. Figure and 
description from: (Weidner 
et al., 2014).  
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membrane-related proteins (Lapointe et al., 2015) suggests that the Bfr1p targets are 
directly translated to the ER. 
1.6. Identification of new putative post-transcriptional regulators 
A tethering assay was performed to identify putative trypanosome post-transcriptional 
regulators. The basis of this method is the interaction of the lambda-N peptide with the boxB 
RNA sequence. Proteins of interest were fused N-terminally to the lambda-N peptide and 
inducibly expressed in trypanosomes. About 300 proteins that potentially regulate mRNA 
fate were identified by the screen. Many proteins with no previously known function could 
be identified as activators, and repressors, as well as 25 RBPs and known translation 
initiation factors as activators and 16 RBPs and 4E-IP as repressors (Erben et al., 2014b). 
In the tethering screen only random genomic fragments were used leading to some false-
negatives due to the missing of full-length proteins. There were also false-positives, which 
could arise from wrong folding of the protein fragments. A mini-library of 384 full-length ORF 
fragments was created containing proteins with RNA-binding domains, some translation 
factors, components of the RNA degradation machinery as well as proteins with previously 
unknown function. This mini-library identified 90 proteins that were activators or repressors 
(Lueong et al., 2016). This was the basis of my study. I wanted to investigate the function 
of putative post-transcriptional regulators in more detail. To choose the candidates I set 4 
premises: proteins that 1. were shown to be repressors or activators in the tethering screen 
(Erben et al., 2014b; Lueong et al., 2016), 2. Were shown to be essential by RNA 
interference target sequencing (RIT-Seq) (Alsford et al., 2011), 3. Were shown to bind to 
mRNA by interactome capture (Lueong et al., 2016) and 4. Are located in the cytosol 
according to TrypTag (Dean et al., 2017) (Figure 1.5). 155 of the putative RBPs identified 
by interactome capture (Lueong et al., 2016) were also shown to be essential by RIT-Seq 
(Alsford et al., 2011) (Figure 1.5 A). 24 of these candidates also showed an effect as 
repressor or activator in the tethering screen (Figure 1.5 B). Next, the localization of these 
proteins according to TrypTag was investigated (Dean et al., 2017). I will focus on proteins 
that are located outside the nucleus, because post-transcriptional regulation of gene 
expression, like regulation of translation, mRNA degradation, etc. occurs in the cytoplasm. 
The two proteins, which were chosen as candidates are one activator, Tb927.10.14150, 
and one suppressor, ZC3H5 (Erben et al., 2014b). (Figure 1.5 B). Tb927.10.14150 is a 
protein of unknown function that is conserved in all Kinetoplastids, but no other organisms. 
It showed in vivo mRNA binding (Lueong et al., 2016), although it lacks a canonical RNA-
binding domain. Tb927.10.14150 shows the same relative protein abundance in both stages 
during differentiation (Dejung et al., 2016). In addition, it has some similarities to yeast Bfr1p 
(TriTrypDataBase). Tb927.10.14150 was shown to be essential in a high-throughput screen 
in bloodstream form cells (Alsford et al., 2011). According to TrypTag, a C-terminally tagged 
version is located in the cytoplasm and at the ER (Figure 1.5 D) (Dean et al., 2017). ZC3H5 
is an RNA-binding protein that is conserved in Trypanosomatids and contains a single 
C3H1-type zinc finger domain. It was shown to be essential in a high-throughput screen in 
bloodstream form cells (Alsford et al., 2011). According to TrypTag, a N-terminally tagged 
version is located in the cytosol and a C-terminally tagged version is located in the cytosol 
as patchy structures (Figure 1.5 C) (Dean et al., 2017). 
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1.7. Aim of the study 
In this thesis, I will investigate the function of the two candidates Tb927.10.14150 and 
ZC3H5 in more detail. 
The specific aims were 
- localization of proteins 
- Analysis of knock-down and effect on mRNA activity/stability 
- Identification of the target mRNAs 
- Identification of the protein interaction partners 
Dependent on these aims a deeper knowledge on the role of the two candidate proteins in 
the post-transcriptional regulation of gene expression should be investigated. 
  
Figure 1.5: How to choose candidate RBPs? A. Activators or repressors of the tethering screen 
(n=90) (Lueong et al., 2016) were compared with essential RBPs (n=155). Essential RBPs are 
proteins, which were identified in the mRNA interactome capture (Lueong et al., 2016) and showed 
reduced growth fitness by RNA interference target sequencing (Alsford et al., 2011). B. Table of the 
overlapping candidates form figure A. Green=activator; red=repressor in the tethering screen. Grey 
box: candidates that were chosen for closer analysis. C. TrypTag images of N-terminally and C-
terminally GFP-tagged ZC3H5 (green). Nucleus and Kinetoplast were stained with Hoechst (cyan) 
(Dean et al., 2017). D. TrypTag images of C-terminally GFP-tagged Tb927.10.14150 (green). Protein 
is not tagged N-terminally, yet. Nucleus and Kinetoplast were stained with Hoechst (cyan) (Dean et 
al., 2017). 
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2. mRNAs encoding ribosomal proteins might be regulated by 
BFR1L 
2.1. Results 
2.1.1. Knock-down of Tb927.10.14150 affects cell growth in the bloodstream form 
In this part of the thesis, I will report on the characterization of Tb927.10.14150, which is a 
putative RNA-binding protein without any canonical RNA-binding domain that is conserved 
in Kinetoplastids and has also some orthologues in oomycetes and brown algae. Sequence 
identity in Kinetoplastida is equally spread through the protein sequence (Suppl. Figure 1). 
However, sequence identity to the oomycetes and brown algae is not very high. 
Tb927.10.14150 was an up-regulator in the tethering screen (Erben et al., 2014b) and the 
relative protein abundance of the protein is similar in both stages during differentiation 
(Dejung et al., 2016). Tb927.10.14150 protein displays in vivo mRNA binding (Lueong et 
al., 2016) although it lacks canonical RNA-binding domains. It has some similarities to yeast 
Bfr1p (Brefeldin A resistance protein), an ER- and polysome-associated protein (Lang et 
al., 2001; Weidner et al., 2014), which is not essential (Jackson and Kepes, 1994). Bfr1p 
interacts with RNA, although it lacks canonical RNA-binding domains. Bfr1p together with 
Scd160 inhibits P-body formation under normal growth conditions and thereby protects 
RNAs at ribosomes (Weidner et al., 2014). Since Tb927.10.14150 has some similarities to 
the yeast Bfr1 protein, even if the sequence identity is very low (Suppl. Figure 2.1), I will 
rename Tb927.1014150 as BFR1-like (BFR1L) protein. BFR1L consists of 479 amino acids. 
It has a predicted molecular weight of 55.3 kDa and contains four low complexity regions, 
of which one is located in the N-terminal region and the other three are located in the C-
terminal region (Figure 2.1 A). To investigate whether BFR1L is essential in bloodstream 
form trypanosomes (BF), cell growth after RNAi-mediated knock-down of BFR1L was 
analyzed. I could observe a growth defect upon RNAi (+ Tet) in comparison to the 
uninduced cells (- Tet), but it was not lethal (Figure 2.1 B). The decrease of the in situ V5-
tagged protein after RNAi was monitored over time and analyzed by Western Blotting 
(Figure 2.1 C). The protein level decreased already after 1 day of Tetracycline induction 
and was not detectable at later points, which showed successful knock-down. The division 
Figure 2.1: Knockdown of BFR1L expression in BF V5-BFR1L cells. A. Domains of BFR1L. LC: 
Low complexity region. B. Growth curve for dsRNAi of BFR1L in BF V5-BFR1L cells of three 
independent clones. Error bars indicate standard deviation. +Tet (dashed lines) and -Tet (solid 
lines). C. 3x106 cells were collected each day after counting and Western Blot of V5-BFR1L was 
performed. Aldolase was used as loading control. Numbers below the blot indicate quantification of 
the V5-BFR1L signal. Day 0 was set as 1. D. Division times (in h) of +/- Tet calculated from 3 
independent clones time ± standard deviation. 
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time after knock-down (+Tet) was 11.6 ± 0.5 h, whereas the division time of the control cells 
(-Tet) was 7.9 ± 0.3 h (Figure 2.1 D). 
To investigate whether BFR1L is essential in the bloodstream form, both ORFs of BFR1L 
were replaced with two different genes encoding for antibiotic resistances (Figure 2.2 A). At 
first, a single knockout (SKO) was created in which one ORF of BFR1L was replaced by the 
gene encoding for Blasticidin-S deaminase (BSD). To create a double knockout (DKO) the 
second ORF of BFR1L was replaced by the gene encoding for Puromycin N-
acetyltransferase (PAC). To confirm that both genes of BFR1L were knocked out in this cell 
Figure 2.2: Growth of bloodstream form cells without BFR1L. A. Schematic representation of 
the different fragments that were amplified by PCR. BSD: Blasticidin-S deaminase; PAC: Puromycin 
N-acetyltransferase. B. gDNA of wild type BF cells (WT) and BF BFR1L-/- (DKO) was extracted and 
amplified using different primer pairs to amplify the different fragments described in A. C. 
Cumulative growth curve of 3 independent experiments, which were done at different times but with 
the same clones, for BF (WT), BF BFR1L+/- (SKO) and BF BFR1L-/- (DKO). Error bars indicate 
standard deviation. 
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line, gDNA of the WT and DKO was extracted and different fragments were amplified by 
PCR, as shown in figure 2.2 A. The amplified PCR fragments can be seen in figure 2.2 B. 
Fragment 1 or 2 could only be amplified using the DKO gDNA as template, but not the WT 
gDNA as template, which indicated that one allele of the BFR1L ORF was replaced by BSD 
gene. Otherwise, primers to amplify the ORF of BFR1L could only amplify fragment 3 by 
using the WT genomic DNA (gDNA) as template, but not by using the DKO gDNA as 
template. Replacement of the second BFR1L allele by PAC gene was investigated by 
amplification of fragment 4 and 5. In both cases, the fragment could be amplified by using 
the DKO gDNA as template, but not by using the WT gDNA. In addition, primers to amplify 
the PAC gene can only amplify fragment 6 by using the DKO gDNA as template, but not by 
using the WT gDNA as template. Finally, amplification of fragment 7 was investigated. This 
fragment has different sizes dependent on the sequence length of the different genes. It 
can be seen that fragment 7 had a size of 2200 bp, when WT gDNA was used as template. 
When DKO gDNA was used as template two bands with sizes of 1100 bp and 1300 bp 
appeared indicating replacement of the BFR1L gene by the PAC and BSD gene. After 
confirmation of successful knock-out of BFR1L, the growth of DKO cells was compared with 
SKO cells and WT cells over seven days in 3 independent experiments (Figure 2.2 C). The 
SKO cells showed a negligible growth defect in comparison to the WT cells. I could observe 
a growth defect of the DKO cells in comparison to the WT and SKO cells, but it was not 
lethal. This reflects the data of BFR1L knock-down by dsRNAi. 
Next, I investigated, whether the growth defect of the DKO bloodstream form cells could be 
complemented by overexpression of myc-tagged BFR1L. For that reason, double-knockout 
cells with inducible ectopically expressed N-terminally myc-BFR1L (BF BFR1L-/-, MYC) were 
created, which is a conditional DKO (cDKO). The growth of these cells with and without 
induction of myc-tagged BFR1L expression was compared with the growth of WT BF cells 
and the BFR1L-/- cells (DKO). As described before, I could observe a growth defect of the 
DKO cells in comparison to the WT cells. The BF BFR1L-/-, MYC cells grew as the WT in both 
cases: with and without tetracycline induction (Figure 2.3 A). However, the overexpression 
plasmid is leaky as it can be seen by Western Blotting. Even in the uninduced cells (-Tet), 
a myc-BFR1L band could be observed. Surprisingly, BFR1L appeared as double band, 
which I could not observe on other WBs (see figure 2.1 C). This experiment showed that 
the growth defect of the DKO cells can be rescued by overexpression of myc-tagged 
BFR1L. However, when repeating this experiment, I could not observe a growth defect of 
the DKO. It is possible that cells have simply been adapted to loss of BFR1L during 
culturing. In procyclic cells (PC), I was not able to generate a gene knock-down of the 
protein neither by dsRNAi nor by stem-loop RNAi, despite several attempts (data not 
shown). In addition, I was also not able to generate a double knockout of BFR1L in PCs; 
however, I could create a SKO of the protein in PCs. These cells were then transfected with 
the ectopic expression plasmid to create PC BFR1L-/+, MYC cells (conditional SKO=cSKO). 
In these cells, myc-tagged BFR1L was expressed by Tetracycline induction and then they 
were transfected with a plasmid that replaces the second ORF of BFR1L with the PAC gene 
to create a conditional DKO (PC BFR1L-/-, MYC). Surprisingly, all different cell lines (SKO, 
cSKO, cDKO) cells grew as the WT in both cases: with and without tetracycline induction 
(Figure 2.3 B; performed by Pia Hartwig (PH)). As it can be seen by Western Blotting, the 
overexpression of myc-BFR1L is tightly regulated by tetracycline induction. In the uninduced 
cells no myc-BFR1L signal can be observed, which suggests that BFR1L is not essential in 
the procyclic form.  
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Taken together, knock-down or knock-out of BFR1L in BF trypanosomes leads to a slight 
growth defect, which can be rescued by ectopic expression of the protein, whereas I was 
neither able to generate a RNAi-mediated knock-down cell line of BFR1L nor to generate a 
DKO cell line in PC trypanosomes. However, I was able to generate a cDKO in PCs. 
Surprisingly, growth was not restricted by removing of tetracycline from these cells and cells 
grew as wildtype even without ectopic expression of myc-tagged BFR1L. 
2.1.2. BFR1L localizes to ER and partially to mitochondria 
Immunofluorescence microscopy data of the TrypTag project (Dean et al., 2017) suggests 
a localization of BFR1L at the ER. To investigate the localization of the BFR1L in more 
detail, immunofluorescence microscopy was performed using bloodstream form cells 
expressing N-terminally V5-tagged BFR1L from the endogenous locus. Proteins with known 
localization were used as controls and the kinetoplast and nuclear DNA was stained with 
DAPI. Wild type BF cells were used as control to validate that the V5-antibody binds 
specifically to V5-tagged BFR1L. I recorded Z-stacks and deconvoluted the images 
afterwards. Figure 2.4 A shows the localization of V5-tagged BFR1L and Trypanothione 
Reductase (TR), a protein located in the cytoplasm. There might be partial co-localization 
with TR. However, TR is not an exclusively cytosolic marker, because I could observe signal 
in the nucleus. I could not observe a signal of V5-BFR1L in the nucleus. In figure 2.4 B the 
localization of V5-tagged BFR1L and Aldolase, a protein located in the glycosomes, can be 
seen. 
Figure 2.3: Effect of conditional BFR1L DKO on growth of bloodstream form and procyclic 
cells. A. Growth curve for BF (WT), BF BFR1L-/- (DKO) and BF BFR1L-/-, MYC (DKO plus ectopic 
expression plasmid for myc-BFR1L) without (-Tet) and with (+Tet) tetracycline induction. 3x106 cells 
were collected each day after counting and a Western Blot for myc-BFR1L was performed. Ponceau 
staining was used as loading control. Solid and dashed lines are two replicates. B. Growth curve for 
PC (WT), SKO (BFR1L+/-), cSKO (BFR1L+/-, MYC) and cDKO (BFR1L-/-, MYC) without (-Tet) and with 
(+Tet) tetracycline induction. 3x106 cells were collected each day after counting and Western Blot of 
myc-BFR1L was performed. Aldolase was used as loading control. Representative growth curves 
out of two replicates is shown (PH). 
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Figure 2.4: Fluorescence microscopy of BF V5-BFR1L cells. BF V5-BFR1L cells were subjected 
to fluorescence microscopy. BF cells without V5 served as control. Nuclear and kinetoplast DNA 
was stained with DAPI (blue) in all four immunofluorescence sets.  A. Parasites were treated with 
antibodies against V5-tag (red) and Trypanothione Reductase (=TR) (green). B. Parasites were 
treated with antibodies against V5-tag (red) and the glycosomal Aldolase (green). C. Parasites were 
treated with Mitotracker (red), which stains the mitochondria, and with an antibody against V5-tag 
(green). D. Parasites were treated with antibodies against V5-tg (red) and the ER protein BiP 
(green). All four immunofluorescence sets are representative for three independent experiments. Z-
stacks were examined using the Olympus CellR microscope and 100 x magnifications. Images were 
deconvoluted and one image was chosen for this figure (Scale bar: 10 µm). 
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I could not observe any co-localization. In addition, I investigated the localization of V5-
tagged BFR1L and Mitotracker, which stains the mitochondria (Figure 2.4 C). It looks like 
there is some co-localization at the membranes of the parasite. As seen in figure 2.4 D V5-
tagged BFR1L co-localizes with BiP (binding immunoglobulin protein), a marker of the 
endoplasmic reticulum. It can be shown that the ER, as expected, formed a continuous 
network through the cells. Although BFR1L doesn’t seem to have a mitochondrial 
localization signal or a signal peptide according to localization site prediction tools 
(PSORTII, MitoPro and TargetP), the N-terminal V5-tag could influence the localization of 
the protein. For that purpose, the immunofluorescence microscopy was also done with a 
cell line expressing C-terminally myc-tagged BFR1L from the endogenous locus. As 
described above co-localization of myc-tagged BFR1L with TR, Aldolase, Mitotracker and 
BiP was investigated (Figure 2.5). I could not observe a co-localization with TR (Figure 2.5 
A). In contrast to the immunofluorescence microscopy results of the N-terminally V5-tagged 
protein, the C-terminally tagged protein showed partial co-localization with Aldolase (Figure 
2.5 B) as well as with Mitotracker (Figure 2.5 C) and BiP (Figure 2.5 D).  
In addition, the localization of BFR1L was determined by digitonin titration. Digitonin is a 
non-ionic detergent that has a high affinity for cholesterol and permeabilizes cell 
membranes. Cells with N-terminally or C-terminally tagged BFR1L were pelleted and 
treated with increasing digitonin concentrations. The supernatants and pellets were 
collected and samples were analyzed by Western blotting (Figure 2.6). TR was used as 
cytoplasmic marker; Aldolase was used as glycosomal marker; LipDH (Lipoamide 
dehydrogenase) was used as mitochondrial marker and BiP was used as ER marker. V5-
BFR1L (Figure 2.6 A), as well as, BFR1L-myc (Figure 2.6 B) could already be found in the 
early fractions of the supernatant, which suggested that BFR1L was located in the cytosol, 
and the amount of protein increased going to fractions with higher digitonin concentrations. 
Nevertheless, TR, which was used as cytoplasmic marker, was almost completely in the 
supernatant fractions and could not be found in the pellet fractions, whereas BFR1L could 
also be found in the pellet fractions, especially in the ones from lower digitonin:protein ratios. 
In contrast, only very low amounts of Aldolase protein could be found in the supernatant 
fractions with low digitonin:protein ratios and the same was seen for LipDH and BiP: only 
very low amounts of protein could be found in the supernatant fractions with low 
digitonin:protein ratio. However, more LipDH and BiP could be found in the pellet fractions 
than in comparison to Aldolase. The localization of N- and C-terminally tagged BFR1L in 
the pellet fractions suggests partial co-localization with membranes.  
Taken together, no co-localization of BFR1L with DAPI and Aldolase, but partially with TR 
and Mitotracker could be observed according to immunofluorescence microscopy and 
digitonin titration. A clear co-localization with BiP could be observed, which suggests that 
the protein co-localizes fully with the ER and partially with mitochondria. These data agree 
with the localization of BFR1L to the ER in the procyclic form according to the TrypTag 
database and with the data about yeast BFR1p, which localizes to the ER under normal 
growth conditions (Lang et al., 2001). It could also be that BFR1L does not go into the 
organelles, but attaches to the membranes of the organelles from the cytosolic side and 
thereby it looks like partial co-localization. 
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Figure 2.5: Fluorescence microscopy of BF BFR1L-myc cells. BF BFR1L-myc cells were 
subjected to fluorescence microscopy. Nuclear and kinetoplast DNA were stained with DAPI (blue) 
in all four immunofluorescence sets.  A. Parasites were treated with antibodies against V5-tag (red) 
and the cytoplasmic Trypanothione Reductase (=TR) (green). B. Parasites were treated with 
antibodies against V5-tag (red) and the glycosomal Aldolase (green). C. Parasites were treated with 
Mitotracker (red), which stains the mitochondria, and antibodies against V5-tag (green). D. Parasites 
were treated with antibodies against V5-tag (red) and the ER protein BiP (green). All four 
immunofluorescence sets are representative for three independent experiments. Z-stacks were 
examined using the Olympus CellR microscope and 100 x magnifications. Images were 
deconvoluted and one image was chosen for this figure (Scale bar: 10 µm). 
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2.1.3. Protein interactome of BFR1L  
In order to identify the protein interaction partners of BFR1L, which could give a hint how 
BFR1L acts as an RNA-binding protein, tandem affinity purification followed by mass 
spectrometry analysis was performed using in situ expressed TAP-BFR1L, while the other 
allele was deleted. Samples of all steps of the affinity purification were analyzed by Western 
Blotting. Figure 2.7 A shows a representative blot. The first purification step shows that 
cleavage of the TAP-tagged protein by TEV protease released the protein from the beads. 
However, it could not be detected in the elution, because the tag has been removed. 
Aldolase was used as negative control, which should not bind to the beads. Since Aldolase 
is so abundant a small amount was bound to the beads. However, the majority could be 
found in the unbound fraction. In addition, Aldolase should not be released form the beads 
after TEV cleavage. It can be seen that it was still bound to the beads after cleavage. I 
proceeded with a second purification step. As it can be seen by Western Blotting, the elution 
of CBP-BFR1L from the beads did work well, since the majority of the protein was found in 
the elution. The eluted protein and its interaction partners were then analyzed by mass 
spectrometry. Purification of a TAP-tagged ZC3H5 construct served as control. Liquid 
chromatography-tandem mass spectrometry (LC/MS/MS) of four independent TAP-BFR1L 
purifications revealed a total list of 4 putative interaction partners (Figure 2.7 B). BFR1L was 
also significantly enriched, which showed successful pull-down. The candidates were the 
following: Tb927.6.4300 (GAPDH), Tb927.10.2110 (EEF1A), Tb927.10.5620 (Aldolase) 
and Tb10.v4.0052 (microtubule-associated protein 2). Treatment with RNase A had no 
effect on any of these interactions (Figure 2.7 C), indicating that they were not RNA 
Figure 2.6: Digitonin titration of BF V5-BFR1L and BFR1L-myc. Bloodstream form cells with 
endogenous N-terminal V5-tagged BFR1L (A) or C-terminal myc-tagged BFR1L (B) were pelleted 
and treated with increasing digitonin:protein (mg:mg) ratios as indicated on top. Samples were 
centrifuged and fractions of supernatant and pellet were collected and Western Blotting was 
performed. The samples applied for Western Blotting correspond to 3x106 cells. Numbers below the 
blot indicate quantification of the corresponding signal. TR: Trypanothione Reductase (cytosol); 
LipDH: Lipoamide Dehydrogenase (mitochondria); BiP: binding immunoglobulin protein (ER). 
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dependent. The pull-down with RNase A gave a list of 16 putative interaction partners. 
However, the putative candidates in both sets of pull-downs were abundant proteins and it 
did not look like these interactions were specific. By setting a lower threshold, Tb927.9.9550 
was detected as putative interaction partner by MS analysis. In addition, a pull-down of V5-
BFR1L was performed and the elution was also analyzed by LC/MS/MS. Pull-downs of V5-
Tb927.8.1500, V5-Tb927.7.3040 and V5-Tb927.11.4900 served as controls and also total 
lysate of BF was analyzed. The heat map was done with the spectral counts for all the 
proteins that are present in two out of three replicates. Tb927.9.9550 was identified in two 
out of three replicates and especially in the first replicate it had a high number of spectral 
counts (Figure 2.7 D). The heat map showed that Tb927.9.9550 is a specific putative 
interaction partner of BFR1L, because it couldn’t be identified in any other of the performed 
pull-downs. The Tb927.9.9550 protein consists of 212 amino acids and has a predicted 
molecular weight of 24.5 kDa. The polypeptide contains a single transmembrane domain 
spanning residues 4-26 and two low complexity region (Suppl. Figure 2 A). It is conserved 
among Kinetoplastida. However, low sequence identity can be found with the Leishmania 
major orthologue (Suppl. Figure 3). According to the TrypTag website (Dean et al., 2017) a 
C-terminally tagged version of Tb927.9.9550 is located at the ER and the nuclear envelope 
(Suppl. Figure 2B) and it is not essential according to the RNA interference target 
sequencing (Alsford et al., 2011). Tb927.9.9550 protein displays in vivo mRNA binding 
(Lueong et al., 2016) although it lacks any canonical RNA-binding domain and was an up-
regulator in the tethering screen (Erben et al., 2014b). 
Figure 2.7: Affinity purification of TAP-BFR1L revealed one putative interaction partner. To 
identify proteins associated with the candidate protein, I performed Tandem Affinity Purification in a 
BFR1L single knock-out bloodstream form cell line using in situ expressed TAP-BFR1L. Associated 
proteins were analyzed by Mass Spectrometry and compared with TAP-ZC3H5 and TAP-GFP.  
A. 20 µl sample of each step was collected and applied for Western Blotting. B &C. In the volcano 
plot, the ratio of TAP-BFR1L to control (TAP-ZC3H5) in label-free quantification are plotted against 
the log10 of the false discovery rate (FDR) calculated by a permutation-based FDR adapted t-test. 
Significant outliers are labeled. B: without RNase A; C: with RNase A. Tb927.6.4300 (GAPDH), 
Tb927.10.2110 (EEF1A), Tb927.10.5620 (Aldolase) and Tb10.v4.0052 (microtubule-associated 
protein 2). D. Endogenously V5-tagged BFR1L and controls (Tb927.8.1500, Tb927.7.3040 or 
Tb927.11.4900) were purified three times and analyzed as described above. Heat map shows the 
spectral counts considering at least two out of 3 samples with one or more peptides detected. The 
hierarchical clustering was made with one minus Pearson’s correlation. I choose these lines out of 
the whole analysis, because Tb927.9.9550 was the only putative candidate and all other putative 
interaction partners were abundant proteins, which are most likely unspecific. 
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Since the protein interactome of TAP-tagged BFR1L revealed a very short list of putative 
interaction partners, a yeast-two-hybrid (Y2H) assay was performed to find putative new 
candidates. The protein was N-terminally fused with the binding-domain (BD) and 
transformed into yeast (bait). As prey I used yeast containing the mini-ORFeome library 
fused to the activating domain (AD). The bait and prey strains were then combined by 
mating. Unfortunately, I did not get any colonies (data not shown).  
Since BFR1L was identified as an up-regulator in the high-throughput tethering screen 
(Erben et al., 2014), I performed CAT assays to validate the screen result. Expression of 
chloramphenicol acetyltransferase (CAT) was measured in cells expressing different myc-
lambda-N-fusion proteins (BFR1L and Tb927.7.2780). Tb927.7.2780, which is a known 
activator of gene expression, served as positive control (Figure 2.8 A). Expression of the 
proteins was analyzed by Western Blotting (Figure 2.8 B). Indeed, the different proteins 
were expressed even though in different concentrations. Expression of the lambda-N 
proteins was induced with tetracycline for 24h. However, tethering of BFR1L to the CAT 
reporter did not confirm BFR1L as activator of gene expression.  
Taken together, BFR1L might interact with one putative protein (Tb927.9.9550) and it may 
not be an activator of expression when tethered to an mRNA.  
 
Figure 2.8: BFR1L could not be 
validated as activator of gene 
expression by CAT assay.  
A. Expression of chloramphenicol 
acetyltransferase (CAT) was 
measured in cells expressing 
different myc-lambda-N-fusion 
proteins (BFR1L and 
Tb927.7.2780). Tb927.7.2780, 
which is a known activator of gene 
expression, served as control. 
Expression of the lambda-N-myc 
proteins was induced with 
tetracycline (+Tet) for 24h. Results 
show arithmetic mean (black bar) & 
individual values of 3 independent 
experiments. B. Expression of the 
myc-lambda-N-fusion proteins was 
validated by Western Blotting. 
mRNAs encoding ribosomal proteins might be regulated by BFR1L 
24 
2.1.4. Most of the mRNAs associated with BFR1L encode ribosomal proteins 
For the identification of the mRNA targets of BFR1L, Affinity Purification was performed 
from cells expressing TAP-tagged BFR1L. Samples of all steps of the affinity purification 
were analyzed by Western Blotting as described above (Figure 2.9 A). The Western Blot 
showed that the protein was released from the beads. I directly analyzed the RNAs of this 
elution and did not proceed with the second purification step to avoid RNA degradation and 
because this method has worked for several other proteins in our lab. The sequences of 
associated RNAs were determined by RNA-sequencing and compared with total RNA. The 
experiment was performed in duplicates. However, the library preparation of one unbound 
sample failed, so the eluted RNA was compared with the WT total RNA. Principle 
component analysis showed that the elution samples clustered as well as the WT samples. 
Surprisingly, the unbound and WT samples did not cluster well. However, they are still 
clearly separated from the elution samples (Figure 2.9 B). I could identify 46 bound 
transcripts that were at least 2-fold enriched compared to total RNA. Strikingly, more than 
50% of the bound transcripts encoded ribosomal proteins (Figure 2.9 C). According to the 
Fisher’s exact test, the class ‘Ribosome’ was strongly enriched (p-value of    ̴ 2.2e-16). 
DREME analysis (Bailey, 2011) for the identification of a common binding motif in the 
5’UTR, CDS or 3’UTR of the targets was negative. It is known that mRNAs encoding 
ribosomal proteins have relatively low ribosome densities although they are abundant and 
very stable (Antwi et al., 2016). The regulation of mRNAs encoding ribosomal proteins after 
stress is very different from that of most RNAs, since they are neither found in starvation 
stress granules (Fritz et al., 2015) nor in heat-shock granules (Minia et al., 2016). Thus, 
Figure 2.9: Most of the mRNAs associated with TAP-BFR1L encode ribosomal proteins. To 
identify RNAs bound by BFR1L, Affinity Purification in a BFR1L-/TAP bloodstream form cells was 
performed. The bound RNA was purified and analyzed by RNA-seq. Bound RNA was compared 
with total RNA. A. 20 µl sample of each step was collected and applied for Western Blotting. B. 
Principle component analysis (PCA) of the eluted (E), unbound (UB) and wild type (WT) RNA in 
duplicates (KL). C. Functional categories enriched in RIP-Seq data. D. Unbound and eluted RNA 
was analyzed by RT-qPCR. Expression fold change was calculated and normalized to tubulin. 
Results show mean (black bar) and individual values of 1-2 independent experiments. 
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BFR1L might keep its target mRNAs attached to the ribosomes and prevent sequestration 
in granules.  
I attempted to validate the RIP-Seq results by RT-qPCR. TAP-BFR1L and its bound mRNA 
targets were purified by Tandem Affinity Purification and RNA was purified from the 
unbound and eluted samples. The RNA was reverse transcribed into cDNA and qPCR was 
performed to amplify the cDNA of the target mRNAs (Figure 2.9 D). Three targets that 
appeared to bind to TAP-BFR1L were used: Tb927.11.14020 (nuclear RNA-binding domain 
2), Tb927.9.9750 (60S ribosomal protein L11, putative) and Tb927.4.1860 (putative 
ribosomal protein S19). Tb927.10.7880 (putative Sperm tail C-terminal domain containing 
protein), which was not enriched in the RIP-Seq data, was used as negative control. Ct 
values were normalized to Tubulin and expression fold change was calculated. However, 
all putative mRNA targets as well as Tb927.10.7880, which served as negative control, were 
not enriched in the elution. 
Taken together, RIP-Seq of BFR1L identified 46 putative mRNA targets and most of the 
mRNAs were associated with BFR1L encode for ribosomal proteins. Unfortunately, the 
three tested putative mRNA targets could not be validated by qPCR. 
2.1.5. BFR1L does not colocalize with the stress granule marker Scd6 under 
starvation stress 
Next, I investigated whether BFR1L goes to stress granules, since I hypothesized that the 
protein might prevent the sequestration of its attached mRNAs in granules by keeping them 
away from stress granules. The experiment was performed in procyclic cells, because the 
work flow for the stress granule purification was optimized for these cells (Fritz et al., 2015) 
and the expression of BFR1L protein is the same in procyclic and bloodstream form cells 
(Dejung et al., 2016). For that reason, procyclic cells expressing in situ V5-tagged BFR1L 
were treated with starvation stress (cells were transferred to 1x PBS for 2h). Stress granules 
and localization of BFR1L was investigated by immunofluorescence microscopy (Figure 
2.10 A; (PH)). The known stress granule marker Scd6 was used as control. After 2 h of PBS 
treatment Scd6 localized in stress granules in PC trypanosomes, whereas V5-BFR1L was 
still distributed through the cytosol. In addition, starvation stress granule purification was 
performed as described by Fritz et al. (Fritz et al., 2015) (Figure 2.10 B). The protein content 
of the different pellet and supernatant fractions was analyzed by Western Blotting (Figure 
2.10 C). Known stress granule markers, like DHH1 and SCD6, were used as controls. Both 
proteins could be found in the final granule enriched fraction (P4), whereas V5-BFR1L was 
not there. BiP, an ER marker, which should be absent from the final granule enriched 
fraction was there as a contaminant, but nevertheless it was clear that V5-BFR1L does not 
localize to stress granules. 
The role of BFR1L in the stress response was explored in more detail. The BF BFR1L-/- 
cells (DKO) were stressed by starvation (2h in 1x PBS) and recovery was compared with 
BF cells (WT) and the conditional knock-out (cDKO) with (+Tet) and without (-Tet) 
tetracycline induction. Expression of myc-BFR1L was monitored by Western Blotting. As 
described above, I could see a growth defect of the bloodstream form DKO cell line under 
normal growth conditions in one experiment and the cDKO cells grew as the WT in both 
cases: with and without tetracycline induction (see Figure 2.3 A). However, after 2h of 
starvation stress, the DKO grew as the WT and as the cDKO (Figure 2.11 A). Since the 
relative protein abundance of BFR1L is the same in both stages (Dejung et al., 2016), I also 
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Figure 2.10: Investigation of V5-BFR1L 
localization during starvation stress.  
A. PC V5-BFR1L cells were stressed with 
starvation by 2h incubation in 1xPBS and 
then subjected to fluorescence microscopy. 
Parasites were treated with antibodies 
against V5 (red) and the stress granules 
marker Scd6 (green). Nuclear and 
kinetoplastid DNA were stained with DAPI 
(blue). Z-stacks were examined using the 
Olympus CellR microscope and 100 x 
magnifications. Images were deconvoluted 
and one image was chosen for this figure 
(PH). B. Schematic representation of the 
work flow of stress granule purification 
according to Fritz et al. (Fritz et al., 2015). 
C. PC V5-BFR1L cells were stressed with 
starvation by 2h incubation in 1xPBS and 
stress granules were purified as described 
by Fritz et al., 2015. Fractions were 
analyzed by Western Blotting. 
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examined the growth kinetics in the procyclic form. As described above, the procyclic cDKO 
cells grew as the WT, no matter if ectopic expression of myc-BFR1L was induced by 
tetracycline (+Tet) or not (-Tet) (see figure Figure 2.11 C). In addition, starvation stress (3h 
in 1x PBS) did not influence the growth kinetics of the cDKO cells (Figure 2.11 D).  
Taken together, it seems like BFR1L does not go to stress granules in PCs after 2h 
starvation stress in 1x PBS and starvation stress does not influence the growth of procyclic 
cDKO cells. However, BF DKO cells grow as the WT upon starvation stress, whereas they 
show a growth defect without starvation. 
Figure 2.11: Growth of bloodstream form cells and upon double-knockout of BFR1L and 
starvation stress. A. Growth curve for BF (WT), DKO (BF BFR1L-/-) and cDKO (BF BFR1L-/-, MYC, 
+Tet and -Tet) after 2h of starvation stress in 1x PBS. 3x106 cells were collected each day after 
counting and Western Blot of myc-BFR1L was performed. Ponceau staining was used as loading 
control. B. Experiment was performed as described in A using PC (WT) and cDKO (PC BFR1L-/-, 
MYC, +Tet and -Tet) cells. 
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2.2. Discussion 
Regulation of gene expression in T. brucei mainly depends on post-transcriptional 
mechanisms. To identify putative trypanosome post-transcriptional regulators a tethering 
assay was performed (Erben et al., 2014b). The aim of this study was to characterize two 
candidates in more detail. I choose candidates which were shown to be repressors or 
activators in the tethering screen (Erben et al., 2014b; Lueong et al., 2016), because this 
suggests a role in the regulation of gene expression. In addition, the candidate should bind 
to mRNA by interactome capture (Lueong et al., 2016) as I was interested in the regulation 
of gene expression by RBPs; and the protein should be located in the cytosol, because this 
would be compatible with its RNA-binding activity. The candidate should also be essential 
according to RIT-Seq (Alsford et al., 2011), because that suggests an important role in the 
cells. Tb927.10.14150 was chosen as candidate because it was an activator in the tethering 
screen (Erben et al., 2014b; Lueong et al., 2016), and it showed in vivo mRNA binding and 
was one of the top-ranking hits (Lueong et al., 2016), although it lacks a canonical RNA-
binding domain. The protein was named as BFR1L, because of its similarities to the yeast 
protein Bfr1p. Together with its interacting protein Scp160, Bfr1p binds to mRNAs at 
polysomes under normal growth conditions and protects these mRNAs from P-body 
formation (Weidner et al., 2014). However, there is no homologue of Scp160 in 
trypanosomes. Trypanosome BFR1L is not localized in stress granules (Fritz et al., 2015). 
This led to the hypothesis that BFR1L could prevent sequestration of its target mRNAs in 
granules, which was investigated in more detail in this study. 
I could demonstrate that knock-down or knock-out of BFR1L in BF trypanosomes leads to 
a slight growth defect, which can be rescued by ectopic expression of the protein, whereas 
I was neither able to generate an RNAi-mediated knock-down cell line nor to generate a 
DKO cell line of BFR1L in PC trypanosomes. However, I was able to generate a cDKO in 
PCs. Surprisingly, growth was not restricted by removing of tetracycline from these cells 
and cells grew as wildtype even without ectopic expression of myc-tagged BFR1L. These 
results suggest that BFR1L is not essential neither in the bloodstream form nor in the 
procyclic form. 
The localization of the protein according to TrypTag was not known at the beginning of this 
study. This is why I did immunofluorescence microscopy and digitonin titration, which 
showed that the protein does not co-localize with DAPI and Aldolase, but partially with TR 
and Mitotracker. A clear co-localization with BiP could be observed, which suggests that the 
protein co-localizes with the ER and partially with mitochondria. In the digitonin titration 
assay BFR1L was detected in the early fractions of the supernatant, like TR, which is a 
cytosolic protein. However, BFR1L can also be found in the later fractions of the pellet, like 
LipDH and BiP. These data agree with the localization of BFR1L to the ER according to the 
TrypTag database and with the data about yeast BFR1p, which localizes to the ER under 
normal growth conditions (Lang et al., 2001). Most probably BFR1L is located in the cytosol 
and does not go into the organelles, but attaches to the membranes of the organelles from 
the cytosolic side.  
To get a clearer idea about how BFR1L could function, I was interested in the protein 
interaction partners as well as in the target mRNAs. To identify the interaction partners of 
BFR1L I used an endogenously TAP-tagged BFR1L version as well as a V5-tagged BFR1L 
version and IPs were performed. Mass spectrometry analysis revealed Tb927.9.9550 as a 
putative interaction partner. Tb927.9.9550 is a protein of unknown function, which is 
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conserved among Kinetoplastida. The polypeptide contains a single transmembrane 
domain and two low complexity regions. According to the TrypTag website (Dean et al., 
2017) a C-terminally tagged version of Tb927.9.9550 is located at the ER and the nuclear 
envelope. Preliminary immunofluorescence microscopy data show a co-localization of 
BFR1L and Tb927.9.9550 at the ER (data not shown), which suggests that the two proteins 
could act in concert at the outside of the ER. Tb927.9.9550 is not essential according to 
RIT-Seq (Alsford et al., 2011). The protein displays in vivo mRNA binding (Lueong et al., 
2016) although it lacks any canonical RNA-binding domain and was an up-regulator in the 
tethering screen (Erben et al., 2014b). No homologue of Tb927.9.9550 is known in yeast. 
One possibility is that the interaction between Tb927.9.9550 and BFR1L depends on their 
interactions with mRNAs and they could stabilize their targets. However, the function of 
BFR1L as up-regulator of gene expression, which was suggested by the tethering screen 
(Erben et al., 2014b; Lueong et al., 2016), could not be validated by the CAT assay. In the 
tethering screen proteins were fused N-terminally to the lambda-N peptide and inducibly 
expressed in a trypanosome cell line that contains the Blasticidin reporter construct. The 
cells were grown under non-inducing (tet -) and inducing (tet +) conditions with increasing 
Blasticidin conditions. If the tethered proteins increase reporter gene expression, the cells 
should be resistant to higher Blasticidin concentrations as the control cells. One possible 
explanation why BFR1L was suggested to be an activator of gene expression in the 
tethering screen could be that overexpression of the protein makes the cells more resistant 
to Blasticidin. Blasticidin inhibits the termination of translation and thereby stops the de novo 
synthesis of proteins. Initially, Bfr1p was discovered in the 90s in a genetic screen for high-
copy suppressors of Brefeldin A (BFA) in Saccharomyces cerevisiae. BFA, which is a fungal 
toxin, influences the function and structure of the organelles of the secretory pathway 
(Klausner et al., 1992; Lippincott-Schwartz, 1993). It leads to tubulation of the lysosome, to 
fusion of the trans-Golgi network with the endosomes and to tubulation and fusion of the 
Golgi with the ER (Hunziker et al., 1992; Klausner et al., 1992; Pelham, 1991). Bfr1p can 
partially suppress the phenotypes caused by BFA (Jackson and Kepes, 1994). However, 
the mechanisms of action of BFA and Blasticidin are not related. BFR1L could partially 
suppress the phenotype caused by Blasticidin. The resistance of trypanosomes 
overexpressing BFR1L to Blasticidin should be investigated in the future.  
To identify the mRNA targets of BFR1L, I used an endogenously TAP-tagged BFR1L 
version. RIP-Seq identified 46 putative mRNA targets and most of them encode ribosomal 
proteins. Unfortunately, the three tested putative mRNA targets could not be validated by 
qPCR. DREME analysis (Bailey, 2011) of the BFR1L mRNA targets could not identify any 
motif in the 5’UTR, CDS or 3’UTR. It is known that mRNAs encoding ribosomal proteins 
have relatively low ribosome densities although they are abundant and very stable (Antwi 
et al., 2016). In addition, they have an absolutely optimum codon usage (de Freitas 
Nascimento et al., 2018). The ribosomes may run through very fast giving a low ribosome 
density. The regulation of mRNAs encoding ribosomal proteins after stress is very different 
from that of most RNAs, since they are neither found in starvation stress granules (Fritz et 
al., 2015) nor in heat-shock granules (Minia et al., 2016). According to Fritz and coworkers, 
almost half of the identified target mRNAs of BFR1L are not enriched in the granules fraction 
(Fritz et al., 2015). It is known that BFR1L and its protein interaction partner Tb927.9.9550 
do not localize to stress granules (Fritz et al., 2015). BFR1L might keep the enriched 
mRNAs attached to the ribosomes and thus prevent sequestration in granules as it was 
shown for Bfr1p. Thereby it could have a stress-related function.  
mRNAs encoding ribosomal proteins might be regulated by BFR1L 
30 
To investigate the role of BFR1L under stress conditions, procyclic cells were stressed with 
2h starvation and stress granules were purified. The experiment was performed in procyclic 
cells, since the stress granules purification protocol is optimized for this form (Fritz et al., 
2015) and BFR1L has the same relative protein abundance in both stages (Dejung et al., 
2016). It seems like BFR1L does not go to stress granules in PCs. This strengthens the 
hypothesis that BFR1L prevents the sequestration of its target mRNAs to granules. 
Interestingly, BF DKO cells grow as the WT upon starvation stress, whereas they show a 
growth defect without starvation.  
Taken together, BFR1L as well as its putative interaction partner Tb927.9.9550 are 
suggested to be located in the cytosol and attach to the membrane of the ER, from the 
cytosolic side, which suggests that the proteins post-transcriptionally regulate mRNAs at 
the ER. However, only Tb927.9.9550 has a transmembrane domain, which could be 
inserted in the ER. The targets of yeast Bfr1p were enriched for mRNAs encoding for 
proteins involved in cytoplasmic translation, containing ribosomal proteins, and membrane-
associated functions (Lapointe et al., 2015). In addition, Bfr1p does not localize to P-bodies 
under normal growth conditions (Weidner et al., 2014), it is not essential (Jackson and 
Kepes, 1994), and it localizes to the ER (Lang et al., 2001). Lang and colleagues could 
show that Bfr1p is part of a polyribosome-associated mRNP complex, which contains 
Scp160p, Pap1p, additional unidentified proteins and polyadenylated mRNA (Lang and 
Fridovich-Keil, 2000; Lang et al., 2001). The localization of Bfr1p at the outside of the ER 
(Lang et al., 2001), the association of Bfr1p with polysomes (Weidner et al., 2014) and the 
enrichment of its mRNA targets for membrane-related proteins (Lapointe et al., 2015) 
suggests that the Bfr1p targets are directly translated to the ER. Usually mRNAs encoding 
proteins of the secretory pathway are translated into the ER in an SRP-dependent manner. 
However, recently it could be shown in several studies that ribosomes bound to the ER also 
translate mRNAs encoding cytosolic proteins (Reid and Nicchitta, 2015). In HEK293 cells, 
75% of the ribosomes are bound to the ER and approximately 50% of the mRNAs encoding 
cytosolic proteins are bound to these ER-associated ribosomes (Jagannathan et al., 2014; 
Reid and Nicchitta, 2012). The recruitment of mRNAs to the ER can influence the translation 
rate due to a distinct environment of translation factors and regulatory proteins, which 
suggests a role of these ER-bound ribosomes in the regulation of post-transcriptional gene 
expression (Reid and Nicchitta, 2015). During oxidative stress, mRNAs localized to the ER 
can escape from sequestration into stress granules, while free mRNAs in the cytosol are 
recruited to stress granules (Unsworth et al., 2010). I identified mRNAs encoding ribosomal 
proteins as putative targets of BFR1L. My hypothesis is that BFR1L regulates the 
expression of its targets directly at the ER to produce ribosomal proteins. However, 
ribosome biogenesis in eukaryotes occurs in the nucleolus and the ribosomal proteins have 
to be imported into the nucleus after translation (Greber, 2016). The remaining question is: 
Why the mRNAs encoding ribosomal proteins could be translated at the ER? Parts of the 
rough ER are close to the nucleus, which would explain short ways. The ribosomal proteins 
could be imported into the nucleus directly for the ribosome assembly, but BFR1L co-
localizes with the whole ER and not only around the nucleus. By binding of BFR1L to the 
target mRNAs, the mRNAs might be kept in ribosomes and thereby could not sequester 
into stress granules similar to the mechanism described for Bfr1p in yeast (Weidner et al., 
2014). The attachment of BFR1L to the ER could be mediated via Tb927.9.9550, which has 
a transmembrane domain (Figure 2.12). The interaction of BFR1L with mRNAs encoding 
ribosomal proteins under stress should be investigated in the future by FISH. RIP-Seq of 
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BFR1L under stress should give a similar result as I obtained without stress, if BFR1L keeps 
the target mRNAs away from stress granules. 
This study shows that BFR1L in Trypanosomes has some similarities to Bfr1p in yeast. Both 
proteins seem to keep their targets away from different kind of granules. However, the 
mechanism of action is different for the two proteins. While the targets of Bfr1p are 
suggested to be directly translated into the ER, the targets of BFR1L are suggested to be 
translated at the ER into the cytosol. 
 
 
  
Figure 2.12: BFR1L might prevent sequestration of mRNAs encoding ribosomal proteins into 
stress granules. By binding of BFR1L to the target mRNAs, the mRNAs might be kept in ribosomes 
and thereby could not sequester into stress granules (containing proteins like DHH1, SCD6, PABP1, 
RBPs, etc.). The attachment of BFR1L to the ER could be mediated via Tb927.9.9550, which has a 
transmembrane domain. 
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3. ZC3H5 is required for cytokinesis 
3.1. Results 
3.1.1. Downregulation of ZC3H5 rapidly kills bloodstream form cells 
The ZC3H5 (locus Tb927.3.740) protein consists of 246 amino acids with a predicted 
molecular weight of 25.5 kDa. The polypeptide contains a single C3H1-type zinc finger 
domain spanning residues 87-112 (Figure 3.1 A) and is conserved among Kinetoplastida 
(Suppl. Figure 4). Most sequence identity is concentrated around the zinc finger domain 
Figure 3.1: In vitro growth and cell cycle analysis for ZC3H5. A. Domains of ZC3H5. ZnF: Zinc 
finger domain, LC: Low complexity region. B. ZC3H5 RNAi cell line clones expressing TAP::ZC3H5 
from the endogenous locus were analyzed by Western blotting with an anti-PAP antibody over time 
following tetracycline (Tet) induction. Anti-aldolase antibody was used as a loading control. C. Growth 
curve showing cumulative cell counts from three independent experiments over time following 
tetracycline (Tet) induction (+) or not (−) of ZC3H5 RNAi cell line in culture. Tet+ (dashed lines) and 
Tet- (solid lines) (KL). D. BF YFP-ZC3H5 cells were subjected to fluorescence microscopy. Nuclear 
and kinetoplast DNA were stained with DAPI (blue). Images were examined using the Leica DMi8 
spinning disk microscope (Scale bar: 10 µm). E. ZC3H5 RNAi bloodstream form cells were analyzed 
by fluorescence microscopy. Kinetoplast and nuclear DNA was stained with DAPI and parasites were 
treated with antibodies against tubulin (red) (KL). F. The number of nuclei (N) and kinetoplasts (K) per 
cell of the cells described in E was quantified (n>200) at the time-points indicated (KL). G. Knock-down 
of ZC3H5 was induced for various time points, DNA was stained with Propidium iodide and analyzed 
by FACS. 
ZC3H5 is required for cytokinesis 
33 
and towards a proline-rich C-terminal region. To investigate whether ZC3H5 is essential, 
cell growth after RNAi-mediated knock-down of ZC3H5 was analyzed in a stable cell line in 
which one allele of ZC3H5 was tagged in situ with an N-terminal TAP-tag. This experiment 
was done in the bloodstream form (BF) as all the following experiments. Protein samples 
were collected at each time-point to monitor successful knock-down of ZC3H5 (Figure 3.1 
B). Indeed, downregulation of ZC3H5 led to a cell growth arrest after 12-15 h of RNAi 
induction and killed the cells after 48 h (Figure 3.1 C; performed by Kevin Leiss (KL)), which 
indicates that ZC3H5 is essential in this form. According to my results endogenously 
expressed N-terminally YFP-tagged ZC3H5 is located in the cytosol (Figure 3.1 D), which 
was also observed in procyclic cells by the TrypTag website (Dean et al., 2017). YFP-
ZC3H5 was equally distributed throughout the cytoplasm and no overlap with the DAPI 
signal of the nucleus and kinetoplast DNA was observed. The phenotype observed upon 
knock-down of ZC3H5 was also analyzed by fluorescence microscopy (Figure 3.1 E; KL). 
The nuclear and kinetoplast DNA were stained with DAPI and Tubulin staining was used to 
visualize the cell shape. After staining for DNA, cells were scored for different cell cycle 
stages: cells with a single nucleus and kinetoplast (1N1K) are in G1 or S phase, cells with 
two kinetoplasts and one nucleus (1N2K) are in G2 phase, and cells with two kinetoplasts 
and two nuclei (2N2K) are mitotic or post-mitotic. The number of cells with 2 nuclei and 2 
kinetoplasts (2N2K) increased rapidly to approximately 45% of cells after 18 h of ZC3H5 
knock-down (Figure 3.1 F; KL). In addition, even larger numbers of xNxK conformations 
could be observed upon knock-down of ZC3H5. To examine this phenotype in more detail, 
I did FACS analysis of ZC3H5 knock-down cells (Figure 3.1 G). Knock-down of ZC3H5 was 
induced for various times, DNA was stained with Propidium iodide and the cells were 
analyzed by FACS. In the uninduced cells the peaks of the G1-phase (2N) and G2/M-phase 
(4N) showed the same height. After 12h and 15h an increase of the second peak (G2/M-
phase) could be seen. This showed that the number of cells with 2 nuclei and 2 kinetoplasts 
(2N2K) increased rapidly. 18h after induction of ZC3H5 knock-down a decrease of both 
peaks could be observed, because the cells were already dying.  
I conclude that down-regulation of ZC3H5 rapidly kills bloodstream form trypanosomes. In 
addition, the proportion of cells in G2/M phase increased rapidly and cells were often 
arrested in the cytokinesis stage. 
3.1.2. Proteins interacting with ZC3H5 form a complex 
To identify interaction partners of ZC3H5 the cell line described above with endogenously 
TAP-tagged ZC3H5 was used for tandem affinity purification. The purified complexes were 
then analyzed by liquid chromatography-tandem mass spectrometry (Figure 3.2 A; 
performed by Esteban Erben (EE)). Purification of TAP-tagged GFP and TAP-tagged 
BFR1L, which are not related to ZC3H5, served as controls. The quantitative analysis 
revealed a list of 3 putative interaction partners encoded by: Tb927.11.4900, Tb927.7.3040 
and Tb927.8.1500. Tb927.11.4900 protein consists of 560 amino acids with a predicted 
molecular weight of 61.9 kDa. The polypeptide contains four WD40-domains (Figure 3.2 B) 
and most sequence identity is concentrated around the WD40-domains (Suppl. Figure 5). 
Tb927.7.3040 protein consists of 635 amino acids with a predicted molecular weight of 69.1 
kDa. The polypeptide contains three WD40-domains (Figure 3.2 B). However, there is not 
much sequence homology to the Leishmania major homologue (Suppl. Figure 6). 
Tb927.8.1500 protein consists of 601 amino acids with a predicted molecular weight of 63.2 
kDa. The polypeptide contains several low complexity regions (Figure 3.2 B) and most 
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Figure 3.2: TAP-tagged 
ZC3H5 interacts with 
three proteins.  
A. Endogenously TAP-
tagged ZC3H5 and 
controls (TAP-BFR1L 
and TAP-GFP) were 
purified three times. Raw 
data were analyzed by 
MaxQuant, and specific 
interactors were selected 
from background using 
label-free quantification 
in Perseus. In the 
volcano plots, the ratio of 
ZC3H5 to controls are 
plotted against the log10 
of the false discovery rate 
(FDR) calculated by a 
permutation-based FDR 
adapted t-test. Significant 
outliers are labeled (EE). 
B. Conservation of the 
four proteins among 
different Kinetoplastid 
species was analyzed.  
C. Protein complexes 
were purified using an 
anti-V5 affinity matrix. 30 
µg of input (In) and 
unbound (U) proteins and 
total amount of immuno-
precipitated (E) proteins 
were analyzed by 
Western blotting (EE: 
Tb927.7.3040 & Tb927. 
11.4900 pull-down). 
D.-F. Endogenously V5-
tagged proteins (Tb927. 
8.1500, Tb927.7.3040 or 
Tb927.11.4900) and 
control (Tb927.10. 
14150) were purified 
three times and analyzed 
as described above.  
G. Heat map of the 
samples described in D.-
F. It shows the spectral 
counts considering at 
least two out of 3 
samples with one or more 
peptides detected. The 
hierarchical clustering 
was made with Pearson’s 
correlation. The grey box 
indicates ZC3H5 and its 
interaction partners. 
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sequence identity is concentrated in the N-terminal region (Suppl. Figure 7). According to 
the TrypTag website (Dean et al., 2017) an N-terminally tagged version of Tb927.11.4900 
is located in the cytosol and the localization of the two other proteins is not determined yet. 
According to RIT-Seq Tb927.11.4900 and Tb927.8.1500 are essential whereas 
Tb927.7.3040 is not essential (Alsford et al., 2011). ZC3H5 and its interacting proteins are 
all conserved among Kinetoplastida. The interaction of these proteins with ZC3H5 was 
validated by co-immunoprecipitation using cells expressing endogenously YFP-tagged 
ZC3H5 and endogenously V5-tagged protein (Figure 3.2 C; partially EE). After pull-down of 
V5-Tb927.11.4900, V5-Tb927.7.3040 or V5-Tb927.8.1500, YFP-ZC3H5 was enriched in 
the eluted fraction, whereas it was not enriched in the elution of control cells without V5-
tagged protein. Unfortunately, the cells lost the YFP-tagged ZC3H5 expression quickly. The 
interaction was RNA-independent, since RNase treatment did not influence the outcome 
(data not shown). To investigate the protein interactome in more detail, V5-pull-downs of 
endogenously V5-tagged Tb927.8.1500, Tb927.7.3040 and Tb927.11.4900 were 
performed and analyzed by mass spectrometry. Purification of V5-tagged BFR1L served 
again as control. As shown by the volcano plots in figure 3.2 D-F, in each pull-down all three 
ZC3H5 interaction partners were enriched in the elutions and BFR1L was clearly 
underrepresented. However, ZC3H5 was not significantly enriched according to this 
analysis. Comparing the spectral counts for all the proteins that were present in two out of 
three replicates, ZC3H5 was present in the elution of all three replicates of Tb927.7.3040 
and Tb927.11.4900, but not in the elution of Tb927.8.1500 and also not in the elution of the 
negative control BFR1L (Figure 3.2 G). On one hand, ZC3H5 and its interaction partners 
had only low spectral counts in the total lysate, which shows the enrichment of the ZC3H5 
complex upon pull-down of each of the complex proteins. On the other hand, proteins, which 
were abundant in the total lysate, were not enriched in the pull-downs, which shows that 
the purifications were very specific. As already described by the volcano plots, the three 
proteins interacting with ZC3H5 are enriched in all three pull-downs. These experiments 
strongly suggest that the three proteins form a complex that interacts with ZC3H5. To 
identify the stoichiometry of the protein complex subunits the iBAQs of the mass 
spectrometry data of the tandem affinity purification were analyzed. The iBAQ is the sum of 
all the protein’s total intensity divided by the number of observable peptides of a protein 
(Schwanhausser et al., 2011). The stoichiometry of the protein complex subunits was 
determined as 1:2:2 (ZC3H5:Tb927.11.4900:Tb927.7.3040). The stoichiometry calculated 
for Tb927.8.1500 was 0.76, which is inconclusive. Interestingly, Tb927.11.4900 is 
suggested to be a guanine nucleotide-binding beta subunit-like protein (G protein). The 
evidence for Tb927.11.4900 to be a G protein is the conserved G-domains which can be 
found in the sequence (Suppl. Figure 8). However, there are not in the typical G1-G5 order, 
but in a circular permutation of G4-G5-G1-G2-G3, which was shown to be the only possible 
circular permutation that exists in nature (Anand et al., 2006). G-proteins have a GTP-
binding domain and hydrolysis of the bound GTP to GDP leads to conformational changes, 
which can regulate a diversity of functions. G-proteins can be found in all three major 
kingdoms of life, but mainly in eukaryotes (Wittinghofer and Vetter, 2011). Preliminary 
results show that the mutation of the GTP-binding pocket of Tb927.11.4900 is lethal (data 
not shown). The mass spectrometry analysis of the ZC3H5 interaction partners identified 
four proteins, which could assist in the exchange of GTP/GDP: Homologue of SDO1 
(guanine nucleotide exchange factor), TBC-B (likely GTPase activating protein), ADP-
ribosylation factor (GTP/GDP exchange protein) and ARL3C (GTP/GDP exchange protein) 
(Figure 3.2 G). 
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Since yeast two-hybrid (Y2H) of the deadenylase CAF1, which is part of the CAF1-NOT 
complex, gave ZC3H5 as putative interaction partner (Lueong et al., 2016), the interaction 
of ZC3H5 with CAF1 was investigated. This could provide a first link between the repressive 
activity of ZC3H5 and a potential mechanism. N-terminally myc-tagged CAF1 was 
overexpressed in the BF ZC3H5+/TAP cells and affinity purification was performed. 
Uninduced cells served as control. The proteins in the input, unbound and eluted fractions 
were then analyzed by Western Blotting (Figure 3.3 A). Pull-down of TAP-ZC3H5 was 
successful, because it was clearly enriched in the elution. It can be seen that CAF1-myc is 
expressed upon induction with tetracycline. However, only very little CAF1-myc could be 
detected in the elution and this band could also be detected in the control, suggesting that 
ZC3H5 does not interact with CAF1. Finally, the interaction between ZC3H5 and TRACK1 
was explored by Co-IP (Figure 3.3 B), since TRACK1 was detected as putative interaction 
partner by MS analysis by setting a lower threshold. Affinity purification of TAP-tagged 
ZC3H5 was performed and proteins were analyzed by Western Blotting. TAP-BFR1L 
served as control. However, TRACK1 could not be identified neither in the elution of TAP-
ZC3H5 nor in the elution of TAP-BFR1L.  
The previous results suggest that ZC3H5 and the three interaction partners form a complex, 
which was investigated in more detail. A Y2H assay was performed doing pairwise 
interactions of ZC3H5 with the validated interaction partners to map intra-complex 
interactions (Figure 3.4 A). In addition, the deadenylase CAF1 was included in the Y2H 
assay, for the reasons explained above. Successful expression of the constructs in the 
different yeast clones was monitored by western blotting (Figure 3.4 B). All proteins were 
expressed, although at different levels. The Y2H results showed that ZC3H5 as well as 
CAF1 were auto activators as baits. However, ZC3H5 as prey interacted with pBD-
Tb927.11.4900 and pAD-Tb927.11.4900 interacted with pBD-Tb927.7.3040, which 
suggests that Tb927.11.4900 is the linker between ZC3H5 and Tb927.7.3040. Figure 3.4 C 
summarizes all protein interactions between ZC3H5 and the three proteins that were 
identified so far by MS analysis, Co-IPs and Y2H. 
Figure 3.3: ZC3H5 seems not to 
interact with CAF1 and TRACK1. 
A. CAF1-myc expression was 
induced (+Tet) or not (-Tet) in a 
bloodstream form cell line with 
endogenously TAP-tagged ZC3H5. 
TAP-ZC3H5 was purified on an 
anti-PAP affinity matrix. Input (I), 
Unbound (U) and eluted (E) 
proteins were analyzed by Western 
blotting. B. Endogenously TAP-
tagged ZC3H5 was purified by an 
anti-PAP affinity matrix. Input (I), 
Unbound (U) and eluted (E) 
proteins were analyzed by Western 
blotting using anti-PAP and anti-
TRACK1 antibodies. 
Endogenously TAP-tagged BFR1L 
served as control. 
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Figure 3.4: ZC3H5 and its interacting proteins form a complex. A. Two-hybrid interactions of 
ZC3H5 with its putative interaction partners. Interactions marked with + were positive both in 
quadruple dropout plates and via alpha-galactosidase assay. B. Expression of proteins was 
analyzed by Western Blotting. C. Summary of interactions between ZC3H5, Tb927.7.3040, 
Tb927.8.2500 and Tb927.11.4900 by Y2H, Co-IPs and mass spectrometry analysis.  
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Since ZC3H5 was identified as a down-regulator in the tethering screen (Erben et al., 2014), 
I performed CAT assays to validate the screen result and to investigate whether the 
interacting proteins also act as repressors of gene expression. Tethering of these interaction 
partners to a CAT reporter showed that ZC3H5 as well as Tb927.8.1500, Tb927.7.3040 and 
Tb927.11.4900 did act as repressors, whereas the positive control (Tb927.7.2780) acted as 
an activator (Figure 3.5 A). Expression of the proteins was confirmed by Western Blotting 
(Figure 3.5 B&C). 
I conclude from these results that ZC3H5 interacts with Tb927.8.1500, Tb927.7.3040 and 
Tb927.11.4900 and the three proteins also interact with each other. iBAQ analysis suggests 
a stoichiometry of 1:2:2 (ZC3H5:Tb927.11.4900:Tb927.7.3040) and according to the Y2H 
data Tb927.11.4900 is the linker between ZC3H5 and Tb927.7.3040. In addition, all three 
proteins as well as ZC3H5 are repressors of gene expression according to CAT assays. 
These results suggest that ZC3H5 and its interacting proteins form a repressive complex. 
3.1.3. Knock-down of proteins interacting with ZC3H5 results in reduced growth 
Since knock-down of ZC3H5 led to an increase of cells in G2/M phase, I was wondering 
whether knock-down of the three interacting proteins would result in similar cell cycle 
phenotypes. Cell growth after RNAi-mediated knock-down was analyzed and expression of 
proteins was monitored by Western blotting. Down-regulation of all three proteins led to a 
Figure 3.5: ZC3H5 and its interacting proteins decrease reporter gene expression.  
A. Expression of chloramphenicol acetyltransferase (CAT) was measured in bloodstream form cells 
expressing different myc-lambda-N-fusion proteins (Tb927.7.2780, ZC3H5, Tb927.7.3040, 
Tb927.8.1500 or Tb927.11.4900). Tb927.7.2780, which is a known activator of gene expression, 
served as control. Expression of the lambda-N proteins was induced with tetracycline (+Tet) for 24h. 
Results show arithmetic mean (black bar) and individual values of 3 independent experiments.  
B&C. Expression of the myc-lambda-N-fusion proteins was validated by Western Blotting. 
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cell growth arrest after 2 days of RNAi induction (Figure 3.6 A-C). In contrast to ZC3H5 
knock-down, the cells did not die and recovered form reduced growth after 4 days. However, 
the Western Blots showed that the cells escaped from the knock-down after some days, 
because also protein levels increased again (Figure 3.6 D-F). To examine cell cycle 
behavior of the three proteins in more detail, I did FACS analysis upon knock-down of the 
proteins. Knock-down was induced for various time points, DNA was stained with Propidium 
iodide and analyzed by FACS (Figure 3.6 H-J). Upon knock-down of the proteins for 18h an 
increase of the peak of the G2/M-phase (4N) could be seen. This showed that the number 
of cells with 2 nuclei and 2 kinetoplasts (2N2K) increased. 24h after induction of knock-
down a decrease of both peaks could be observed, because the cells were already dying. 
Upon knock-down of Tb927.8.1500 (Figure 3.6 I), the peak of the G2/M-phase (4N) was 
already higher than the peak of the G1-phase (2N) in the uninduced cells. This showed that 
the number of cells with 2 nuclei and 2 kinetoplasts (2N2K) was already increased without 
induction of RNAi. However, this was not surprising, because the cells already grew slower 
without induction of RNAi. The calculated division time was 8.9±0.6 h, whereas it was 
7.3±0.5 h (BF Tb927.11.4900V5/WT RNAi) and 7.6±0.6 h (BF Tb927.7.3040V5/WT RNAi) for the 
Figure 6: Knockdown of the interaction partners of ZC3H5 in bloodstream form cells. A-C. 
Growth curve of three independent experiments for RNAi targeting Tb927.11.4900, Tb927.8.1500 or 
Tb927.7.3040 in BF cells with endogenously V5-tagged protein. Error bars indicate standard 
deviation. Tet + (dark red) and Tet - (light red). D-F. 3x106 cells were collected and Western Blot of 
V5-tagged protein was performed. S9 was used as loading control. H-J. Knock-down of 
Tb927.11.4900, Tb927.8.1500 or Tb927.7.3040 was induced for various times, DNA was stained 
with Propidium iodide and analyzed by FACS. 
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other two cell lines without induction of RNAi. This suggests that the Tb927.8.1500 RNAi 
plasmid is leaky and the protein is already knocked-down without induction.  
Taken together, RNAi of the three interacting proteins leads to a growth defect from which 
the cells recover after 4 days, when the RNAi is not efficient anymore and the protein level 
increases. In addition, the increase of cells with 2N2K, as it was observed for ZC3H5 knock-
down, could be observed for all three interacting proteins with knock-down of Tb927.8.1500 
showing the strongest effect. 
3.1.4. RIP-Seq identifies mRNAs encoding cytoskeleton proteins as ZC3H5 targets 
To gain further information about the mRNA targets of ZC3H5, RNA affinity purification 
followed by next-generation sequencing (RIP-Seq) was performed using the described 
endogenously TAP-tagged ZC3H5 cell line. The RIP-Seq identified 918 putative mRNA 
targets with a log2 fold change between bound/unbound >1 (Figure 3.7 A, EE). Further 
analysis revealed that longer transcripts were slightly more enriched than shorter (p=0.38) 
(Figure 3.7 B, EE) with a negative correlation between cellular mRNA abundance and 
enrichment after RIP-Seq (Pearson correlation -0.31) (Figure 3.7 C, EE). Principle 
component analysis showed that the elution and unbound samples clustered and one 
component that separated the two sample types accounted for nearly all variance (Figure 
3.7 D, KL). Procyclin-associated gene mRNA (PAG1), was the most highly enriched 
transcript (29-fold) and the mostly enriched class of biological processes was ‘cytoskeleton’ 
(79 transcripts) (Figure 3.7 E, EE). On the other hand, transcripts of the category ‘ribosomal 
proteins’ were strikingly underrepresented. The targets were also compared with the cell 
cycle dependent transcriptome (Archer et al., 2011) and 261 putative targets peak in the S-
phase of the cell cycle. The RIP-Seq data were validated by RT-qPCR. TAP-ZC3H5 and its 
bound mRNA targets were affinity purified and the RNA from the unbound and eluted 
samples was purified. RNA was reverse transcribed into cDNA and qPCR was performed 
to amplify the cDNA of the target mRNAs. Five targets that appeared to bind to TAP-ZC3H5 
were used: Tb927.10.10350 (putative Protein Kinase), Tb927.10.7880 (putative Sperm tail 
C-terminal domain containing protein), Tb927.11.10900 (component of motile flagella 9), 
Tb927.9.15050 (nexin-dynein regulatory complex 4) and Tb927.11.5810 (putative surfeit 
locus protein 6). Tb927.4.1860 (putative ribosomal protein S19), which was 
underrepresented in the elution of the RIP-Seq data, was used as negative control. Ct 
values were normalized to Tb927.4.1860 and expression fold change was calculated. All 
putative mRNA targets were enriched in the elution in 3 independent experiments (Figure 
3.7 F). I also normalized the Ct values to Tubulin, which showed that Tb927.10.10350 was 
enriched and the other targets were slightly enriched, whereas the negative control 
Tb927.4.1860 was not enriched (Figure 3.7 G). DREME analysis (Bailey, 2011) for the 
identification of a common binding motif in the 5’UTR, CDS or 3’UTR of the targets identified 
a set of putative binding motifs. Set of mRNAs, which were not enriched in the RIP-Seq 
data, were used as control set of mRNAs. The motifs with the lowest E-value were showing 
a TAG motif surround by a small variety of nucleotides. The motif identified in the 5’UTR of 
the targets had the highest E-value of 1.1E-8 (Figure 3.7 H), the motif identified in the CDS 
of the targets had the lowest E-value of 2.8E-78 (Figure 3.7 I) and the motif identified in the 
3’UTR of the targets had an E-value of 3.3E-19 (Figure 3.7 J). Taken together, RIP-Seq 
identified cytoskeleton enriched ZC3H5 targets and some targets could be validated by RT-
qPCR. 
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Figure 3.7: RIP-Seq identified 918 putative mRNA targets. A: To identify RNAs bound by ZC3H5, 
Tandem Affinity Purification in a cell line expressing in situ tagged TAP-ZC3H5 was performed. The 
bound RNA was purified and sequenced, and the results were analyzed by DEseq2. Bound RNA 
was compared with total RNA. We could identify 981 bound transcripts, which were at least 2-fold 
enriched compared to total RNA (Padj >0.05) (EE). B. Correlation analysis of enriched mRNAs and 
transcript length. C. Comparison of enriched mRNAs and RPKM (reads assigned per kilobase of 
target per million mapped reads). D. Principle component analysis (PCA) of the eluted (E) and 
unbound (UB) in duplicates (KL). E. Functional categories (grey) enriched in RIP-Seq data and cell 
cycle phase, in which targets peak (light red) (EE). F & G. Validation of the RIP-Seq data by qPCR. 
Unbound and eluted RNA was analyzed by RT-qPCR. Expression fold change was calculated and 
normalized to Tb927.4.1860 or tubulin. Results show arithmetic mean (black bar) and individual 
values of 3 independent experiments.  H-J. Identification of possible binding motifs in the ZC3H5 
mRNA targets. Depicted are the sequence motif logos of possible ZC3H5 binding sites in the 5’UTR, 
CDS or 3’UTR. The 918 significantly overrepresented and underrepresented mRNAs in the elution 
fraction of the RIP-Seq experiments were used and all sequences were removed which were shorter 
than 8 nucleotides. Motif identification was done using the DREME algorithm (Bailey, 2011). 
Positives / negatives give information about how many sequences tested contained the motif. As 
control mRNA set, mRNAs that were not enriched in the RIP-Seq analysis and having on average 
the same size, were used. Analysis was restricted to the sense strand. 
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3.1.5. Short-term down-regulation of ZC3H5 results in a minor effect on the 
transcriptome 
To identify the mRNAs that are affected by ZC3H5 knock-down, transcriptome analysis after 
9h and 12h of ZC3H5 knock-down was performed. ZC3H5 knock-down was induced in two 
independent clones (Figure 3.8 A, EE) and the reduction of ZC3H5 protein level upon knock-
down was monitored by Western Blotting (Figure 3.8 B, EE). After 9h and 12h of ZC3H5 
knock-down, RNA was extracted and RNA sequencing was performed. Principle 
component analysis showed that the uninduced (WT) and induced samples (9h and 12h) 
clustered within their group very close. PC1 (83%) and PC2 (10%) accounted for nearly all 
variance within the samples (Figure 3.8 C, KL). However, this showed only minor effects. 
In fact, after 12 h induction only 44 transcripts were up-regulated by >2-fold and only 31 
transcripts were down-regulated by >2-fold (Figure 3.8 D, EE). Reassuringly, the ZC3H5 
mRNA was decreased, which indicated a successful knock-down. Further analysis revealed 
that longer transcripts were slightly more enriched than shorter transcripts in the mRNAs 
identified upon knock-down of ZC3H5 for 9h and 12h (Pearson correlation 0.22) (Figure 3.8 
E, EE) with a positive correlation between cellular mRNA abundance and increasing after 
RNAi (Pearson correlation 0.13) (Figure 3.8 F, EE). To analyze the group of genes that 
were up-regulated upon knock-down of ZC3H5 a threshold of at least 1.5-fold enrichment 
was set, since 2-fold enrichment only gave 44 candidates. The functional group that was 
up-regulated most was ‘ribosomal proteins’ (Figure 3.8 G, EE). Since the tethering screen 
suggested ZC3H5 to be a post-transcriptional repressor, it was expected that target mRNAs 
of ZC3H5 would be increased upon ZC3H5 knock-down. However, comparison of the 
transcriptomic data with the RIP-Seq data did not show any correlation or overlap (Figure 
3.8 I). Transcripts showing the greatest increase in abundance after knock-down of ZC3H5 
were neither selectively enriched nor underrepresented in the RIP-Seq. To validate the 
transcriptomic data, I induced knock-down of ZC3H5 for 12h and 18h, harvested the cells 
and isolated the RNA from the different time points. The RNA was then analyzed by 
Northern blotting using probes specific for the putative up-regulated mRNAs (Figure 3.8 H). 
Upon knock-down of ZC3H5, I observed decrease of the ZC3H5 mRNA and an increase on 
the mRNA levels encoding the proteins Tb927.7.3040 (F-box and WD40 domain containing 
protein), Tb927.11.10340 (putative Serine/threonine-protein phosphatase PGAM5) and 
Tb927.2.4550 (2’-O-ribose RNA methyltransferase SPB1 homologue), which were up-
regulated in the transcriptomic data. mRNA levels of Tb927.3.1660 (SUMO-interacting 
motif-containing protein), which was not up-regulated in the transcriptomic data, remained 
unchanged. Taken together, the abundance of only a few mRNAs changed upon knock-
down of ZC3H5. 
3.1.6. Effect of ZC3H5 down-regulation on ribosomal biogenesis, transcription and 
mRNA processing 
The mRNAs that go up upon ZC3H5 knock-down, are characterized by a long half-life (e.g. 
mRNAs encoding for ribosomal proteins) (Figure 3.9 A), which led to the question of whether 
the transcription and mRNA processing machinery (splicing, transport and turnover) are 
affected. To analyze that, ZC3H5 was knocked-down in bloodstream form trypanosomes 
for 18 h, RNA was isolated and the spliced-leader RNA was analyzed by Northern blotting. 
However, the amount of spliced leader-containing RNA did not change after 18 h induction 
of ZC3H5 knock-down (Figure 3.9 B). This showed that even after knock-down of ZC3H5 
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Figure 3.8: Short term down-regulation of ZC3H5 only slightly affects the transcriptome.  
A. Growth curves showing cell counts over time following knock-down of ZC3H5 RNAi by tetracycline 
induction for two independent clones (EE). B. ZC3H5 RNAi cell line was analyzed by Western 
blotting with an anti-PAP antibody over time following tetracycline induction. Anti-aldolase antibody 
was used as a loading control (EE). C. Downregulation of ZC3H5 was induced for 9h and 12h and 
total RNA was analyzed by DEseq2. The figure shows an MA plot. As down-regulated proteins only 
these were considered, which go down both at 9h and 12h, and being down-regulated more after 
12h than 9h (12h<9h<WT), and vice versa for the up-regulated proteins (EE). D. Principle 
component analysis (PCA) of the WT and ZC3H5 knock-downs in duplicates (EE). E. Correlation 
analysis of fold change average of all mRNAs identified at 9h&12h and transcript length. Pearson 
correlation: P=0.22 (EE). F. Correlation analysis of fold change average up-regulated at 9h&12h and 
RPKM (reads assigned per kilobase of target per million mapped reads). Pearson correlation: 
P=0.13 (EE). G. Functional categories up-regulated upon knock-down of ZC3H5 (EE). H. 
Downregulation of ZC3H5 was induced for 12h and 18h and total RNA was analyzed by Northern 
blotting. Blots were probed with ZC3H5, Tubulin and four mRNAs that were increased in the 
transcriptomic data upon ZC3H5 RNAi. I. Comparison of the fold change of the RIP seq data with 
the fold change of the RNAs of the transcriptomic data upon average knock-down of ZC3H5 for 9h 
& 12h (EE). Red dots are the candidates that are affected by 2-fold in both experiments. All 
transcripts quantified in both experiments with an adjusted P-value of less than 0.05 are shown. 
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for 18h the transcription was still functional and thereby also the mRNA processing 
machinery, because a deregulation of this machinery would affect the mRNA levels, which 
should be seen in the SL Northern Blot. 
The transcriptomic data showed an up-regulation of the functional groups ‘ribosomal 
proteins’ and ‘translation’, which suggests that ribosome biogenesis or translation could be 
affected by ZC3H5 knock-down. To analyze if ribosome biogenesis was affected, ZC3H5 
RNAi was induced for 24 h, RNA was isolated and the levels of pre-5.8S rRNA and pre-18S 
rRNA were analyzed by Northern blotting using probes to detect the rRNA precursors as 
described by Sakyiama et al. (Sakyiama et al., 2013) (Figure 3.10 A). Successful knock-
down of ZC3H5 was monitored by Western Blotting (Figure 3.10 B). A decrease of the 0.17 
kb pre-5.8S rRNA precursor could be seen in one out of three replicates upon knock-down 
of ZC3H5 (Figure 3.10 C&D). The amount of the 5.9 kb pre-5.8S rRNA precursor and 2.7 
kb and 3.7 kb pre-18S rRNA precursors did not change upon knock-down of ZC3H5 (Figure 
3.10 E&F), whereas I could see an increase of the 9.6 kb pre-18S rRNA precursor in one 
out of three replicates. To analyze, whether translation was affected, a 35S-Methionine 
incorporation assay upon ZC3H5 knock-down was performed. BF cells served as control 
and cycloheximide (CHX) treated cells, which inhibits protein synthesis, served as negative 
control. It can be seen that CHX inhibited protein synthesis efficiently and almost no 35S-
Methionine was incorporated in BF as well as uninduced BF ZC3H5TAP/WT RNAi cells. Only 
a slight reduction of 35S-Methionine incorporation after 9h and 18h of ZC3H5 RNAi induction 
could be observed (Figure 3.11). 
Figure 3.9: Short-term down-regulation of ZC3H5 
does not affect transcription and mRNA processing 
machinery in general. A. mRNA half-life of the 
candidates up- or down-regulated upon knock-down of 
ZC3H5 and the total transcriptome. Numbers below 
indicate median (EE). B. Knock-down of endogenously 
TAP-tagged ZC3H5 was induced with Tetracycline (+Tet) 
for 18 h or not (-Tet) in bloodstream form cells, RNA was 
extracted and analyzed by Northern Blotting using a 
probe against the spliced leader RNA. Methylene blue 
staining served as loading control. Spliced leader signal 
was quantified and normalized to Methylene blue 
staining. 
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Taken together, neither transcription and the mRNA processing machinery nor translation 
are heavily affected upon knock-down of ZC3H5. There was also no reproducible effect on 
rRNA processing. 
Figure 3.10: Knock-down of ZC3H5 does not affect pre-rRNA processing. A. Schematic 
representation of the T. brucei rRNA transcription unit, probes used for Northern blotting (gray bars) 
labeled with A (18S rRNA precursor) or B (5.8S rRNA precursor). Processing products observed by 
Northern blotting with corresponding length. Figure modified from: (Sakyiama et al., 2013). B. ZC3H5 
RNAi cell line was analyzed by Western blotting with an anti-PAP antibody following tetracycline 
induction for 24h. Anti-aldolase antibody was used as a loading control. C & D. Knock-down of 
ZC3H5 was induced with Tetracycline (+Tet) for 24 h or not (-Tet) in bloodstream form cells, RNA 
was extracted and analyzed by Northern Blotting using a probe against the pre-18S-rRNA or pre-
5.8S-rRNA in triplicates. Methylene blue staining served as loading control. E & F. Indicated bands 
were quantified and normalized to Methylene blue staining in all three replicates.  
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3.1.7. Short-term down-regulation of ZC3H5 leads to an increase in monosomes 
To investigate the effect of ZC3H5 knock-down on its target mRNAs in more detail, 
polysome fractionation upon ZC3H5 knock-down was performed. Knock-down of ZC3H5 
resulted in a slight increase of the monosomal peak after 12h induction (Figure 3.12). This 
peak increased heavily after 18h induction. However, the calculated monosome/polysome 
ratio after 18h induction is the minimum value, because the monosome peak after 18h of 
knock-down was so high that it could not be detected completely due to technical limitations. 
In addition, a slight decrease of the heavy polysomal fractions could be observed and an 
increase of the 60S peak. I could also observe a peak between the 2mer (2 ribosomes 
attached to the mRNA) and 3mer (3 ribosomes attached to the mRNA) polysome peaks 
upon knock-down of ZC3H5, which suggested a 2 ½mer, that consists of a mRNA with 2 
bound ribosomes and one 40S subunit. 
Since an increase of the monosomal peak could be seen upon knock-down of ZC3H5, it 
was investigated in which fractions of the polysome fractionation ZC3H5 and its protein 
interaction partners can be found. Migration of endogenously TAP-tagged ZC3H5 and 
endogenously V5-tagged Tb927.8.1500, Tb927.7.3040 and Tb927.11.4900 in the different 
fractions of the polysome fractionation was analyzed by Western Blotting (Figure 3.13). TR, 
which is known to not go to the polysomal fractions, and S9, a ribosomal protein known to 
go to the polysomal fraction, were used as controls. It can be seen that TR was mainly in 
the free and monosomal fractions, whereas S9 accumulated in the polysomal fractions. All 
four proteins that were investigated, can be found mainly in the free fractions, but a small 
amount of protein could even be detected in the polysomal fractions. However, the cells 
Figure 3.11: Knock-down of ZC3H5 leads 
to a slight decrease in 35S-Methionine 
incorporation. Knock-down of 
endogenously TAP-tagged ZC3H5 was 
induced with Tetracycline (+Tet) for 9h, 12h 
and 18h or not (-Tet) in bloodstream form 
cells. BF cells served as control. Treatment 
with Cycloheximide (CHX) served as 
negative control. Cells were washed in 
1xPBS + 0.5% glucose and incubated with 
radioactively labelled 35S-Methionine. 
Proteins were separated by SDS-PAGE 
and incorporation of 35S-Methionine 
incorporation was analyzed using phosphor 
imager plates. Coomassie staining served 
as loading control. 35S-Methionine 
incorporation was quantified and 
normalized to Coomassie signal (see 
numbers below the blot). 
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expressing V5-tagged Tb927.8.1500 grew slowly and therefore less cells were used for the 
polysome profiling, which explains the lower absorbance peaks and less detected protein. 
The increase of the monosomal peak upon ZC3H5 knock-down suggests that translation is 
reduced in these cells. Since knock-down of ZC3H5 did not alter mRNA abundance and 
translation is not globally affected, polysome profiling was performed to analyze whether 
the effect is target specific. RNA sequencing of free&40S, monosome&60S, light polysomes 
and heavy polysomes of BF cells and ZC3H5 knock-down after 0h and 12h induction, as 
described in figure 3.14, was performed. To decide which fractions to pool, RNA of each 
fraction was analyzed by Northern Blotting using probes against the spliced leader 
sequence (to detect mRNAs). The strong spot below 200nt is the spliced leader precursor 
RNA (SLRNA) and the smear above is trans spliced mRNA. There was no obvious 
difference of the spliced-leader-containing mRNA between the control cells and the ZC3H5 
knock-down. The Northern blot using a probe against spiked in globin served as loading 
control and the methylene blue staining visualized the rRNA. The fractions were pooled 
individually for each polysome fractionation dependent on the absorbance profile and the 
northern blot as indicated. The fractions of the pooled mRNA were analyzed again by 
Northern Blotting, which could be used for normalization of the RNA-seq results (Figure 
3.15 A&B). A shift of the ZC3H5 mRNA to the free fractions could be observed upon knock-
down of ZC3H5. However, the only fraction in which I could see a difference between the 
RNAs in the uninduced and induced samples was the free fraction (Figure 3.16 A-D). An 
increase of mRNAs ‘encoding ribosomal proteins’ and ‘PAG’ and a decrease of the 
functional groups ‘GRESAG’, ‘Cytoskeleton’, ‘Mitochondrial DNA’, ‘RNA binding’ and ‘citric 
acid cycle’ was observed (Figure 3.16 E). However, due to the pooling of several fractions 
a shift of mRNAs from, for example, 8 to 5 ribosomes would not have been detected. 
Figure 3.12: Loss of ZC3H5 results in an increase in monosomes and a loss of heavy 
polysomes. A. Extracts from bloodstream form cells grown with (12h or 18h) or without (0h) 
Tetracycline to induce ZC3H5 RNAi, were separated on sucrose gradients. The absorbance profiles 
of three typical gradients are shown. Arrow indicates half-mers. B. Average of monosome/polysome 
ratio calculated from the polysome profiles. Error bars indicate the standard deviations around the 
means of three biological replicates. 
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Figure 3.13: ZC3H5 and 
its interaction partners 
do mainly localize in 
early fractions of 
polysome profiling. 
Extracts from 
bloodstream form cells 
endogenously 
expressing TAP-tagged 
ZC3H5 (A), 
endogenously V5-tagged 
Tb927.7.3040 (B), 
Tb927.11.4900 (C) or 
Tb927.8.1500 (D) were 
separated on sucrose 
gradients. Proteins of 
each fraction were 
analyzed by Western 
blotting using antibodies 
against the protein-tag 
(TAP or V5), TR and S9.  
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Figure 3.14: Analysis of RNA in 
polysomal gradients. Extracts 
from bloodstream form wild type 
cells (A) and from bloodstream 
form cells grown without (0h, B) 
or with (12h, C) Tetracycline to 
induce ZC3H5 RNAi, were 
separated on sucrose gradients. 
β-Globin mRNA was spiked in in 
each fraction and RNA of each 
fraction was extracted and 
analyzed by Northern Blotting 
using probes against spliced 
leader RNA to detect 
trypanosomal mRNA and against 
β-Globin as loading control. 
Methylene blue staining shows 
rRNAs. RNA fractions were 
pooled as indicated in 4 groups 
(Free&40S; monosome&60S; 
light polysomes; heavy 
polysomes) and analyzed by 
RNA sequencing. 
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Figure 3.15: Analysis of pooled fractions for RNA Seq. A&B. Northern blots of the combined 
fractions described in figure 13 using probes against spliced leader RNA to detect trypanosomal 
mRNA and against β-Globin as loading control. Methylene blue staining shows rRNA depletion. 
F: Free&40S; M: monosome&60S; L: light polysomes; H: heavy polysomes. The Northern blots 
were quantified and the percentage of total signal in each sucrose gradient fraction is shown. 
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Taken together, short-term down-regulation of ZC3H5 leads to an increase of the 
monosomal peak and the occurrence of half-mers. RNA-Seq of the monosomal peak could 
not identify a change in the mRNA levels in this fraction. However, an increase of mRNAs 
encoding ribosomal proteins in the free fractions could be observed. This suggests that the 
increase of the monosomal peak is due to empty ribosomes and not due to a decrease of 
translation, because then an increase of mRNAs in the monosomal fraction should be 
observed. 
  
Figure 3.16: Knock-down of ZC3H5 leads 
to an increase of mRNAs encoding 
ribosomal proteins in the free fraction. 
A.-D. The RNAs of the fractions described 
in Figure 3.15 were analyzed by RNA Seq. 
MA plots of the different pooled fractions are 
shown comparing 12h ZC3H5 RNAi and 
WT. RNAs encoding ribosomal proteins are 
marked in red. RNAs with a padj <0.05 are 
marked in white and RNAs with a padj>0.05 
are marked in black. RNAs, which change 
at least 2-fold are marked in grey. E. 
Functional categories, which go up or down 
in the free fraction upon knock-down of 
ZC3H5. 
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3.2. Discussion 
ZC3H5 is an RNA-binding protein containing a single C3H1-type zinc finger domain that is 
conserved in Kinetoplastids and it was shown to be essential by RIT-Seq in bloodstream 
form cells (Alsford et al., 2011). I could show that ZC3H5 is located in the cytosol by 
immunofluorescence microscopy of a N-terminally tagged version. This coincides with the 
TrypTag data, which show that a N-terminally tagged version is located in the cytosol and 
a C-terminally tagged version is located in the cytosol as patchy structures (Dean et al., 
2017). 
Down-regulation of ZC3H5 rapidly killed bloodstream form trypanosomes. In addition, the 
proportion of cells in G2/M phase increased rapidly and cells were often arrested in 
cytokinesis. In Trypanosoma, cytokinesis can be divided in three steps: 1. Initiation of 
cytokinesis by signaling events; 2. Ingression of cleavage furrow to bisect the cell; 3. 
Abscission to separate the two daughter cells (Hammarton et al., 2007). The arrest of cells 
in cytokinesis that we observed upon knock-down of ZC3H5 is most likely a defect of the 
abscission, because the cells can build a cleavage furrow, but cannot divide. However, in 
most cases the appearance of cells arrested in cytokinesis is a secondary effect and does 
not mean that the protein of interest is directly involved in cytokinesis (Hammarton et al., 
2007). This is why the phenotype had to be investigated in more detail. To get a clearer 
idea about how ZC3H5 could function, we were interested in the protein interaction partners 
as well as in the target mRNAs.  
To gain further information about the mRNA targets of ZC3H5, which might help to explain 
the cytokinesis arrest, RIP-Seq was performed using the described endogenously TAP-
tagged ZC3H5 cell line. RIP-Seq identified 79 cytoskeleton enriched ZC3H5 targets and 
selected targets could be validated by RT-qPCR. Cytoskeleton proteins are known to play 
a crucial role in cytokinesis in humans, but also other organisms (Fremont and Echard, 
2018). The separation of the two daughter cells by abscission might require remodeling of 
the cytoskeleton and membrane leading to accumulation of proteins at the site of abscission 
(Hammarton et al., 2007). In Trypanosoma, it is also suggested that the rotational force of 
the flagellar beat supports abscission. Knock-down of subunits of the dynein regulatory 
complex, which transmits signals to the axonemal dynein motor, lead to a disturbance of 
the flagellar beat and to cells arrested in cytokinesis (Ralston et al., 2006). The list of 
putative targets of ZC3H5 contains several mRNAs encoding dynein proteins and 
deregulation of this proteins upon knock-down of ZC3H5 could lead to a defect in the 
rotational force of the flagellar beat. Two recent studies identified two cytokinesis initiation 
factors, CIF1 and CIF3, which promote cytokinesis (Kurasawa et al., 2018; Zhou et al., 
2016). If CIF1 is knocked-down the KAT60/KAT80 complex, which is required for the 
cytokinesis furrow ingression, is not localized to the new FAZ tip and the cytokinesis is 
inhibited (Zhou et al., 2016). Secondly, CIF3 interacts with CIF1 and this complex localizes 
to the new FAZ. On one hand CIF1 stabilizes CIF3 and on the other hand CIF3 sustains 
the localization of CIF1 at the new FAZ. These data suggest that both proteins, CIF1 and 
CIF3, are needed for the initiation of cytokinesis (Kurasawa et al., 2018). The mRNAs 
encoding CIF1 and CIF3 as well as an mRNA encoding for katanin (Tb927.11.3870) and 
several mRNAs encoding for flagellar proteins (flagellar attachment zone protein 18, 
paraflagellar rod protein 8, Flagellar member 4, paraflagellar rod protein 10, etc.) were found 
by RIP-Seq as putative targets of ZC3H5. Taken together, an enrichment of mRNA targets 
of the group ‘cytoskeleton’ could explain the cell arrest in cytokinesis upon knock-down of 
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ZC3H5. If the translation of mRNAs encoding cytoskeleton proteins were decreased, the 
cells would lack proteins needed for proper cytokinesis. 
To identify the interaction partners of ZC3H5 an endogenously TAP-tagged ZC3H5 version 
was used. However, we don’t know if it is functional or not, because we never investigated 
that. But we were not able to knock-out the second copy and since the cells lose the YFP-
tag quickly, the tagging might affect the function. Mass spectrometry analysis revealed three 
putative interaction partners, which were later validated by Co-IPs: Tb927.7.3040, 
Tb927.8.1500 and Tb927.11.4900. Tb927.11.4900 and Tb927.7.3040 contain WD40 
domains while Tb927.8.1500 contains several low complexity regions. Tb927.11.4900 is 
located in the cytosol according to TrypTag and the localization of Tb927.7.3040 and 
Tb927.8.1500 is not determined yet (Dean et al., 2017). Further IPs of the three candidates 
followed by MS analysis showed that the three proteins associate with each other, which 
indicates that they form a complex. iBAQ analysis of the TAP purification suggests a 
stoichiometry of 1:2:2 (ZC3H5:Tb927.11.4900:Tb927.7.3040). However, this could not be 
validated by the pull-downs of the three proteins interacting with ZC3H5. According to the 
Y2H data Tb927.11.4900 is the linker between ZC3H5 and Tb927.7.3040. All three proteins 
as well as ZC3H5 are repressors of gene expression according to CAT assays. These 
results suggest that ZC3H5 and its interacting proteins form a repressive complex. In 
addition, the complex is conserved in other Kinetoplastid species, which suggests that it 
could play a role in these species as well.  
Interestingly, Tb927.11.4900 is suggested to be a guanine nucleotide-binding beta subunit-
like protein (G-protein). These proteins have a GTP-binding domain and hydrolysis of the 
bound GTP to GDP leads to conformational changes, which can regulate a diversity of 
functions. G-proteins can be found in all three major kingdoms of life, but mainly in 
eukaryotes (Wittinghofer and Vetter, 2011). The mass spectrometry analysis of the ZC3H5 
interaction partners identified four proteins, which could assist in the exchange of 
GTP/GDP: Homologue of SDO1 (guanine nucleotide exchange factor), TBC-B (likely 
GTPase activating protein), ADP-ribosylation factor (GTP/GDP exchange protein) and 
ARL3C (GTP/GDP exchange protein). All of them are located in the cytoplasm according 
to TrypTag (Dean et al., 2017), which would enable an interaction with Tb927.11.4900. 
Since Tb927.11.4900 is supposed to be the linker between ZC3H5 and TB927.7.3040, 
binding of Tb927.11.4900-GTP to ZC3H5 could recruit Tb927.7.3040, which makes the 
complex active. Hydrolysis of GTP to GDP might lead to the dissociation of the complex. 
RIT-Seq suggested that Tb927.11.4900 and Tb927.8.1500 are essential, while 
Tb927.7.3040 was not (Alsford et al., 2011). However, I could show that RNAi of all three 
proteins leads to a strong growth defect. After 4 days, the cells recovered, when the RNAi 
was not efficient anymore and the protein level increased. In addition, a slight increase of 
cells with 2N2K, as it was observed for ZC3H5 knock-down, could be observed after 
depletion of all three interacting proteins with Tb927.8.1500 down-regulation showing the 
strongest effect. This suggests that knock-down of any protein of the complex leads to an 
arrest in cytokinesis. However, fluorescence microscopy data (DAPI staining) are missing 
at the moment. This should be investigated in the future. 
To identify the mRNAs that are affected by ZC3H5 knock-down, transcriptomic analysis 
upon short-term down-regulation of ZC3H5 was performed. Short-term down-regulation 
was used, because we were interested in catching the primary direct effect. Interestingly, 
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the abundance of only a few mRNAs changed upon knock-down of ZC3H5, which suggests 
that knock-down of ZC3H5 does not affect the transcriptome in general. Perhaps as a 
consequence, the RIP-Seq data show negligible overlap with the transcripts changing at 
least 1.5-fold. The mRNAs that go up upon ZC3H5 knock-down, are characterized by a long 
half-life (e.g. mRNAs encoding for ribosomal proteins), which led to the question, if the 
transcription and the mRNA processing machinery (splicing, transport) were affected. In 
addition, the transcriptomic data showed an up-regulation of the functional groups 
‘ribosomal proteins’ and ‘translation’, which suggests that translation could be affected by 
ZC3H5 knock-down. However, neither general transcription or the mRNA processing 
machinery nor translation were heavily affected upon knock-down of ZC3H5.  
To investigate the effect of ZC3H5 depletion on its target mRNAs in more detail, polysome 
fractionation upon ZC3H5 knock-down was performed. Knock-down of ZC3H5 resulted in 
a slight increase of the monosomal peak after 12h induction and a heavy increase after 18h 
induction. The increase of the monosomal peak upon ZC3H5 knock-down suggests that 
translation is reduced in these cells. However, only a slight decrease of the heavy 
polysomes can be observed, which agree with the de novo protein synthesis results 
(methionine labelling). If the translation is inhibited, the amount of polysomes would heavily 
decrease. The increase of the monosomal peak could be explained by empty ribosomes, 
which were identified in bacteria as a small and large subunit ribosomal subunit without 
bound mRNA (Noll et al., 1973), or by mRNAs, which are bound by only one ribosome. In 
yeast, it was shown by ribosome profiling that monosomes can actively elongate. They 
translate mRNAs encoding low abundance, regulatory proteins, short ORFs, NMD targets 
and uORFs in yeast (Heyer and Moore, 2016). In addition, I could observe in T. brucei a 
peak between the 2mer (2 ribosomes attached to the mRNA) and 3mer (3 ribosomes 
attached to the mRNA) polysome peaks upon knock-down of ZC3H5, which suggested a 2 
½mer, that consists of a mRNA with 2 bound ribosomes and one 40S subunit. It was shown 
in yeast that this half-mers represent stalled translation initiation complexes (Helser et al., 
1981). Half-mers are thought to reflect inefficiencies in translation initiation and to comprise 
monosomes or polysomes with an additional 43S complex (40S ribosomal subunit with 
attached initiation factors) at the initiation codon, before the addition of a 60S ribosomal 
subunit. Half-mers could be observed in T. brucei and yeast under conditions that lead to 
large subunit defects (Jensen et al., 2005; Rotenberg et al., 1988). I suggest that the 
increase in the levels of transcripts characterized by long half-lives upon ZC3H5 down-
regulation might be a consequence of cell cycle arrest. While transcription and mRNA 
processing continue virtually unaltered, mRNAs begin to accumulate. Thus, an apparent 
enrichment of mRNAs characterized by long half-lives become apparent relatively to control 
(uninduced) cells. 
To investigate the increase of the monosomal peak in more detail, RNA-seq of free&40S, 
monosome&60S, light polysomes and heavy polysomes of BF cells and ZC3H5 knock-
down after 0h and 12h induction was performed. The only fraction in which I could see a 
difference between the RNAs in the WT and induced samples was the free fraction. 
However, due to the pooling of several fractions a shift of mRNAs from, for example, 8 to 5 
ribosomes would not have been detected due to insufficient resolution of the experiment. 
Ribosome profiling would be needed to investigate it in general or northern blots across the 
polysome gradient for a few of the target mRNAs of ZC3H5. An increase of mRNAs 
encoding ‘ribosomal proteins’ (as seen in the transcriptome analysis) and ‘PAG’ (putative 
targets of RIP-Seq) and a decrease of the functional groups ‘GRESAG’, ‘Cytoskeleton’, 
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‘Mitochondrial DNA’, ‘RNA binding’ and ‘citric acid cycle’ was observed in the free fraction. 
This suggests that the increase of the monosomal peak is due to empty ribosomes and not 
due to a decrease of translation, because then an increase of mRNAs in the monosomal 
fraction should be observed. An increase of mRNAs in the free fraction could be due to the 
arrest in cytokinesis: the cells are not dividing, which leads to an accumulation of mRNAs. 
The phenotype observed is similar to the arrest of stumpy forms, which are not dividing, 
and stationary procyclic form cells in G0/G1. In the stumpy form, the translation is reduced, 
which leads to an increase of the monosomal peak and a decrease of the shoulder of heavy 
polysomes and a shift of the rRNA from the heavy polysome fractions to the free and 
monosome fractions (Brecht and Parsons, 1998).  
Taken together, the increase of mRNAs encoding ribosomal proteins upon knock-down of 
ZC3H5 in the transcriptome analysis, and the increase of the monosomal peak without an 
increase of mRNAs in this fraction, the occurrence of half-mers as well as the increase of 
mRNAs encoding ribosomal proteins in the free fraction upon knock-down of ZC3H5 in the 
polysome profiles, suggest that the ribosome assembly is disturbed upon knock-down of 
ZC3H5. However, the defect in ribosome assembly seems to be a secondary effect. Knock-
down of ZC3H5 leads to an arrest of cells in cytokinesis, which then leads to an adaptation 
of the cell to the new situation and to the deregulation of ribosome assembly. The primary 
function of the ZC3H5 complex is the regulation of mRNAs encoding cytoskeleton proteins 
and thereby the regulation of cytokinesis (Figure 3.17). The exact mechanism of action is 
not known at the moment, but it is tempting to speculate that the function of Tb927.11.4900 
as G-protein is responsible for the association and dissociation of the complex. This could 
be cell cycle dependent, because the target mRNAs peak in S-phase, which is before 
Figure 3.17: ZC3H5 is required for cytokinesis. ZC3H5 binds to mRNAs encoding cytoskeleton 
proteins. The mRNAs peak in S-phase and the cytoskeleton proteins are needed for cytokinesis. 
ZC3H5 interacts with Tb927.7.3040, Tb927.8.1500 and Tb927.11.4900 as a repressive complex. 
Tb927.11.4900 is suggested to be a G-protein, which could interact with GTP. The exchange of GTP 
to GDP could lead to the disassembly of the complex.  
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cytokinesis happens and the cytoskeleton proteins are needed during cytokinesis. Maybe 
the ZC3H5 complex represses its targets during the rest of the cell cycle and targets are 
de-repressed in S-phase to produce the proteins needed for cytokinesis. However, the 
remaining question is how a repressive complex can act on the targets in a non-constitutive 
way? Maybe the assembly/disassembly of the complex is regulated by post-translational 
modifications of ZC3H5 or one of the other complex proteins or by regulation of the 
GTP/GDP ratio. ZC3H5 depletion neither affects target turnover (transcriptome does not 
change) nor the translation heavily (no difference in methionine labelling and still polysomes 
upon knock-down). Translation might be affected, but not in the extent that we expected. 
One surprising finding of our study is the translational regulation of the molecular machinery 
responsible for executing cytokinesis. 
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4. Material and Methods 
4.1. Trypanosoma cell culture 
4.1.1. Bloodstream form cells 
Monomorphic Lister 427 bloodstream-form trypanosomes were cultured in supplemented 
HMI-9 medium (components listed below) at 37°C in an incubator with 5% CO2. The cell 
concentration was determined by counting using an improved Neubauer counting chamber. 
All work was done under sterile conditions in a laminar flow hood.  
Table 1: Supplemented HMI-9 
quantity ingredients 
17.66g/l Iscove’s modified Dulbecco’s medium 
36 mM NaHCO3 
1 mM Hypoxanthine 
1 mM Sodium pyruvate 
160 mM Thymidine 
50 mM bathocuprono disulfonic acid disodium salt, pH 6.3 
10% (v/v) Heat-inactivated (56°C, 30 min) FBS 
50U/l Penicillin/Streptomycin 
1.5 mM L-Cysteine 
0.14% -Mercaptoethanol 
 
4.1.2. Procyclic cells 
Monomorphic Lister 427 procyclic trypanosomes were cultured in supplemented MEM-Pros 
medium (components listed below) at 27°C. The caps of the cell culture flasks were closed 
tightly and the cells were grown at densities between 0.2-4x106 cells/ml. As described above 
for bloodstream-form cells, an improved Neubauer counting chamber was used for counting 
and work was done in a laminar flow hood. 
Table 2: Supplemented MEM-Pros medium 
quantity ingredients 
1 pkg. MEM-Pros mixture 
1 pkg. MEM vitamins 
1 pkg. MEM non-essential amino acid solution 
100 mg Phenol red 
10% (v/v) Heat-inactivated (56°C, 30 min) FBS 
50U/l Penicillin/Streptomycin 
7.5 mg/l Hemin 
0.14% -Mercaptoethanol 
 
4.1.3. Antibiotics 
For the selection of transgenic trypanosomes, the appropriate antibiotics were added in the 
following concentrations (see table below). All growth experiments were performed in the 
absence of antibiotics. For the inducible expression of genes tetracycline was added to a 
final concentration of 500 ng/ml. 
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Table 3: Antibiotic concentrations 
Antibiotic Bloodstream form Procyclic form 
Phleomycin 1 μg/ml 1 μg/ml 
G418  5 μg/ml 15 μg/ml 
Hygromycin 15 μg/ml 50 μg/ml 
Puromycin 0.2 μg/ml 1 μg/ml 
Blasticidin 5 μg/ml 10 μg/ml 
 
4.1.4. Transfection of bloodstream-form trypanosomes 
2.5x107 cells were pelleted by centrifugation at 2300 rpm for 7 min (centrifuge 5804, 
Eppendorf). Cell pellet was resuspended in 100 µl transfection buffer (components listed 
below) and 5-10 µg linearized plasmid was added. The solution was transferred to an 
electroporation cuvette (2 mm electrodes gap, Peqlab) and electroporation was performed 
using an electroporation machine and program X-001 (Amaxa Biosystems, Nucleofactor II). 
The cells were transferred to 25 ml supplemented HMI-9 medium and grown for 6-8 h at 
37°C and 5% CO2. Afterwards, the appropriate antibiotics were added and 1ml of culture 
was transferred into the first four wells of a 24-well plate each. Culture was diluted by serial 
dilution throughout the plate. Cells were grown at 37°C and 5% CO2 and after 5 days wells 
were analyzed by microscopy to identify single clones. 
Table 4: Transfection buffer 
quantity ingredients 
90 mM Sodium phosphate buffer, pH 7.3 
5 mM Potassium chloride 
0.15 mM Calcium chloride 
50 mM HEPES, pH 7.3 
 
4.1.5. Transfection of procyclic trypanosomes 
1.5x107 cells were pelleted by centrifugation at 2300 rpm for 7 min (centrifuge 5804, 
Eppendorf). Cell pellet was resuspended in 1 ml ZPFM buffer (Zimmerman's Post Fusion 
Medium, components listed below) and pelleted again by centrifugation as described above. 
Cell pellet was resuspended in 500 µl transfection buffer and 5-10 µg linearized plasmid 
was added. The solution was transferred to an electroporation cuvette (2 mm electrodes 
gap, Peqlab) and electroporation was performed using 1.5 kV and resistance R2 (Electro 
Cell Manipulator 600, BTX electroporation systems). The cells were transferred to 25 ml 
supplemented MEM-Pros and grown for 6-8 h at 27°C. Afterwards, the appropriate 
antibiotics were added and 1ml of culture was transferred into each well of a 24-well plate. 
Cells were grown at 27°C and after 7 days wells were analyzed by microscopy to identify 
single clones. 
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Table 5: ZPFM buffer 
quantity ingredients 
132 mM Sodium chloride 
8 mM Potassium chloride 
8 mM Na2HPO4 
1.5 mM KH2PO4 
1.5 mM MgAc x 4 H2O 
90 µM Calcium chloride 
Adjust pH to 7.0 with NaOH 
 
4.2. Cloning 
Genes were amplified and cloned into plasmids using standard molecular biology cloning 
techniques. PCRs were performed using Q5® High-Fidelity DNA Polymerase (NEB) and 
GoTaq® Hot Start Polymerase (Promega) following the manufacturer’s protocol. All 
restriction enzymes were purchased from NEB as well as the T4 DNA ligase, which was 
used for ligations. One step Gateway ligations (Fu et al., 2008) were performed using the 
Gateway LR Clonase II enzyme mix or BP Clonase II enzyme mix (Thermo Fisher 
Scientific). Gibson cloning (2x Gibson Master Mix, NEB, E2611S) was used to assemble 
multiple DNA fragments into a plasmid.  
4.3. SDS-PAGE and Western Blotting 
3-5x106 cells were collected per sample, resuspended in 6x Laemmli Buffer and heated at 
95°C for 10 min. The samples were subjected to SDS-PAGE gel electrophoresis using 10% 
polyacrylamide gels. The gels were then stained with SERVA blue G or blotted on a 0.45 
µm nitrocellulose blotting membrane (Neolabs). To verify the protein transfer, the 
membrane was stained with Ponceau S (SERVA). The membrane was blocked with 5% 
milk in TBS-Tween and incubated with appropriate concentrations of first and secondary 
antibodies (see table below). Western Lightning Ultra® (Pekin Elmer) was used as 
chemiluminescence system and signals were detected with the LAS-4000 imager (GE 
Healthcare) and CCD camera (FujifilmTM). 
Table 6: 6x Laemmli buffer 
quantity ingredients 
375 mM Tris-HCl pH 6.8 
12% SDS 
45 mM EDTA 
30% ß-Mercaptoethanol 
60% Glycerol 
0.01% Bromophenol Blue 
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Table 7: Antibodies for Western Blotting 
antibody company Product 
number 
host dilution 
Aldolase 
  
rabbit 1:50000 
c-myc (9E10) Santa Cruz  
Biotechnology 
B0614 mouse 1:2000 
PAP (Peroxidase-anti  
Peroxidase) 
Sigma P-2026 rabbit 1:20000 
S9 
  
rat 1:1000 
TR 
  
rabbit 1:2000 
V5 Biorad MCA1360 mouse 1: 2000 
BiP J. Bangs, Buffalo 
(from Krauth-Siegel lab) 
rabbit 1:1000 
CBP Millipore 07-482 rabbit 1:4000 
LipDH 
  
rabbit 1:4000 
Scd6 used in A. Singh paper 
 
rabbit 1:10000 
Dhh1 from Susanne Kramer 
 
rabbit 1:15000 
TRACK from Esteban Erben 
 
rabbit 1:2000 
HA Roche 11867423001 rat 1:1000 
GFP Santa Cruz 
 
mouse 1:2000 
ECL Anti mouse IgG GE Healthcare NA931V 
 
1:2000 
ECL Anti rabbit IgG GE Healthcare NA934V 
 
1:2000 
ECL Anti rat IgG GE Healthcare NA935V goat 1:2000 
ECL Anti mouse IgG  
true blot 
Rockland 18-8817-33 
 
1:2000 
 
4.4. Digitonin Titration 
For each sample 3x107 cells were collected by centrifugation at 2000g for 10 min at 4°C. 
The pellet was resuspended in 100 µl 1x PBS and centrifuged at 10000g for 5 min at 4°C. 
Pellet was resuspended in 50 µl STE buffer (components listed below) and centrifuged at 
10000g for 5 min at 4°C. A 10 µg/µl digitonin stock solution was heated at 98°C for 5 min 
and cooled down before use. Seven different digitonin containing solutions, ranging from 0-
1.65 µg/µl Digitonin, were prepared and each pellet was resuspended properly in 60 µl of 
one solution. The samples were incubated at 25°C for 5 min and then centrifuged 
immediately at 10000g and 4°C for 5min. The supernatant was transferred to another tube 
containing 20 µl 4x SDS-PAGE sample buffer. The pellet was washed twice with 1x PBS 
by centrifugation (4°C, 10000g, 5 min) and finally resuspend it in 80 µl 1x Laemmli buffer. 
Samples were analyzed by Western Blotting. 
Table 8: STE buffer 
quantity ingredients 
10 mM Tris-HCl, pH 8.0 
0.15 M NaCl 
1 mM EDTA, pH 8.0 
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4.5. Tandem affinity purification 
4.5.1. 1st step of TAP 
1x109 bloodstream-form trypanosomes with a concentration of 1x106 cells/ml were pelleted 
by centrifugation at 3000 rpm for 13 min. The pellet was resuspended in 50 ml 1x PBS and 
the cells were UV-crosslinked (2x2400 µJoules, Stratagene UV crosslinker) in two P15 Petri 
dishes on ice. The cells were transferred to a Falcon and pelleted by centrifugation at 2300 
rpm for 7 min. Cells were snap-frozen in liquid nitrogen. Cells were lysed in 0.5 ml lysis 
buffer (components listed below) by passing them 20 times through a 21G x 1 ½” needle 
using a 1 ml syringe and 20 times through a 27G x ¾ needle. Cell debris was pelleted by 
centrifugation at 10,000 g for 15 min at 4°C. Afterwards the supernatant was transferred to 
a new tube and salt concentration was adjusted to 150 mM KCl. 250 µl IgG Sepharose 6 
Fast Flow beads (GE Healthcare, 17-0969-01) were washed 3 times with 2 ml IPP-150 
buffer (components listed below) by centrifugation at 3000 rpm, 3 min, 4°C and let beads 
settle down for 10 min afterwards. Cell lysate was added to the washed beads and 
incubated for 2h at 4°C while rotating. Afterwards unbound fraction was collected. Beads 
were transferred to a 10 ml Poly-Prep Chromatography column (Biorad, 731-1550) and 
beads were washed 4 times with 10 ml IPP-150 buffer. At the end, beads were transferred 
in 2 ml IPP-150 buffer to a 2 ml tube and centrifuged as described before to remove the 
remaining buffer. 0.5 ml TEV cleavage buffer (0.5 ml IPP-150 buffer + 5 µl TEV Protease) 
was added to the beads and beads were rotated at 16°C for 2h. Beads were centrifuged as 
described above and elution was collected. Beads were washed again in 500 µl IPP-150 
buffer to elute remaining protein. 
Table 9: lysis buffer for TAP 
quantity ingredients 
20 mM  Tris pH 7.5 
5 mM  MgCl2 
0.1% IGEPAL 
1 mM DTT 
100U RNasin 
200 µl of 1 pill complete Mini, EDTA-free in 1 ml H2O per 1x109 cells 
 
Table 10: IPP-150 buffer 
quantity ingredients 
20 mM Tris pH 7.5 
5 mM MgCl2 
0.1% IGEPAL 
1 mM DTT 
100U RNasin 
150 mM KCl 
 
4.5.2. 2nd step of TAP 
200 µl calmodulin affinity bead suspension (Agilent Technologies, #214303-52) was 
transferred to a 10 ml Biorad column and washed 3 times with 10 ml IPP-150 Calmodulin-
binding buffer (components listed below). 3 ml Calmodulin-binding buffer and 3 µl CaCl2 
was added to 1ml TEV eluate and solution was transferred to the washed beads. Columns 
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were rotated at 4°C for 1h. The unbound sample was collected and the beads were washed 
3 times with 10 ml Calmodulin-binding buffer. Afterwards, the proteins were eluted in 1 ml 
Calmodulin-elution buffer (components listed below). For the elution the beads were 
transferred in an Eppendorf tube and rotated for 1h at 4°C. The beads were pelleted by 
centrifugation at 3000 rpm at 4°C for 3 min and elution was removed from the beads. 
Table 11: Calmodulin-binding buffer 
quantity ingredients 
add the following ingredients to IPP-150 buffer: 
10 mM ß-mercaptoethanol 
1 mM magnesium acetate 
1 mM imidazole 
2 mM CaCl2 
 
Table 12: Calmodulin-elution buffer 
quantity ingredients 
add the following ingredients to IPP-150 buffer: 
10 mM ß-mercaptoethanol 
1 mM magnesium acetate 
1 mM imidazole 
10 mM EGTA 
 
4.6. Trichloroacetic acid (TCA)-Acetone precipitation 
The proteins of the unbound and eluate fractions were concentrated by TCA precipitation.  
6 volumes of 13% TCA in acetone was added to the sample and the proteins were 
precipitated at 4°C overnight. At the next day, samples were centrifuged at 7000 rpm for 2h 
at 4°C. The supernatant was removed with a glass pipet keeping 1ml left. The pellet was 
resuspended in remaining liquid and was transferred to an Eppendorf tube and centrifuged 
at 13200 rpm for 20 min at 4°C. Supernatant was removed and pellet was washed with 1ml 
acetone. Finally, the pellet was resuspended in 2x Laemmli buffer and boiled at 95°C for 10 
min. Samples were loaded on a 4-12% Bis-Tris 1.5 Nu PAGE gel (#15071080-2289, 
Novex). The gel was run at 30 mA until the running front reached 1.5 cm in NuPAGE Mops 
SDS Running Buffer (NP0001; Invitrogen). Gel was stained with colloidal Coomassie blue 
G-250 and handed to the Mass Spec facility for protein analysis.  
4.7. decrosslinking 
RNA of unbound and eluate fractions was de-crosslinked from the protein with Proteinase 
K. 10 µl 10% SDS, 10 µl 0.4 M EDTA and 20 µl Proteinase K (NEB, P8107S) were added 
to 500 µl sample and incubated for 15 min at 42°C. Afterwards total mRNA was extracted 
using peqGold Trifast (peqLab) according to manufacturer’s protocol. If RNA was used for 
cDNA synthesis it was, in addition, purified with the Nucleospin RNA purification kit 
(Macherey-Nagel). 
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4.8. rRNA depletion 
rRNA of the unbound sample was depleted by an RNaseH. RNA was mixed with 
hybridization buffer (components listed below) and anti-rRNA oligo mix (131 oligos ~50b, in 
3,275μl of the mix – 0.5μM conc. of each oligo) and hybridized for 2 min at 95°C. Afterwards 
the temperature was cooled down to 37°C in steps of 0.1°C per second. RNaseH (Thermo 
Fisher) and 10x RNaseH buffer (Thermo Fisher) was added and sample was incubated at 
37°C for 20 min. DNA was removed by adding Turbo DNase (Ambion) and another 
incubation at 37°C for 20 min. RNA was cleaned up with RNA clean-up & concentrator 
columns (Zymo Research, R1015) according to manufacturer’s protocol. 
Table 13: 5x hybridization buffer 
quantity ingredients 
500 mM  Tris pH 7.5 
1 M NaCl 
 
4.9. RNA Sequencing 
RNA-seq was done by David Ibberson of the CellNetworks Deep Sequencing Core Facility 
at the University of Heidelberg. NEBNext Ultra RNA Library Prep Kit for Illumina (New 
England BioLabs Inc.) was used for library preparation. The libraries were multiplexed and 
sequenced with a HiSeq 2000 system or NEXTseq system, generating 50 bp single-end 
sequencing reads. The quality of the raw sequencing data was checked using FastQC 
(http://www. bioinformatics.babraham.ac.uk/projects/fastqc), and then the sequencing 
primers were removed using Cutadapt (Martin, 2011). The data was aligned to the T. brucei 
TREU 927 reference genome using Bowtie2 (Langmead and Salzberg, 2012), then sorted 
and indexed using SAMtools (Li et al., 2009). Reads aligning to open reading frames of the 
TREU 927 genome were counted using custom python scripts and a custom pipeline was 
used (Leiss et al., 2016). Analysis for differentially expressed genes was done in R using 
the DESeq2 package (Love et al., 2014), using a custom tool for trypanosome 
transcriptomes (Leiss and Clayton, 2016) which also yields principal component analysis 
plots. Comparative analysis was limited to a list of unique genes modified from (Siegel et 
al., 2010). Gene annotations are manually updated versions of those in TriTrypDB and 
categories were assigned manually. Other statistical analysis was done in R. The 5’UTR, 
CDS and 3’UTR motif enrichment search was done using DREME (Bailey, 2011); annotated 
5’UTR, CDS and 3’UTR sequences were downloaded from TriTrypDB and we considered 
only the mRNAs with 3’UTRs >8 nt.  
4.10. RNA isolation and Northern Blotting 
5x107 cells were used for the extraction of total mRNA using peqGold Trifast (peqLab) 
according to manufacturer’s protocol. The RNA was separated on Agarose-Formaldehyde 
gels and blotted on a nylon membrane (Amersham Hybond-N+, GE Healthcare, RPN203B). 
RNA was cross-linked on membrane by UV light (2x240 mJoules) and stained afterwards 
with methylene blue (SERVA). In case of radioactively labelled DNA probes, the blot was 
pre-hybridized for 1 h at 65°C with hybridization solution (components listed below). The 
northern blots were then hybridized with the appropriate probes. [α-32P]dCTP radioactively 
labelled DNA probes (Prime-IT RmT Random Primer Labelling Kit, Stratagene) were used 
to detect the mRNAs. Membrane was incubated with the probe overnight at 65°C. At the 
next day, blot was washed twice with 2xSSC/0.1% SDS at RT for 10 min and once with 
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1xSSC/0.1% SDS at 65°C for 10 min. To detect the SL RNA, the appropriate oligonucleotide 
(CZ4490) was labelled with [γ-32P]ATP using T4 polynucleotide kinase (NEB). In this case, 
that membrane was pre-hybridized for 1 h at 42°C with hybridization solution (components 
listed below) before the radioactively-labelled oligonucleotide was added and incubated 
with the membrane overnight at 42°C. At the next day, blot was washed 3x with 
6xSSC/0.05% Na-Pyrophosphate at RT for 15 min and once with 6xSSC/0.05% Na-
Pyrophosphate at 42°C for 10 min. Afterwards, the blots were exposed to autoradiography 
films and signal was detected with the phosphoimager. The images were processed using 
ImageJ.  
Table 14: Hybridization solution for DNA probes 
quantity ingredients 
2.5 ml 20x SSC 
5.9 ml H2O 
0.5 ml 10% SDS 
1 ml 50x Denhardt's Solution 
0.1 ml 10 mg/ml Salmon Sperm (denatured at 95°C for 5 min) 
 
Table 15: Hybridization solution for oligonucleotide probes 
quantity ingredients 
2.5 ml 20x SSC 
5.9 ml H2O 
0.5 ml 10% SDS 
1 ml 50x Denhardt's Solution 
0.1 ml 5% Na-pyrophosphate 
0.1 ml 10 mg/ml Salmon Sperm (denatured at 95°C for 5 min) 
 
4.11. Immunofluorescence microscopy 
Tissue culture glass slides with 8 chambers (Falcon, 354108) were treated with 0.1% Poly-
Lysine (Sigma, P-8920). If mitochondria staining was applied, Mitotracker Red CMXRos 
(Thermo Fisher Scientific) was added to the cells to a final concentration of 50 nM five 
minutes before collection. For each chamber of the slide, 2.5x106 T. brucei cells were 
collected and pelleted by centrifugation (2 min, 2300 rpm). The cells were washed once in 
1x PBS. Next, the cell pellet was resuspended in 20 µl 1xPBS and 0.5 ml 4% 
Paraformaldehyde in 1x PBS was added and incubated for exactly 18 min. Cells were 
pelleted by centrifugation (2 min, 2300 rpm) and washed 3 times with 1x PBS. Finally, the 
pellet was resuspended in 200 µl 1x PBS and transferred to the chamber of the chamber 
glass slide. The chamber glass slide was left at 4°C overnight that a sufficient number of 
cells can settle down. At the next day, liquid and unbound cells were removed from the 
chamber and 0.2% (w/v) Triton X-100 in 1x PBS was added. Slide was incubated at RT on 
a shaker for 20 min. The chamber glass slide was washed 3 times with an excess of 1x 
PBS to remove the residual Triton X-100. 0.5% (w/v) gelatin in 1x PBS was added to the 
chambers and incubated at RT on a shaker for 20 min. The blocking solution was removed 
and the first antibody was added to each chamber diluted in 0.5% gelatin in 1x PBS 
(dilutions: see table below) and incubated at RT on a shaker for 60 min. Afterwards, slide 
was washed twice with an excess of 1x PBS and twice with an excess of 0.5% gelatin in 1x 
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PBS. The washing solution was removed and the secondary antibody was added to each 
chamber diluted in 0.5% gelatin in 1x PBS (dilutions: see table below) and incubated at RT 
on a shaker for 60 min in the dark. Slide was washed twice with an excess of 1x PBS 
followed by 15 min incubation with 1x PBS containing 100 ng/ml DAPI (D9542, Sigma-
Aldrich) to stain the nuclear and kinetoplast DNA. Slide was washed twice with an excess 
of 1x PBS. The chamber scaffold was removed and the glass slide was air-dried. One drop 
of mounting medium (H-1000, VECTASHIELD) was added to each part of the slide and a 
cover slide was placed on top. Cover slide was fixed on the glass slide with nail polish and 
slides were stored at 4°C in the dark until they were analyzed by fluorescent microscopy. 
All images were examined with the Olympus IX81 microscope. A 100x Oil objective with a 
numerical aperture of 1.45 was used. Digital images were taken with ORCA-R2 digital CCD 
camera C10600 (Hamamatsu) and using the xcellence rt software. The bright field images 
were taken using differential interference contrast (DIC). Fluorescent images were taken as 
Z-Stacks with a high of roughly 4 µm and a step width of 0.2 µm. The images were 
deconvoluted (Wiener Filter, Sub-Volume overlap: 20) and then processed using ImageJ. 
At first the background was subtracted and brightness and contrast were adjusted 
automatically. The most in focus image of the deconvoluted stack was used.  
Table 16: Antibodies for immunofluorescence microscopy 
antibody company 
product 
number host dilution 
Aldolase   rabbit 1:500 
TR   rabbit 1:500 
V5 Biorad MCA1360 mouse 1:200 
BiP J. Bangs, Buffalo (from Krauth-Siegel lab) rabbit 1:1000 
Scd6 used in A. Singh paper  rabbit 1:1000 
c-myc Sigma  mouse 1:1000 
Alexa 488 anti-mouse    1:500 
Alexa 488 anti-rabbit    1:500 
Cy3 anti-mouse    1:500 
 
4.12. Expression and Purification of TEV Protease 
Rosetta (DE3)pLysS cells with pHT24 TEV were grown in LB medium containing 10 mg/ml 
Ampicillin and 40 mg/ml Chloramphenicol at 37°C to an OD600 of 0.6 before they were 
inducted with 1 mM IPTG. Cells were then shifted to 20°C and grown over night. Cells were 
harvested by centrifugation (5000 g, 4°C, 20 min) and lysed in buffer A (components listed 
below). For lysis, cells were sonicated 6x for 30 sec. Triton X-100 was added 1/100 to the 
lysate and cell debris was pelleted by centrifugation (7000 rpm, 4°C, 60 min). The soluble 
fraction was filtered through a 0.45 µm filter. The cell extract was loaded on Ni-NTA super 
flow beads (1018611, Qiagen), which were equilibrated with buffer A before, and incubated 
for 1 h at 4°C while rotating. Beads were washed with wash buffer (buffer A + 20 mM 
Imidazole). Afterwards TEV protease was eluted with elution buffer (buffer A + 500 mM 
Imidazole). EDTA (to a final concentration of 2 mM) and DTT (to a final concentration of 10 
mM) was added to the eluate and protein concentration was measured with Bradford assay. 
Enrichment of the TEV protease was investigated by analyzing the different fractions of the 
purification steps on a 10% SDS gel followed by Coomassie staining. The TEV protease 
was used for TAP. 
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Table 17: Buffer A 
quantity ingredients 
50 mM Na2HPO4 
300 mM NaCl 
5 µg/ml  Leupeptin 
0.5 mg/ml Heparin 
 
4.13. Stress granules purification 
Stress granules were purified from 5x108 control or starvation-stressed cells (2h in 1x PBS) 
procyclic cells as described by (Fritz et al., 2015). 
4.14. 35S-Methionine labeling 
5x106 cells were collected by centrifugation (2300 rpm, 7 min) and washed twice with 1x 
PBS + 0.5% glucose (3000 rpm, 5 min). The pellet was resuspended in 500 µl labeling 
medium (components listed below) and incubated for 15 min at 37°C. 10 µCi 35S-Methionine 
was added and incubated for 30 min at 37°C. Cells were washed twice with 1x PBS + 0.5% 
glucose (3000 rpm, 5 min). Finally, supernatant was removed and pellet was resuspended 
in 1x Laemmli buffer and boiled at 94°C for 10 min. Samples were run on a 10% SDS gel 
and stained with Coomassie afterwards. Gel was dried, exposed exposed to 
autoradiography films and signal was detected with the phosphoimager. The images were 
processed using ImageJ.  
Table 18: Labelling medium 
quantity ingredients 
Dulbecco's modified eagle medium (GIBCO) supplemented with: 
25 mM HEPES 
2 mM Glutamine 
0.1 mM Hypoxanthine 
1.5 mM L-Cysteine 
0.0028% β-Mercaptoethanol 
0.05 mM Bathocuproine sulfate 
10% heat-inactivated FCS previously dialyzed against 30 mM 
HEPES pH7.3/150 mM NaCl 
 
4.15. CAT assay 
Expression of protein of interest tagged lambda-myc was induced with 500 ng/ml 
Tetracycline overnight. 3x106 cells were collected for a Western Blot. 1x107 cells were 
pelleted by centrifugation (2300 rpm, 7 min) and washed twice in 1 ml cold 1x PBS (spin 
down at 3000 rpm for 5 min at 4°C).  Finally, the pellet was resuspended in 200 µl 100 mM 
Tris-HCl, pH 7.8. For lysis, the cells went through two freeze-thaw cycles on dry ice. Cell 
lysate was centrifuged at 13000 rpm for 3 min at 4°C and supernatant was transferred to a 
new tube. Protein concentration was determined by Bradford assay and 1 µg protein was 
used for the CAT assay. 1 µg protein in solution was filled up to 50 µl with 100 mM Tris-
HCl, pH 7.8 and mixed with 200 µl 100 mM Tris-HCl, pH 7.8, 2 µl 40 mg/ml Chloramphenicol 
(Serva, 16785.03) and 10 µl 14C-butyryl-CoA in a scintillation tube (NEB). 4 ml Ultima Gold 
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F Scintillation Cocktail (PerkinElmer, 6013171) was added and measurement was started 
using a scintillation counter (LS6000IC, Beckman) measuring 14C.  
4.16. Bradford assay 
The Bradford assay was used to determine protein concentrations. Bradford reagent 
(Protein Assay Dye Reagent Concentrate, Bio-Rad, #5000006) was diluted 1:5 in water and 
200 µl of this dilution was added in each well of a 96-well plate. 0 µg, 0.5 µg, 1 µg, 2 µg and 
2.5 µg BSA was prepared in H2O for a BSA standard curve, respectively. 10 µl of these 
solutions were added to separate wells of a 96-well plate. In addition, 5-10 µl of the protein 
solutions of which the protein amount should be determined, was added to separate wells. 
The plate was incubated at RT for 5 min and then measured with the plate reader (Tecan). 
The wavelength at 562 nm was determined using FLUOR4.excel. A BSA standard curve 
was calculated in Excel and the linear regression line was determined. With the help of the 
linear regression line the protein concentration was calculated.  
4.17. IP using magnetic beads 
1x109 bloodstream-form trypanosomes with a concentration of 1x106 cells/ml were pelleted 
by centrifugation at 3000 rpm for 13 min. The pellet was resuspended in 50 ml 1x PBS and 
the cells were UV-crosslinked (2x2400 µJoules, Stratagene UV crosslinker) in two P15 Petri 
dishes on ice, when the RNA was used for further experiments. The cells were transferred 
to a conical tube and pelleted by centrifugation at 2300 rpm for 8 min. Cells were snap-
frozen in liquid nitrogen. Cells were lysed in 0.5 ml lysis buffer (components listed below) 
by passing them 20 times through a 21G x 1 ½” needle using a 1 ml syringe and 20 times 
through a 27G x ¾ needle and salt concentration was adjusted to 300 mM KCl. 1x DNase 
buffer (components listed below) and 10 µl DNaseI (NEB, M0303S) was added and sample 
was incubated at 37°C for 10 min. 5 mM stop solution (components listed below) was added, 
sample was mixed and incubated on ice for some minutes. Cell debris was pelleted by 
centrifugation at 10,000 g for 10 min at 4°C. Afterwards the supernatant was transferred to 
a new tube. The protein concentration was determined by Bradford assay and 700 µg 
protein in 700 µl wash buffer (components listed below) was used for the Co-IP. 30 µl 
magnetic beads (Dynabeads™ M-280 Tosyl-activated, Invitrogen, 14203) coupled to the 
appropriate antibody according to manufacturer’s protocol were washed 3 times with wash 
buffer for 3 min each. Magnetic beads were pelleted with the help of a magnetic rack 
(DynaMag-2 magnet, Invitrogen, 12321D) and the washes were removed by flipping tubes 
attached to the magnet. Beads were incubated with the protein for 1 h at 4°C on a rotator. 
Unbound sample was removed and 30µl sample was collected for a Western Blot. Beads 
were washed 6 times by rotating for 5 min in-between. Proteins were eluted by adding 50 
µl 2x Laemmli and boiling at 95°C for 10 min. Tubes were attached to the magnetic rack to 
remove the eluate. 30 µg total protein, 30 µg unbound sample and half of the eluate were 
analyzed by SDS-PAGE and Western Blotting.  
Table 19: Lysis buffer for IP with magnetic beads 
quantity ingredients 
25 mM  Tris pH 7.5 
0.1% IGEPAL 
0.5 mM DTT 
100U RNasin 
100 µl of 1 pill complete Mini, EDTA-free in 1 ml H2O per 1x109 cells 
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Table 20: 200x DNase buffer 
quantity ingredients 
500 mM  MgCl2 
100 mM CaCl2 
 
Table 21: Stop solution 
quantity ingredients 
250 mM EDTA 
250 mM EGTA 
 
Table 22: Wash buffer 
quantity ingredients 
25 mM  Tris pH 7.5 
0.1% IGEPAL 
0.5 mM DTT 
100U RNasin 
200 mM KCl 
 
4.18. Mass Spectrometry analysis 
Proteins that co-purified with BFR1L, Tb927.8.1500, Tb927.7.3040 and Tb927.11.4900 
were analyzed in three independent experiments by LC/MS by the ZMBH Mass 
Spectrometry facility. Cell lines expressing TAP-GFP served as control for TAP-BFR1L pull-
down. V5-BFR1L served as control for V5-Tb927.8.1500, V5-Tb927.7.3040 and V5-
Tb927.11.4900. Raw data were analyzed using MaxQuant 1.5.8.3, with label-free 
quantification (LFQ), match between runs (between triplicates), and the iBAQ algorithm 
enabled. The identified proteins were filtered for known contaminants and reverse hits, as 
well as hits without unique peptides. Statistical analysis was performed in Perseus (Tyanova 
et al., 2016). Data were filtered for at least two valid values in at least one condition and 
remaining missing values were imputed with a normal distribution based on the whole data 
set (width = 0.3; shift = 1.8). We determined significant outlier with t-test statistics 
(permutation-based false discovery rate of 1% and S0 of 1).  
4.19. Yeast two-hybrid assay 
The ORFs of the genes of interest (ZC3H5, CAF1, Tb927.8.1500, Tb927.11.4900, 
Tb927.7.3040) were amplified by PCR and cloned into pBD-gate2 and pAD-GW (Maier et 
al., 2008). As negative controls the pGBKT7 plasmid containing Lamin and pAD-T7 were 
used. The pBD-gate2 plasmid was used as bait and contains an N-terminal-GAL4 DNA 
binding domain and a myc-tag. The pAD-GW plasmid was used as prey and contains an 
N-terminal fused GAL4 activation domain and a HA-tag. The Matchmaker Yeast Two-Hybrid 
System (Clontech) was used according to the manufacturer’s protocol for pairwise co-
transformation of the bait and prey plasmids into the AH109 yeast strain. Clones expressing 
the bait and prey plasmid were selected on double dropout medium (minimal SD medium 
lacking tryptophan and leucine). Positive interactions were indicated by the change to blue 
color on quadruple dropout medium (minimal SD media lacking tryptophan, leucine, 
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histidine and adenine) containing X-α-gal. Western Blotting confirmed the expression of the 
proteins containing the myc- and HA-tags. In addition, the plasmids were extracted (see 
DNA isolation of yeast) from the different clones and PCRs using primer pairs, which are 
specific for the different ORFs, were performed. The plasmids were also retransformed in 
DH5α for amplification and analyzed by Sanger sequencing.  
4.20. DNA isolation of yeast 
A yeast colony was inoculated in 500 µl SD medium overnight at 30°C by shaking at 250 
rpm. Cells were pelleted by centrifugation at 14000 rpm for 5 min. The pellet was 
resuspended in 40 µl SD medium and 10 µl Lyticase (5 units/µl, Sigma-Aldrich, L4025) was 
added and incubated at 37°C for 60 min by shaking at 250 rpm. 20 µl 10% SDS was added 
and vortexed for 1 min. Samples went through three freeze-thaw cycles at -20°C. Plasmids 
were then purified using the NucleoSpin Plasmid Purification Kit (Macherey-Nagel, 
740588.50) according to the manufacturer’s protocol.  
4.21. qPCR 
RNA was extracted using peqGold Trifast (peqLab) according to manufacturer’s protocol 
and cDNA was synthesized using Maxima First Strand cDNA synthesis kit for RT-qPCR 
(Thermo Scientific, K1671) according to manufacturer’s protocol. For qPCR the Luna 
Universal qPCR Master Mix (NEB, #M3003S) was used according to manufacturer’s 
protocol and samples were measured in triplicates using different cDNA concentrations. 
Tubulin was used as loading control and Ct values were normalized according to tubulin.   
4.22. Polysome fractionation 
On the day before the experiment, sucrose gradients were prepared out of 5 different 
sucrose solutions in polysome buffer (50%, 42.5%, 35%, 22.5% and 15%; components 
listed below) in polyallomer 14 x 89mm tubes (Beckman). To pour the gradients, 790μL of 
each sucrose solution was added sequentially in a polyallomer tube, starting with 50% 
sucrose. Tubes were covered with aluminum foil and frozen at -80°C for 20min, before 
adding the next sucrose solution. In the evening before the polysome fractionation 
experiment, gradients were transferred to the cold room to thaw them. 5x108 cells per 
gradient were collected by centrifugation at 3000 rpm for 15 min.  The cell pellet was 
resuspended in 50 ml serum-free medium and transferred to a 50 ml conical tube. The cells 
were incubated with 100µg/ml Cycloheximide for 7 min at RT. Cells were pelleted by 
centrifugation at 2300 rpm for 7 min at 4°C and washed with 1 ml ice-cold 1x PBS and 
transferred to an Eppendorf tube. Cells were lysed in 350 µl lysis buffer (components listed 
below) and passed 15 times through the 21-gauge needle using a 1 ml syringe and then 15 
times through the 27-gauge needle. The lysate was cleared by centrifugation at 15000 g for 
10 min at 4°C in a microfuge. Salt concentration was adjusted to 120 mM KCl and the lysate 
was loaded on the 4 ml continuous linear 15-50% sucrose gradient. The gradients were 
centrifuged at 40000 rpm in the Beckmann SW60 centrifuge for 2h at 4°C using the swinging 
bucket rotor. Afterwards, 16 fractions with a volume of 300 µl were collected by fractionation 
with the UV/VIS detector (Teledyne Isco). For RNA purification, 900μL TriFast was added 
to each tube and RNA was purified as described above. 
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Table 23: Polysome buffer 
quantity ingredients 
20 mM  Tris pH 7.5 
2 mM  MgCl2 
10 µg/ml Leupeptin 
1 mM DTT 
100 µg/ml Cycloheximide 
120 mM KCl 
 
Table 24: Lysis buffer polysome fractionation 
quantity ingredients 
20 mM  Tris pH 7.5 
20 mM  KCl 
2 mM   MgCl2 
2 mM DTT 
1000U RNasin 
10 µg/ml Leupeptin 
0.2% IGEPAL 
200 mM sucrose 
100 µg/ml Cycloheximide 
1 pill complete Mini, EDTA-free per 1x109 cells 
 
4.23. FACS analysis 
2x107 cells were collected by centrifugation (1500 rpm, 10 min, 4°C). Cells were washed 
twice with 5 ml cold TDB buffer (components listed below) + 2 mM EDTA and finally 
resuspended in 200 µl TDB buffer + 2 mM EDTA in a 15 ml conical tube. Cells were fixed 
by adding 2ml of ice-cold 70% ethanol dropwise while vortexing on high speed. Cells can 
be stored at 4°C. Nuclear and kinetoplast DNA was stained with Propidium iodide for FACS 
analysis. 1 ml of cells in 70% Ethanol were pelleted by centrifugation (1500 rpm, 10 min, 
4°C) and resuspended in 500 µl staining solution (components listed below). Cells were 
incubated for 30 min at 37°C and then directly analyzed by FACS. 
Table 25: TDB buffer 
quantity ingredients 
20 mM Na2HPO4 
2 mM NaH2PO4 
80 mM NaCl 
1 mM MgSO4 
20 mM Glucose 
5 mM KCl 
 
Table 26: Propidium iodide staining solution (per ml) 
quantity ingredients 
930 µl 1x PBS + 2 mM EDTA 
20 µl RNAse A (10 mg/ml) 
50 µl Propidium iodide (1 mg/ml) 
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4.24. Genomic DNA extraction 
The cells were lysed in EB buffer in presence of RNAse A. 5 M ammonium acetate was 
used to precipitate proteins and cells debris. The DNA was then precipitated with 
isopropanol, washed with ethanol and resuspended in water.  
Table 27: EB buffer 
quantity ingredients 
10 mM Tris-HCl pH 8 
10 mM NaCl 
10 mM EDTA 
5% SDS 
 
4.25. Oligonucleotide list 
Table 28: Oligonucleotide list 
number explanation sequence 
a14150 fwd; 400 nt insert of Tb927.10.14150 used 
for RNAi (S. Lueong) 
CACGATCCGCGGATGAGCAAGACAGAGAC 
GG 
a14150 rev; 400 nt insert of Tb927.10.14150 used 
for RNAi (S. Lueong) 
CACGATTCTAGAGCCTCGTCGAACTCCTC 
CZ2351 rev; for colony PCR of p2T7 with insert  CCGCTCTAGAACTAGTGGA 
CZ2698 rev; CAT probe GAAAGACGGTGAGCTGGT 
CZ3634 fwd; CAT GCCGCTGGCGATTCAG 
CZ3634 fwd; CAT, also for CmR fwd in empty Y2H 
plasmids 
GCCGCTGGCGATTCAG 
CZ3798 fwd; Tubulin for qPCR   
CZ3799 rev; Tubulin for qPCR   
CZ4049 fwd; beta-Tubulin AGGCTGGCCAATGCGGTAAC 
CZ4051 rev; beta-Tubulin CTCCGTGCACCAACTTGTGG 
CZ4490 spliced leader for 5'end labelling CAATATAGTACAGAAACTGTTCTAATAATAGC
GTTAGT 
CZ4615 fwd; CAT NB probe ATGGAGAAAAAAATCATCGGATAT 
CZ4650 fwd; pray (AD) for sequencing   
CZ4651 fwd; bait for sequencing   
CZ5184 rev; pHD1146 sequencing TCATCCAACAAATTAAACTGCAG 
CZ5496 fwd; Tb927.7.2780 ATGTCTAAAGCTCCTTCGCAA 
CZ5497 rev; Tb927.7.2780 CTGAGACAATCCATTAACTCC 
CZ5598 fwd; pray (AD) for sequencing   
CZ5711 rev; Actin GGCATAGGGCTGAGTACAGGCACCAC 
CZ6020 fwd; 400 nt Tb927.10.14150 mini-ORF for 
TAP-tagging, HindIII-site 
GATCAAGCTTCCATGAGCAAGACAGAGACG 
CZ6021 rev; 400 nt Tb927.10.14150 mini-ORF for 
TAP-tagging, ApaI-site 
GATCGGGCCCGCCTCGTCGAACTCCTC  
CZ6022 fwd; 400 nt Tb927.10.14150 5'UTR for Tap-
tagging, SacI-site 
GATCGAGCTCTTGCCACCATTTGAATTTA  
CZ6023 rev; 400 nt Tb927.10.14150 5'UTR for Tap-
tagging, NdeI-site 
GATCCATATGTGCTGCTGATGCTTTTTG  
CZ6093 fwd; AttL1universal primer for 2nd PCR, 
Gateway 
CCCCGATGAGCAATGCTTTTTTATAATGCCAA 
CTTTGTACAAAAAAGCAGGCTCCAT 
CZ6094 rev; AttL1universal primer for 2nd PCR, 
Gateway 
GGGGGATAGCAATGCTTTCTTATAATGCCA 
ACTTTGTACAAGAAAGCTGGGT 
CZ6183 fwd; 300 nt Tb927.10.14150 5'UTR, XhoI-
site 
GATCCTCGAGTCCCTTTTTTTTTCTGCTCT 
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CZ6184 rev; 300 nt Tb927.10.14150 5'UTR, HindIII-
site 
GATCAAGCTTTGCTGCTGATGCTTTTTGG 
CZ6185 fwd; 300 nt Tb927.10.14150 3'UTR, EcoRI-
site 
GATCGAATTCAATAATTGTGTCGTGAGGTA 
CZ6186 rev; 300 nt Tb927.10.14150 3'UTR, SacII-
site 
GATCCCGCGGCCCAATAATATTCAACGTGA 
CZ6233 fwd; 5'UTR 14150 to test the replacement of 
Tb927.10.14150 by BLA 
CCGACGATAGCGCCATGTGTTTG 
CZ6234 rev; BLA ATGATATACATTGACACCAGTGAAGATGC 
CZ6235 fwd; BLA CTGACTTGTATCGTCGCGATCGGAAATG 
CZ6236 rev; 3'UTR 14150 to test the replacement of 
Tb927.10.14150 by BLA 
CACCTTCTCACTAACCAGTTGATTGTTAT 
CZ6252 fwd; 300 bp end of Tb927.10.14150 CDS, 
KpnI-site 
GATCGGTACCCAAGCCAATAAAGCAAAGAGG 
GATTC 
CZ6253 rev; 300 bp end of Tb927.10.14150 CDS, 
XhoI-site 
GATCCTCGAGCGCAAAATCCTCCCCCTCTCC 
CZ6254 fwd; 300 bp beginning of Tb927.10.14150 
3'UTR, BamHI-site 
GATCGGATCCATAATTGTGTCGTGAGGTAGG 
GATGTTGC 
CZ6255 rev; 300 bp beginning of Tb927.10.14150 
3'UTR, NotI-site 
CCCCAATAATATTCAACGTGATATTCTTTTTT 
CCGCGGCCGCGATC 
CZ6379 rev; Tb927.10.14150 5'UTR for Tap-tagging, 
NdeI-site plus ClaI-site 
GATCCATATGGATCATCGATTGCTGCTGATG
CTTTTTG 
CZ6415 rev; 400 nt Tb927.10.14150 5'UTR for Tap-
tagging, NdeI-site plus NotI-site 
GATCCATATGGATCGCGGCCGCTGCTGCTGA
TGCTTTTTG 
CZ6417 fwd; 400 nt Tb927.10.14150 5'UTR for Tap-
tagging, SacI-site plus HpaI-site 
GATCGAGCTCGATCGTTAACTTGCCACCATTT 
GAATTTA  
CZ6418 fwd; RNAi stemloop Tb927.10.14150 GATCAAGCTTAGATCTCAGCGCAAAGATCAC 
CAGTA 
CZ6419 rev; RNAi stemloop Tb927.10.14150 GATCGTCGACGAATTCATTGGCTTGTTGCTT 
CTGCT 
CZ6497 fwd; RT-PCR Tb927.4.1860 CDS CCTGAGATTACAACTCGCGC 
CZ6498 rev; RT-PCR Tb927.4.1860 CDS ACTTTGCCTTTGTCTCAGCG 
CZ6505 fwd; RT-PCR Tb927.9.7590 CDS CTGACACAGGTTCCTTTGGC 
CZ6506 rev; RT-PCR Tb927.9.7590 CDS TTCATGGCCTCCTCCTTACG 
CZ6512 fwd; Puro resistance, HindIII-site GATCAAGCTTATGACCGAGTACAAGCCCA 
CZ6513 rev; Puro resistance, EcoRI-site GATCGAATTCATCAGGCACCGGGCTT 
CZ6538 fwd; BLA V5, XbaI-site TCTAGAATGGCCAAGCCTTTGTCT 
CZ6539 rev; BLA V5, XhoI-site CTCGAGCGTAGAATCGAGACCGAGGA 
CZ6548 fwd; Tb927.10.14150, beginning of CDS, 
EcoRI-site 
GATCGAATTCATGAGCAAGACAGAGA 
CZ6551 rev; ZC3H5 CCGCGGAGACACCCACCA  
CZ6557 fwd; Tb927.10.14150 beginning of CDS, 
ApaI-site 
GATCGGGCCCATGAGCAAGACAGAGAC 
CZ6570 fwd; Tb927.7.3040 ORF for Northern probe CTGTCACGGAGGAGGTGGAC 
CZ6571 rev; Tb927.7.3040 ORF for Northern probe ACCTTGTTGTTCTCCGGGGT 
CZ6572 fwd; Tb927.11.10340 ORF for Northern 
probe 
GGAGGAACAGGCGAGACTCA 
CZ6573 rev; Tb927.11.10340 ORF for Northern 
probe 
TATTGTGGGACACGCCAATG 
CZ6574 fwd; Tb927.3.1660 ORF for Northern probe GTCGAGCGGAGTGGTAGTGG 
CZ6575 rev; Tb927.3.1660 ORF for Northern probe GCAACCACGAAAGCGAAAAG 
CZ6578 rev; Tb927.7.3040 CGACTCCACTGGTTTGCT 
CZ6580 rev; Tb927.11.4900 GCTCATTGTCAGGAAGCTG 
CZ6639 rev; Tb927.10.14150, end of CDS, BamHI-
site 
GATCGGATCCCGCAAAATCCTCCCCCC 
CZ6640 fwd; RT-PCR Tb927.11.14020 TTGTCAGTGCTCAGATCCGT 
CZ6641 rev; RT-PCR Tb927.11.14020 CCTTCACAAACTTCTGCGCT 
CZ6642 fwd; RT-PCR Tb927.9.3920 GAGTCCCCGTCACAAGAAGA 
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CZ6643 rev; RT-PCR Tb927.9.3920 ACTTGTAGACGTGGGCAAGA 
CZ6644 fwd; RT-PCR Tb927.7.2340 CGAACATTACACAGGAGCGG 
CZ6645 rev; RT-PCR Tb927.7.2340 TGGCCAATCATCTCACCCTT 
CZ6683 fwd; AttL1-Tb927.7.3040 primer for 1st 
PCR, Gateway 
AAAGCAGGCTCCATGATTGACCCATTTCGC 
CZ6684 rev; AttL1-Tb927.7.3040 primer for 1st PCR, 
Gateway 
GTACAAGAAAGCTGGGTTCAGTCTCTCACGG 
AATACA 
CZ6685 fwd; AttL1-Tb927.11.4900 primer for 1st 
PCR, Gateway 
AAAGCAGGCTCCATGATGCGAATCAAGGTAG
ACG 
CZ6686 rev; AttL1-Tb927.11.4900 primer for 1st 
PCR, Gateway 
GTACAAGAAAGCTGGGTTTACGCAGCATAC 
GCTTC 
CZ6691 fwd; AttL1-Tb927.10.14150 primer for 1st 
PCR, Gateway 
AAAAAGCAGGCTCAATGAGCAAGACAGAGAC 
CZ6723 rev; AttL1-Tb927.10.14150 primer for 1st 
PCR, Gateway 
AGAAAGCTGGGTTACGCAAAATCCTCCCCCT 
CZ6724 rev; Tb927.10.14150, NotI-site GATCGCGGCCGCTGCAGCTCCTGCAAGTA 
CZ6725 fwd; Hygro resistance, SacI-site GATCGAGCTCATGAAAAAGCCTGAACTCA 
CZ6726 rev; Hygro resistance, BstBI-site GATCTTCGAACTATTCCTTTGCCCTCGGA 
CZ6727 fwd; Hygro resistance, NdeI-site GATCCATATGATGAAAAAGCCTGAACTCA 
CZ6732 fwd; Puro resistance, NdeI-site GATCCATATGACCGAGTACAAGCCCAC 
CZ6733 rev; Puro resistance, BstBI-site GATCTTCGAATCAGGCACCGGGCTTGC 
CZ6764 fwd; end of Tubulin AGGTACTAGCACCACTAAC 
CZ6782 fwd; AttL1-Tb927.11.4900 primer for 1st 
PCR, Gateway 
AAAAAGCAGGCTCAATGCGAATCAAGGTA 
GAC 
CZ6783 rev; AttL1-Tb927.11.4900 primer for 1st 
PCR, Gateway 
AGAAAGCTGGGTTTACGCAGCATACGCTT 
CZ6784 fwd; AttL1-Tb927.7.3040 primer for 1st 
PCR, Gateway 
AAAAAGCAGGCTCAATGATTGACCCATTTC 
GCT 
CZ6785 rev; AttL1-Tb927.7.3040 primer for 1st PCR, 
Gateway 
AGAAAGCTGGGTTCAGTCTCTCACGGAATAC 
CZ6786 fwd; AttL1-Tb927.8.1500 primer for 1st 
PCR, Gateway 
AAAAAGCAGGCTCAATGGCAATGCAGTTAT 
TTA 
CZ6787 rev; AttL1-Tb927.8.1500 primer for 1st PCR, 
Gateway 
AGAAAGCTGGGTTCAGTCATCGCAGATTC 
CZ6823 fwd; G418 CACCCGCGCTGGGTGGAAAGCTAGCTTTA 
ATTTGTTGGATGAGCTATTTCATTAATTTTT 
TTG 
CZ6824 rev; G418 CACCTGTGGCGCCGGTGATGCCGGCAATA 
CTGCATAGATAACAAACGCATC 
CZ6825 fwd; Tb927.8.1500 5'UTR CGACGTTGTAAAACGACGGCCAGTGAATT 
CCTTTAAGCATCTCTCTGTAGTAGGGTTATG 
CZ6826 rev; Tb927.8.1500 5'UTR ATTCTTCTTGAGACAAAGGCTTGGCCATTGC 
CCAGAAGATGCTGTATCC 
CZ6827 fwd; Tb927.8.1500 ORF CCCTCTCCTCGGTCTCGATTCTACGATGGCA 
ATGCAGTTATTTACCTTTGG 
CZ6828 rev; Tb927.8.1500 ORF AACAGCTATGACCATGATTACGCCAAGCTTC 
CGCGTAAGCAAGCAGTT 
CZ6829 fwd; Tb927.11.4900 5'UTR TTGTAAAACGACGGCCAGTGAATTCATTTTT 
GTTCTTTTCCATCATC  
CZ6830 rev; Tb927.11.4900 5'UTR GCTTGGCCATTTCCCTTCCTTATTTCCTTG  
CZ6831 fwd; BLA-V5-Tb927.11.4900 AGGAAGGGAAATGGCCAAGCCTTTGTCTC  
CZ6832 rev; BLA-V5-Tb927.11.4900 TGATTCGCATCGTAGAATCGAGACCGAG  
CZ6833 fwd; Tb927.11.4900 ORF CGATTCTACGATGCGAATCAAGGTAGACG  
CZ6834 rev; Tb927.11.4900 ORF CTATGACCATGATTACGCCAAGCTTCTGCA 
ATCCAGACGACGC  
CZ6835 fwd; Tb927.7.3040 5'UTR TTGTAAAACGACGGCCAGTGAATTCACCGA 
CTGACCGAAGTTTAG  
CZ6836 rev; Tb927.7.3040 5'UTR GCTTGGCCATCTAGGACAGTTTCCTACTT 
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GAC  
CZ6837 fwd; BLA-V5-Tb927.7.3040 ACTGTCCTAGATGGCCAAGCCTTTGTCTC  
CZ6838 rev; BLA-V5-Tb927.7.3040 GGTCAATCATCGTAGAATCGAGACCGAG  
CZ6839 fwd; Tb927.7.3040 ORF CGATTCTACGATGATTGACCCATTTCGC  
CZ6840 rev; Tb927.7.3040 ORF CTATGACCATGATTACGCCAAGCTTATACA 
TTTTGCAACACATTC  
CZ6843 fwd; Tb927.7.3040 ORF, AttB site GGGACAAGTTTGTACAAAAAAGCAGGCTCCT 
GTCACGGAGGAGGTGGAC 
CZ6845 fwd; Tb927.11.4900 ORF, AttB site GGGACAAGTTTGTACAAAAAAGCAGGCTCCC 
ATGCACGTTATACCGGAC 
CZ6847 fwd; Tb927.8.1500 ORF, AttB site GGGACAAGTTTGTACAAAAAAGCAGGCTCCC 
CCATCGCCTTGAAGATTG 
CZ6849 fwd; ZC3H5 ORF, AttB site GGGACAAGTTTGTACAAAAAAGCAGGCTCGG 
GGAACACAAACAGGTAGC 
CZ6850 rev; ZC3H5 ORF, AttB site ACCCAGCTTTCTTGTACAAAGTGGTCCCCCA 
TTCACCTGCACTGTTCC 
CZ6855 fwd; Tb927.2.4550, NB probe CGGATGGTTTTACGCACGAT 
CZ6856 rev; Tb927.2.4550, NB probe CCTTCGTCTTCCCCTTCACT 
CZ6871 rev; Tb927.7.3040 ORF, AttB site GGGACCACTTTGTACAAGAAAGCTGGGTAC 
CCCGGAGAACAACAAGGT 
CZ6872 rev; Tb927.11.4900 ORF, AttB site GGGACCACTTTGTACAAGAAAGCTGGGTCG 
CGTGAACATATCCAACGT 
CZ6873 rev; Tb927.8.1500 ORF, AttB site GGGACCACTTTGTACAAGAAAGCTGGGTTT 
GCTGCTATTGTTGCCGTT 
CZ6876 rev; ZC3H5 ORF, AttB site GGGACCACTTTGTACAAGAAAGCTGGGTCCA 
TTCACCTGCACTGTTCC 
CZ6877 fwd; ZC3H5, NB probe GGGGAACACAAACAGGTAGC 
CZ6878 rev; ZC3H5, NB probe CCATTCACCTGCACTGTTCC 
CZ6879 fwd; BLA-V5-Tb927.8.1500 GGATACAGCATCTTCTGGGCAATGGCCAAG 
CCTTTGTCT 
CZ6880 rev; BLA-V5-Tb927.8.1500 GTAAATAACTGCATTGCCATCGTAGAATCGA 
GACCGAGGA 
CZ6907 fwd; primer for sequencing of pGL 2084 AAAGTAGCGCTTACGGCGT 
CZ6908 rev; primer for sequencing of pGL 2084 ATTCCTGCAGGGGCCCT 
CZ6984 pre-18S rRNA TCAAGTGTAAGCGCGTGATCCGCTGTGG 
CZ6985 pre-5.8S rRNA CCATCGCGACACGTTGTGGGAGCCG 
CZ6990 fwd; Puromycin, EcoRI-site GATCGAATTCATGACCGAGTACAAGCCC 
CZ6991 rev; Puromycin, NcoI-site GATCCCATGGATCAGGCACCGGGCTTG 
CZ6992 fwd; G418, EcoRI-site GATCGAATTCATGATTGAACAAGATGGA 
CZ6993 rev; G418, NcoI-site GATCCCATGGTCAGAAGAACTCGTCAAG 
CZ7032 fwd; V5-Tb927.11.4900, BamHI-site GATCGGATCCATGGGTAAGCCTATCCCTAA 
CCCTCTCCTCGGTCTCGATTCTACGATGCG 
AATCAAGGTAGACG 
CZ7033 rev; Tb927.11.4900, EcoRI-site GATCGAATTCCGCAGCATACGCTTCAGTC 
CZ7053 rev; G418, SalI-site GATCGTCGACTCAGAAGAACTCGTCAAG 
CZ7079 rev; RNAi Tb927.7.3040, BamHI-site GATCGGATCCACCCCGGAGAACAACAA 
CZ7080 fwd; RNAi Tb927.7.3040, XhoI-site GATCCTCGAGCTGTCACGGAGGAGGTG 
CZ7129 fwd; Tb927.10.10350 for qPCR TGCACCGGGACATCAAGGGG 
CZ7130 rev; Tb927.10.10350 for qPCR CCGTAACCTCCAGCCTCGCC 
CZ7133 fwd; Tb927.10.7880 for qPCR GCGGGAGGAAGATGCGGAGG 
CZ7134 rev; Tb927.10.7880 for qPCR CGGAGGGCCTCGATGAGACG 
CZ7135 fwd; Tb927.11.10900 for qPCR GAGGCCCTCAACGAGCGACA 
CZ7136 rev; Tb927.11.10900 for qPCR CATCACACACTGCGCGCGTT 
CZ7137 fwd; Tb927.9.15050 for qPCR GTGACCGGGACAAGGCGGAG 
CZ7138 rev; Tb927.9.15050 CAAGGGTCCGTTCGGCCTCA 
CZ7141 fwd; Tb927.11.5810 for qPCR TCCCAACAGCAGTCGACCGC 
CZ7142 rev; Tb927.11.5810 for qPCR ACCACCTCCACGCTGCCCTA 
G1887 fwd; ß-Globin (AG Stoecklin) TCAGATCGCCTGGAGACG 
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G1888 rev; ß-Globin (AG Stoecklin) CTTGAGCATCTGACTTCTGGCT 
N1Tb927. 
10.14150 
fwd; for N-terminal V5-tagging of 
Tb927.10.14150 (S. Lueong) 
TAGATTGAGGAAGTTGCCTCATTAATTTGCAC 
GATTAGTGTACCAAGGGGGAAAGGTTCTGCC 
AAAAAGCATCAGCAGCAATGGCCAAGCCTTT 
GTCTCAAG 
N1Tb927. 
10.14150 
rev; for N-terminal V5-tagging of 
Tb927.10.14150 (S. Lueong) 
GGAGCTGTCATCCACCGCGGTTGAGGACGC 
CTTTCCGTCGGCGCGGGCGCAGCTTCAGGT 
GCCGTCTCTGTCTTGCTCATCGTAGAATCGA 
GACCGAGGAGAGG 
  rev; T7 TAATACGACTCACTATAGGG 
  fwd; T3 AATTAACCCTCACTAAAGGG 
  fwd; T7 TAATACGACTCACTATAGGG 
  fwd; AttB universal primer GGGACAAGTTTGTACAAAAAAGCAGGCTC 
  rev; AttB universal primer GGGACCACTTTGTACAAGAAAGCTGGGT 
  fwd; lambda ACCAAAAAGTAAAATTCACAAGCTTATGGACG 
CACAAACACGACGAC 
  fwd; ß-Globin for NB probe GGTGAAGGCTCATGGCAAG 
  fwd; RNAi Tb927.11.4900 GGGGACAAGTTTGTACAAAAAAGCAGGCTCA 
GAGGGTTCTAAAAAACAATCG 
  rev; RNAi Tb927.11.4900 GGGGACCACTTTGTACAAGAAAGCTGGGTA 
TAGTTTTTGTCTGTTTCCAACTC 
  fwd; Tb927.11.4900 over expression ACCAAAAAGTAAAATTCACAAGCTTATGGGC 
GGCCGATCGAGATCC 
  rev; Tb927.11.4900 over expression AAAGCCAACTAAATGGGCAGGATCCTTAC 
GCAGCATACGCTTCAGTCTCAGG 
 
4.26. Plasmid list 
Table 29: Plasmid list 
pHD  
number 
plasmid selection marker 
2211 N-terminal V5-Caf1; endogenous Blasticidin 
2268 C-terminal Caf1-myc; overexpression Hygromycin 
2801 p2T7 Tb927.10.14150 RNAi  Hygromycin 
2876 pMOtag33M + Tb927.10.14150; C-terminal myc-tag G418 
2877 for SKO of Tb927.10.14150 Blasticidin 
2878 TAP-Tb927.10.14150 Puromycin 
2879 tethering, lambda myc-Tb927.10.14150 Hygromycin 
2899 pDonr + Tb927.10.14150; Gateway donor vector   
2900 for SKO of Tb927.10.14150 Puromycin 
2902 stem loop RNAi Tb927.10.14150 Hygromycin 
2906 Y2H; pGBKT7 + Tb927.10.14150 Kanamycin 
2907 C-terminal myc-tagged Tb927.101.4150;  
overexpression 
Hygromycin 
2928 eYFP-ZC3H5 Puromycin 
2932 TAP-ZC3H5 Blasticidin 
2941 pRPa+6myc+ZC3H5 Hygromycin 
2942 pHD617GW+lambda myc+Tb927.11.4900 Hygromycin 
2943 pHD2907+Tb927.10.14150 Hygromycin 
2945 pHD2944+ZC3H5 Hygromycin 
2946 pHD2944+Tb927.7.3040 Hygromycin 
2948 eYFP + Tb927.10.14150 Blasticidin 
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2949 Y2H; pGBKCg+Tb927.10.14150; C-terminal   
2964 pHD1991+ZC3H5 RNAi G418 
2965 pBD + Tb927.8.1500   
2969 pBD+TB927.7.3040   
2971 pAD-GW-Tb927.8.1500   
2972 pAD-GW-Tb927.7.3040   
2991 pBD-GW-Tb927.11.4900   
2992 pAD-GW-Tb927.11.4900   
2993 pHD617-lambda-myc-Tb927.8.1500 Hygromycin 
2996 V5-Tb927.11.4900 Blasticidin 
2998 pGL2084+G418 G418 
2999 pUC19+Bla-V5+Tb927.7.3040 Blasticidin 
3020 pUC19+Bla-V5+Tb927.8.1500 Blasticidin 
3024 ZC3H5 RNAi Hygromycin 
3025 Tb927.11.4900 RNAi Hygromycin 
3026 Tb927.8.1500 RNAi Hygromycin 
3035 TAP-ZC3H5 Puromycin 
3036 Tb927.8.1500 RNAi G418 
3050 TAP-ZC3H5 G418 
p2370 pTET-7Bx; for in vitro transcription of beta-Globin;  
from AG Stoecklin 
  
p2829 eYFP + Dhh1; from Susanne Kramer Blasticidin 
p2845 mCherry- Dhh1; from Susanne Kramer Blasticidin 
p3295 PABP2+eYFP; from Susanne Kramer G418 
3137 pAD-GW-ZC3H5   
  pAD + T control   
 2248 pBD-Caf1   
2251 pAD-Caf1   
2342 pHD1743+Caf1   
3138 pBD-GW-ZC3H5   
  pBD-Lamin (Y2H control)   
  pGBK p53   
3139 pHD1146 + ZC3H5 Hygromycin 
  Tb927.7.3040 RNAi Hygromycin 
  pBS-BLA-V5 Blasticidin 
 3140 BP14150 pDonor   
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4.27. Plasmid maps 
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4.28. Web resources 
TriTrypDB   http://tritrypdb.org 
GeneDB    http://www.genedb.org 
BLAST NCBI    http://blast.ncbi.nlm.nih.gov/Blast.cgi 
TrypTag   http://tryptag.org/?pageType=landing 
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Supplementary Figure 1: Sequence analysis of Tb927.10.14150. Sequences of Tb927.10.14150 
homologues were compared using Clustal Omega. Low complexity regions are marked in grey. The 
asterisk (*) marks fully conserved residue. Colon (:) marks conservation between amino acid groups 
with similar properties. Period (.) marks conservation between amino acid groups of weakly similar 
properties. 
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Supplementary 2 
 
Supplementary Figure 2: Domains and localization of Tb927.9.9550. A. Domains of 
Tb927.9.9550. LC: Low complexity region. TMHMM: Transmembrane domain. B. TrypTag images 
of C-terminally GFP-tagged Tb927.9.9550 (green). Nucleus and Kinetoplast were stained with 
Hoechst (cyan) (Dean et al., 2017). 
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Supplementary Figure 3: Sequence analysis of Tb927.9.9550. Sequences of Tb927.9.9550 
homologues in Kinetoplastida were compared using Clustal Omega. Low complexity regions are 
marked in grey and transmembrane domain is marked in blue. The asterisk (*) marks fully conserved 
residue. Colon (:) marks conservation between amino acid groups with similar properties. Period (.) 
marks conservation between amino acid groups of weakly similar properties. 
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Supplementary Figure 4: Sequence analysis of ZC3H5. Sequences of ZC3H5 homologues in 
Kinetoplastida were compared using Clustal Omega. Low complexity regions are marked in grey 
and zinc finger domain is marked in red. The asterisk (*) marks fully conserved residue. Colon (:) 
marks conservation between amino acid groups with similar properties. Period (.) marks 
conservation between amino acid groups of weakly similar properties. 
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Supplementary Figure 5: Sequence analysis of Tb927.11.4900. Sequences of Tb927.11.4900 
homologues in Kinetoplastida were compared using Clustal Omega. WD40 domains are marked in 
green. The asterisk (*) marks fully conserved residue. Colon (:) marks conservation between amino 
acid groups with similar properties. Period (.) marks conservation between amino acid groups of 
weakly similar properties.  
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Supplementary Figure 6: Sequence analysis of Tb927.7.3040. Sequences of Tb927.7.3040 
homologues in Kinetoplastida were compared using Clustal Omega. WD40 domains are marked 
in grey. The asterisk (*) marks fully conserved residue. Colon (:) marks conservation between 
amino acid groups with similar properties. Period (.) marks conservation between amino acid 
groups of weakly similar properties.  
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Supplementary Figure 7: Sequence analysis of Tb927.8.1500. Sequences of Tb927.8.1500 
homologues in Kinetoplastida were compared using Clustal Omega. Low complexity regions are 
marked in grey. The asterisk (*) marks fully conserved residue. Colon (:) marks conservation 
between amino acid groups with similar properties. Period (.) marks conservation between amino 
acid groups of weakly similar properties.  
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Supplementary 8 
 
Supplementary Figure 8: Tb927.11.4900 is a putative G-protein. Sequence of Tb927.11.4900 
with the G-domains in the circular permutation of G4-G5-G1-G2-G3 and the WD40-domains. 
